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A B S T R A C T
Background
Specialised diseasemanagement programmes for heart failure aim to improve care, clinical outcomes and/or reduce healthcare utilisation.
Since the last version of this review in 2010, several new trials of structured telephone support and non-invasive home telemonitoring
have been published which have raised questions about their effectiveness.
Objectives
To review randomised controlled trials (RCTs) of structured telephone support or non-invasive home telemonitoring compared to
standard practice for people with heart failure, in order to quantify the effects of these interventions over and above usual care.
Search methods
We updated the searches of the Cochrane Central Register of Controlled Trials (CENTRAL), Database of Abstracts of Reviews of
Effects (DARE), Health Technology AsseFssment Database (HTA) on the Cochrane Library; MEDLINE (OVID), EMBASE (OVID),
CINAHL (EBSCO), Science Citation Index Expanded (SCI-EXPANDED), Conference Proceedings Citation Index- Science (CPCI-
S) on Web of Science (Thomson Reuters), AMED, Proquest Theses and Dissertations, IEEE Xplore and TROVE in January 2015. We
handsearched bibliographies of relevant studies and systematic reviews and abstract conference proceedings. We applied no language
limits.
Selection criteria
We included only peer-reviewed, published RCTs comparing structured telephone support or non-invasive home telemonitoring to
usual care of people with chronic heart failure. The intervention or usual care could not include protocol-driven home visits or more
intensive than usual (typically four to six weeks) clinic follow-up.
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Data collection and analysis
We present data as risk ratios (RRs) with 95% confidence intervals (CIs). Primary outcomes included all-cause mortality, all-cause and
heart failure-related hospitalisations, which we analysed using a fixed-effect model. Other outcomes included length of stay, health-
related quality of life, heart failure knowledge and self care, acceptability and cost; we described and tabulated these. We performed
meta-regression to assess homogeneity (the null hypothesis) in each subgroup analysis and to see if the effect of the intervention varied
according to some quantitative variable (such as year of publication or median age).
Main results
We include 41 studies of either structured telephone support or non-invasive home telemonitoring for people with heart failure, of
which 17 were new and 24 had been included in the previous Cochrane review. In the current review, 25 studies evaluated structured
telephone support (eight new studies, plus one study previously included but classified as telemonitoring; total of 9332 participants), 18
evaluated telemonitoring (nine new studies; total of 3860 participants). Two of the included studies trialled both structured telephone
support and telemonitoring compared to usual care, therefore 43 comparisons are evident.
Non-invasive telemonitoring reduced all-cause mortality (RR 0.80, 95% CI 0.68 to 0.94; participants = 3740; studies = 17; I² =
24%, GRADE: moderate-quality evidence) and heart failure-related hospitalisations (RR 0.71, 95% CI 0.60 to 0.83; participants
= 2148; studies = 8; I² = 20%, GRADE: moderate-quality evidence). Structured telephone support reduced all-cause mortality (RR
0.87, 95% CI 0.77 to 0.98; participants = 9222; studies = 22; I² = 0%, GRADE: moderate-quality evidence) and heart failure-related
hospitalisations (RR 0.85, 95% CI 0.77 to 0.93; participants = 7030; studies = 16; I² = 27%, GRADE: moderate-quality evidence).
Neither structured telephone support nor telemonitoring demonstrated effectiveness in reducing the risk of all-cause hospitalisations
(structured telephone support: RR 0.95, 95% CI 0.90 to 1.00; participants = 7216; studies = 16; I² = 47%, GRADE: very low-quality
evidence; non-invasive telemonitoring: RR 0.95, 95% CI 0.89 to 1.01; participants = 3332; studies = 13; I² = 71%, GRADE: very
low-quality evidence).
Seven structured telephone support studies reported length of stay, with one reporting a significant reduction in length of stay in
hospital. Nine telemonitoring studies reported length of stay outcome, with one study reporting a significant reduction in the length of
stay with the intervention. One telemonitoring study reported a large difference in the total number of hospitalisations for more than
three days, but this was not an analysis of length of stay per hospitalisation. Nine of 11 structured telephone support studies and five of
11 telemonitoring studies reported significant improvements in health-related quality of life. Nine structured telephone support studies
and six telemonitoring studies reported costs of the intervention or cost effectiveness. Three structured telephone support studies and
one telemonitoring study reported a decrease in costs and two telemonitoring studies reported increases in cost, due both to the cost of
the intervention and to increased medical management. Adherence was rated between 55.1% and 98.5% for those structured telephone
support and telemonitoring studies which reported this outcome. Participant acceptance of the intervention was reported in the range
of 76% to 97% for studies which evaluated this outcome. Seven of nine studies that measured these outcomes reported significant
improvements in heart failure knowledge and self-care behaviours.
Authors’ conclusions
For people with heart failure, structured telephone support and non-invasive home telemonitoring reduce the risk of all-cause mortality
and heart failure-related hospitalisations; these interventions also demonstrated improvements in health-related quality of life and heart
failure knowledge and self-care behaviours. Studies also demonstrated participant satisfaction with the majority of the interventions
which assessed this outcome.
P L A I N L A N G U A G E S U M M A R Y
Structured telephone support and non-invasive telemonitoring in the management of people with heart failure
Review question
We reviewed the evidence about the effect of structured telephone support and non-invasive telemonitoring in themanagement of people
with heart failure. We found 41 studies. Two of the included studies trialled both structured telephone support and telemonitoring
compared to usual care, therefore 43 comparisons are evident. The evidence is current to January 2015.
Background
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In the context of limited health funding and a rapidly expanding population of older people, it is increasingly difficult for healthcare
systems to provide high-quality care to those with heart failure. Multidisciplinary specialist heart failure clinics are available only to a
minority of people and do not have the capacity for frequent patient review. Patients may be unwilling or unable to make frequent
clinic attendance due to cost, difficulty with transport or disability and frailty. Structured telephone support and telemonitoring can
provide specialised heart failure care to a large number of people with limited access to healthcare services.
Study characteristics
We include 41 full-text peer-reviewed studies of either structured telephone support or home telemonitoring in this review. Twenty-five
studies evaluate structured telephone support (eight new studies, plus one previously included study now classified as telemonitoring;
total of 9332 participants), 18 evaluated telemonitoring (nine new studies; total of 3860 participants) and two studies evaluated both
interventions (included in listed counts).
Key results
This review demonstrates that supporting people with heart failure at home using information technology can reduce the rates of death
and heart failure-related hospitalisation. It can improve people’s quality of life and knowledge about heart failure and self care. Most
patients, even those who are elderly, learn to use the technology easily and are satisfied with these interventions.
Quality of the evidence
We assessed the quality of the evidence for the primary outcomes in this review (all-cause mortality, all-cause hospitalisation and heart
failure-related hospitalisation) according to GRADE criteria. We rated it from very low (all-cause hospitalisations) to moderate (all-
cause mortality and heart failure-related hospitalisations).
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Impact of structured telephone support and telemonitoring in heart failure on all-cause mortality2
Patient or population: people with heart failure
Setting:
Intervention: structured telephone support or telemonitoring
Comparison: usual care
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with usual care Risk with Impact of
structured telephone
support and telemoni-
toring in CHF on all-
cause mortality
All-cause mor-
tality: Structured tele-
phone support versus
usual care
Study populat ion RR 0.87
(0.77 to 0.98)
9222
(22 RCTs) MODERATE 1
116 per 1000 101 per 1000
(89 to 113)
Moderate risk populat ion
109 per 1000 94 per 1000
(84 to 106)
All-cause
mortality: Telemonitor-
ing versus usual care
Study populat ion RR 0.80
(0.68 to 0.94)
3740
(17 RCTs) MODERATE 1
145 per 1000 116 per 1000
(99 to 136)
Moderate risk populat ion
155 per 1000 124 per 1000
(105 to 145)
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* The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95% CI).
CI: Conf idence interval; RR: Risk rat io.
GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
M oderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1Publicat ion bias strongly suspected.
2 Length of follow-up ranged f rom 3 months to 18 months for structured telephone support studies and 3 months to 26
months for telemonitoring studies.
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B A C K G R O U N D
A 2010 Cochrane review of structured telephone support or home
telemonitoring for people with heart failure (HF) concluded that
structured telephone support and telemonitoring were effective in
reducing the risk of all-cause mortality and heart failure related-
hospitalisations (Inglis 2010). Since then, doubt has been cast on
the efficacy of these interventions, due to publication of several
neutral studies (Anker 2011; Chaudhry 2010 (Tele-HF); Koehler
2011 (TIM-HF)). Current international heart failure guidelines
have so far not recommended widespread implementation of re-
mote monitoring due to these conflicting trial results (National
Heart Foundation of Australia 2011; Mant 2011; McMurray
2012; Yancy 2013) and have called for more research before rec-
ommending these interventions Ponikowski 2014. This review
sought to update the previous version by identifying and classi-
fying all peer-reviewed trials of structured telephone support or
non-invasive home telemonitoring published since the Inglis 2010
review.
Description of the condition
Heart failure (HF) is a complex, debilitating syndrome due to
cardiac dysfunction that impairs the ability of the ventricle to fill
with or eject blood. As a result, typical symptoms such as dyspnoea
and fatigue occur at rest or with reduced physical effort. Heart
failure often results from damage to the myocardium for which
the aetiology differs according to the population studied. In high-
income countries, hypertension and coronary heart disease are
the most important causes of heart failure (Cleland 2011; Gerber
2015; Maggioni 2013; Yusuf 2014). Hypertension is a risk factor
for coronary disease, which is the most common direct cause for
heart failure with reduced ejection fraction (HFrEF). Hyperten-
sion, often associated with atrial fibrillation, is the predominant
cause of heart failure with preserved ejection fraction (HFpEF).
In low- to middle-income countries, the syndrome is also often
the result of longstanding hypertension but cardiomyopathy and
rheumatic heart disease are also common. However, the incidence
of atherosclerotic disease is increasing in low- to middle-income
countries (Callender 2014b).Heart failure exerts a substantial bur-
den on healthcare systems, due to the high consumption of human
resources caused predominantly by repeated and lengthy admis-
sions to hospital (Dunlay 2014).
Ageing of populations will drive up the prevalence of heart failure
internationally, making it increasingly difficult to maintain the
quality of care. Switching resources from crisis management (by
hospitalising people) to health maintenance (through structured
telephone support or home telemonitoring) may be an affordable
method to maintain and improve the quality of care for heart
failure.
Pharmacological treatments, including angiotensin-converting
enzyme (ACE) inhibitors, angiotensin receptor blockers, an-
giotensin-receptor neprilysin inhibitors beta-blockers, aldosterone
antagonists and ivabradine, and devices such as implantable defib-
rillators and cardiac resynchronisation therapy, can improve symp-
toms and prolong survival in those with heart failure with reduced
left ventricular ejection fraction (LVEF) (McMurray 2012). In
people who are stable, mildly symptomatic (NYHA I - II) and op-
timally treated, annual mortality is 1.6% (Linde 2008), but it rises
up to 12% for those with moderate to severe symptoms (Cleland
2006a; Kjekshus 2007). Several projection models predict an in-
crease in the prevalence of HF and the number of HF hospitalisa-
tions by more than 20% in the next 20 years (Heidenreich 2013;
Stewart 2013).
FewerRCTsofmedicines or devices have been conducted inpeople
with heart failure with preserved LVEF (HFpEF) and none have
been conclusively positive (Cleland 2014b). RCTs in participants
with stable HFpEF suggest an annual mortality of 5% to 13%
(Cleland 2006b; MAGGIC 2012; Zile 2002) and a similar rate of
hospitalisations for worsening heart failure (Massie 2008).
For acute heart failure, no new treatments have been identified in
the last 40 years and much of clinical practice is opinion- rather
than evidence-based (Mebazaa 2015). In RCTs, six-month mor-
tality ranges from 11% to 24%, depending on age (Metra 2015).
Most trials of telemonitoring have focused on people with a re-
cent history of heart failure hospitalisation and have shown a high
mortality in those assigned to usual care, which is consistent with
the above.
The worse outcome of participants in epidemiological studies
compared to RCTs (Jhund 2009; Levy 2002) may reflect the strict
inclusion/exclusion criteria of randomised controlled trials, with
selection of better-educated participants with fewer comorbidities
and a lower likelihood that older and sicker people will agree to
be researched (Cleland 2007; Jhund 2009; Lenzen 2005). Also,
participants in trials are likely to be muchmore closely monitored,
and this may have a favourable influence on prognosis, consistent
with the evidence from trials of telemonitoring. However, perhaps
themost important reason why people in surveys have an outcome
similar to those in trials of acute heart failure is because that is the
point at which most people in surveys of heart failure are enrolled
(Cleland 2001). Surveys suggest that about 20% of participants
will die in the first year of new-onset heart failure (Harjola 2010;
Jhund 2009; Levy 2002). The mortality one year after an acute
exacerbation of chronic heart failure is about 30% (Harjola 2010),
but much worse in older people. Using National Audit data for
England and Wales, which captures an even broader population
admitted with heart failure, inpatient mortality ranges from less
than 5% in those aged under 65 years to almost 15% in those aged
over 84 years. Rates of death and readmission in the following
weeks are also high; 30-day mortality after discharge ranges from
under 10% in people aged less than 65 years to more than 25%
in those aged over 84 years, whilst 30-day rates for readmission
regardless of age run at about 15%, although only one-third are
primarily due to heart failure (Cleland 2003; Cleland 2011). In
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contrast to clinical trials, in epidemiological studies LVEFdoes not
appear to be a major determinant of prognosis, possibly because
people with heart failure with preserved ejection fraction are often
older and have more comorbidities (Bhatia 2006; Cleland 2007;
Cleland 2011; Owan 2006).
Description of the intervention
The effectiveness of multidisciplinary approaches to managing
people with heart failure has been demonstrated by meta-anal-
yses (Holland 2005; McAlister 2004) and specialist heart fail-
ure disease management programmes are recommended in best
practice guidelines (Mant 2011;McMurray 2012; National Heart
Foundation of Australia 2011; Yancy 2013).To date, trials of spe-
cialist, multidisciplinary heart failure management programmes
have tested multifaceted approaches (multidisciplinary input,
home/clinic visits, telephone support). As a consequence, it has
been difficult to identify the incremental benefits of the compo-
nents of each intervention (McAlister 2004; Yu 2006). Neverthe-
less, it is clear that within most populations access to these pro-
grammes is limited as a result of barriers related to funding or
accessibility (Clark 2005; Jaarsma 2006).
To meet the needs of heart failure populations who have dif-
ficulty accessing multidisciplinary heart failure disease manage-
ment programmes, alternative models of care have been proposed
and tested. These alternative models typically involve informa-
tion communication technology and may include self monitor-
ing and education delivered via standard telephone or more ad-
vanced telemonitoring technology (e.g. electronic transfer of phys-
iological data), electrocardiograph (ECG), blood pressure (BP),
weight, pulse oximetry, respiratory rate and medicine administra-
tion (Clark 2007a; Inglis 2010).
In this review, we classified programmes a priori as being ’struc-
tured telephone support’ if the monitoring or self-care manage-
ment or both were delivered using simple telephone technology
(data may have been collected and stored by a computer), and
’telemonitoring’ if there was digital/broadband/satellite/wireless or
blue-tooth transmission of physiological and other non-invasive
data. This review focuses only on non-invasive remote monitor-
ing of people with heart failure. We consider that there is signifi-
cant heterogeneity inmonitoring of people using non-invasive and
invasive technologies, in particular monitoring using implanted
therapeutic devices such as defibrillators; this will form a part of
future reviews.
We consider that structured telephone support and telemonitor-
ing are two similar but distinctly different interventions, and as
such we have reported outcomes for each intervention separately
rather than as either telemonitoring or structured telephone sup-
port. It should be noted that in the context of this review the term
’remote monitoring’ refers to the use of these technologies (struc-
tured telephone support or telemonitoring) outside of a heart-
failure specialist centre of care, and not necessarily remote in the
geographical sense. Most studies have been conducted in urban or
semi-rural populations in regions with high population densities.
In all studies of structured telephone support, having access to a
touch-tone telephone was an essential inclusion criterion.
How the intervention might work
Some studies have demonstrated a beneficial effect of remotemon-
itoring on mortality and morbidity in people with heart fail-
ure. The mechanisms by which improvements in outcomes with
these interventions is achieved are not clear, but may include en-
hanced self care by improving the person’s knowledge and adher-
ence through education and monitoring, higher prescription rates
of guideline-based medication by clinicians, or earlier interven-
tion when heart failure worsens. It might also be that recipients
find the presence of remote monitoring comforting and that it
reduces their anxiety and need for formal contact with healthcare
providers. A common finding is that participants in the active arm
of studies showing a benefit from telemonitoring are more likely
to be on higher doses of disease-modifying agents, which probably
mediates benefit (Abraham 2011; Antonicelli 2010; Cleland 2005
(Struct Tele) (TENS-HMS)). This makes sense; simply monitor-
ing a person will not modify the course of the disease unless action
results.
Structured telephone support and home telemonitoring are more
likely to be effective when delivery of care by conventional means
is deficient. Trials that select participants carefully and ensure that
treatment is optimal prior to randomisation may be less likely to
show a benefit from intervention. Thus, trials that randomly assign
individual participants to different strategies may place structured
telephone support and home telemonitoring at a disadvantage,
since care is likely to improve in those assigned to conventional
care.
Why it is important to do this review
In this era of rapidly advancing and wider community access and
adaptation to information technology, new trials of remote mon-
itoring interventions have been continually commissioned and
published. Results from earlier systematic reviews and meta-analy-
ses (Clark 2007a; Inglis 2010; Klersy 2009; Louis 2003;McAlister
2004) supported the beneficial effect of non-invasive home tele-
monitoring or structured telephone support or both within heart
failure disease management programmes on mortality and hospi-
talisation. In the 2010 Cochrane review, participants assigned to
telemonitoring had lower all-cause mortality and heart failure-re-
lated hospitalisations, while structured telephone support mainly
reduced heart failure-related hospitalisations (Inglis 2010). How-
ever several large trials of remote monitoring interventions have
since been published, and some have shown a lack of clinical ben-
efit. Also, one criticism of the previous Cochrane review (Inglis
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2010) was that it accepted the study by Kielblock 2007 as an RCT
while others considered it to be a cohort study (Anker 2011). A
more recent systematic review and meta-analysis included some
(but not all) of the newer trials and excluded the Kielblock study,
and again provided support for remote monitoring interventions
in reducing all-cause mortality. However, only trials that focused
on people with a recent discharge diagnosis of heart failure were
included (Pandor 2013b).
Remote monitoring interventions have often been more effec-
tive in reducing all-cause mortality rather than heart failure-re-
lated hospitalisations, and some trials have even reported an in-
crease in the number of hospitalisations (Cleland 2005 (Struct
Tele) (TENS-HMS); Cleland 2005 (Telemon) (TENS-HMS);
Steventon 2012a; Steventon 2013a). This may reflect the effect
of overcautious, risk-averse health professionals increasing partic-
ipant anxiety. Alternatively, appropriate expert review and timely
hospitalisation can be life-saving and improved survival means
that more people are alive and at risk of hospitalisation. Given the
conflicting evidence on this topic and the interests of the Euro-
pean Society of Cardiology and the American Heart Association
heart failure guideline committees, an updated systematic review
incorporating recent results is appropriate at this time.
O B J E C T I V E S
To review randomised controlled trials (RCTs) of structured tele-
phone support or non-invasive home telemonitoring compared to
standard practice for people with heart failure, in order to quantify
the effects of these interventions over and above usual care.
This is an update of previous versions (Clark 2007a; Inglis 2010).
M E T H O D S
Criteria for considering studies for this review
Types of studies
We include randomised controlled trials (RCTs) comparing heart
failure management delivered via structured telephone support or
non-invasive home telemonitoring with usual post-discharge care
for people with heart failure living within the community. We
include only RCTs that have been published in full in the peer-
reviewed literature. We excluded any studies that did not report
data for any of our outcomes of interest in an extractable format
(we contacted authors of each primary study in an attempt to
obtain data).
Types of participants
Adults (aged 18 years and over) of either sex, any age or ethnic
group, with a definitive diagnosis of heart failure. Participants may
have been recently discharged from an acute-care setting (includ-
ing emergency departments and acute assessment units) to home
(including a relative’s home but excluding nursing homes or con-
valescence homes) or theymay have been recruited to a studywhile
managed in the community setting. We excluded studies dealing
with general cardiac disorders rather than specifically with heart
failure.
Types of interventions
Structured telephone support or non-invasive telemonitoring in-
terventions needed to be scheduled, as opposed to offering tele-
phone follow-up on an ’as needed’ basis. The intervention must
have been initiated by a healthcare professional (medical, nursing,
social work, pharmacist) and delivered to people with heart failure
living in the community as the only aftercare intervention, with-
out protocol-driven home visits or intensified clinic follow-up.
The intervention had to be targeted at the person and intended to
address their concerns and problems, not those of caregivers. The
participant must not have been visited at home by a specialised
heart failure healthcare professional or study personnel for the pur-
pose of education or clinical assessment other than as an initiation
visit to set up equipment. ’Usual care’ consisted of standard post-
discharge care without intensified attendance at cardiology clinics
or clinic-based heart failure disease management programme, or
home visiting as described above. We excluded studies if there was
any previous exposure to telemonitoring or structured telephone
support for the usual care or intervention arms prior to the start
of the study.
Types of outcome measures
Primary outcomes
• All-cause mortality (total number of deaths at the end of
study follow-up in each arm of the study)
• All-cause hospitalisations (calculated as the proportion of
participants readmitted to hospital at least once during the
period of follow-up)
• Heart failure-related hospitalisations (calculated as the
proportion of participants readmitted to hospital at least once
during the period of follow-up due to heart failure)
Secondary outcomes
• Length of stay (number of days for hospitalisations)
• Health-related quality of life as assessed by validated
questionnaires
• Healthcare costs and cost effectiveness (reduction in
healthcare costs, cost of care)
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• Adherence to the intervention
• Participant acceptance of the intervention
• Heart failure knowledge and self care as assessed by
validated questionnaires
Search methods for identification of studies
This reviewupdates a previously publishedCochrane reviewwhich
examined the period 2006 to November 2008 (Inglis 2010); that
in turn had updated a previously published review examining the
period January 1966 to May 2006 (Clark 2007a).
For this update, we searched all databases from 2008 until January
2015, without any language restrictions. If we found an abstract
or thesis reporting an eligible RCT in the searches, then we in-
cluded the study as long as a full-text peer-reviewed publication
was available (online or in print) by 1 June 2015.
Electronic searches
We searched the following databases on 12 January 2015:
1. Cochrane Central Register of Controlled Trials
(CENTRAL) (Issue 12 of 12, 2014, Cochrane Library);
2. Database of Abstracts of Reviews of Effects (DARE) (Issue
4 of 4, 2014, Cochrane Library);
3. Health Technology Assessment Database (HTA) (Issue 4 of
4, 2014, Cochrane Library),
4. MEDLINE, MEDLINE In-Process & Other Non-Indexed
Citations, MEDLINE Daily and OLDMEDLINE (OVID,
1946 to 12 January 2015);
5. EMBASE (OVID, 1980 to 2015 week 2);
6. CINAHL Plus with Full text (EBSCO, 1937 to 12 January
2015);
7. Science Citation Index Expanded (SCI-EXPANDED, 1970
to 12 January 2015) - and Conference Proceedings Citation
Index- Science (CPCI-S, 1990 to 12 January 2015) on Web of
Science (Thomson Reuters);
8. AMED (to 31 December 2014).
The search strategies are listed in Appendix 1 (for this version of
the review) and Appendix 2 (for the 2010 version of the review
(Inglis 2010)).
Searching other resources
We also searched the following resources (“heart failure” and tele*
/ “cardiac failure” and tele*):
1. IEEE Xplore (2008 to 31 December 2014);
2. TROVE (2008 to 31 December 2014);
3. Proquest Digital Dissertations (2008 to 31 December
2014).
We handsearched bibliographies of identified studies and pub-
lished systematic reviews relevant to this topic area. We also hand-
searched abstracts and conference proceedings from the following
international conferences for relevant studies:
1. European Society of Cardiology Congress (2009, 2010,
2011, 2012, 2013, 2014);
2. American College of Cardiology Congress (2009, 2010,
2011, 2012, 2013, 2014);
3. American Heart Association (2009, 2010, 2011, 2012,
2013, 2014);
4. World Congress of Cardiology (2010, 2012, 2014);
5. Heart Failure Society of America (2009, 2010, 2011, 2012,
2013, 2014);
6. European Society of Cardiology Heart Failure Congress
(2009, 2010, 2011, 2012, 2013, 2014);
7. European Society of Cardiology Annual Spring Meeting of
Cardiovascular Nursing (2009, 2010, 2011, 2012, 2013, 2014).
Data collection and analysis
Two review authors (from SCI, RAC or RD) checked all identified
abstracts and results from database searches for relevance to the
review topic. If the reference appeared to be relevant, we obtained
a full copy of the reference for detailed review, to determine inclu-
sion/exclusion of the study.
Selection of studies
Two review authors (SCI and RAC) independently reviewed the
results of each search according to exclusion and inclusion criteria.
We excluded studies if home visits were performed as part of the
intervention or by the clinical staff involved in the intervention, or
if there were clinic visits (more than usual care) offered to partici-
pants in the intervention or control groups. A third review author
(JGFC) adjudicated in cases of disagreement between the first two
review authors.
Data extraction and management
Two review authors (RD and SA) abstracted the data from the
included studies in a blinded manner, and a third review author
(either SCI or RAC) checked all extracted data.
Assessment of risk of bias in included studies
Two review authors (RD and SA) independently assessed risks
of bias for each study,and a third review author (SCI or RAC)
checked them, using the Cochrane tool for assessing risk of bias
(Higgins 2011).
Measures of treatment effect
Datawere dichotomous and the statisticalmethodused for analysis
was a fixed-effect analysis model (Deeks 2011). We calculated
risk ratios (RRs) and 95% confidence intervals (CIs) for all-cause
mortality, and proportions of participants with at least one all-
cause and heart failure-related hospitalisation. We conducted all
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analyses on an intention-to-treat (ITT) basis, i.e. all participants
and their outcomes analysed in the groups to which they were
allocated, regardless of whether they received the treatment or
whether or not they were measured for the outcome.
We tabulated and described all measured outcomes such as quality
of life, using tools such as validated questionnaires, or length of
stay.
Dealing with missing data
In the absence of appropriate details regarding the participants,
intervention, usual care or outcomes assessed for a study poten-
tially eligible for inclusion, we contacted authors via email to re-
quest further details. We contacted authors of studies which we
identified as a published abstract, to request a copy of a full-text
peer-reviewed publication for the study if one was available. We
sent authors a follow-up email if we received no response.
Assessment of heterogeneity
We explored statistical heterogeneity in each outcome of interest
using theChi² test and I² statistic, as recommended in theCochrane
Handbook (Deeks 2011).
Assessment of reporting biases
We assessed reporting bias through funnel plots and visual assess-
ment.
Data synthesis
Owing to differences in participant populations, programme char-
acteristics, and length of follow-up, we performed all meta-analy-
ses using a fixed-effect model.
Summary of Findings
We assessed the primary outcomes examined in the review using
GRADEPro methodology (Schünemann 2011) to create ’Sum-
mary of findings’ tables. We performed quality assessment and
rated using the measures of very low, low, moderate or high. We
assessed only primary outcomes, as these were the most consis-
tently reported outcomes across the included studies.
Subgroup analysis and investigation of heterogeneity
We conducted several subgroup analyses to investigate heterogene-
ity. These were based on previously published post hoc subgroup
analyses from the data included in the 2010 version of this review
(Inglis 2014), and in Conway 2014.
Each of the subgroup analyses and their methodology are detailed
below:
1. Technology
We categorised included studies according to the following tech-
nology types: a) telephone calls; b) videophone; c) interactive voice
response (IVR) involving the manual input of data using a tele-
phone keypad in response to questions from a computerised in-
teractive voice response system and computer-assisted telephone
interviewing (CATI); d) complex/clinical telemonitoring, involv-
ing automatic transmission of physiological data, such as weight,
heart rate and rhythm, oxygen saturations and blood pressure,
from the measuring device to a central server via telephonic, satel-
lite or broadband capabilities for interpretation by the healthcare
team (Conway 2014).
2. Telemonitoring intensity
We categorised included studies of non-invasive telemonitoring
according to the level of data monitoring and response, adapted
from a categorisation proposed by Anker 2011. Categories in-
cluded: a) office hours (typically Monday to Friday, 9 - 5 pm); b)
24 hours per day/seven days per week.
3. Publication year
We categorised included studies according to the year that a full-
text peer-reviewed publication for that study was published: a)
pre-2000; b) 2000 - 2007; c) since 2008. These nominal periods
were based on time points of change to heart failure care.
• Pre-2000: era before contemporary pharmacological
prescribing (beta-blockers, ACE inhibitors);
• 2000 - 2007: development of several important heart
failure treatments (pharmacological and devices) influencing the
standard of ‘usual care’;
• 2008 onwards: revised heart failure guidelines.
4. Mean/median age of study participants
We categorised included studies according to the mean or median
age of the study participants. Categories included: a) < 70 years of
age; b) ≥ 70 years of age (Inglis 2014).
5. Focus of structured telephone support studies
We categorised included studies of structured telephone support
according to the focus of the intervention. Categories included:
a) clinical monitoring of heart failure signs and symptoms with
clinical support provided (clinical support); b) self-management
education.
Meta-regression
In each subgroup analysis we performed a heterogeneity test to
investigate whether there was enough evidence that the treatment
effect differed between subgroups. We estimated the Q statistics
that follows a Chi² distribution and produced a P value using the
command ’metabin’ from the package ’meta’ in R.
To investigate whether the intervention effect depended on vari-
ables that were originally recorded as a continuous scale (year of
publication and median age), we conducted linear meta-regres-
sions between the logarithm of the RR in the trials and each vari-
able. We performed the meta-regression assuming a fixed-effect
model and using the command ’rma.uni’ in the package ’metareg’
in R.
Sensitivity analysis
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We performed a sensitivity analysis for each of the primary out-
comes, to assess the impact of length of follow-up on outcomes.
We excluded studies with a follow-up period of six months or less
from these sensitivity analyses.
R E S U L T S
Description of studies
Results of the search
We identified 17 new studies for inclusion in the review.
Searching the databases and search engines retrieved a total of 5051
new results (Figure 1):
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Figure 1. Study flow diagram for update
12Structured telephone support or non-invasive telemonitoring for patients with heart failure (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
• CENTRAL n = 548
• DARE n = 62
• HTA n = 19
• MEDLINE, MEDLINE In-Process & Other Non-Indexed
Citations, MEDLINE Daily and OLDMEDLINE (OVID) n =
731
• EMBASE (OVID) n = 936
• Science Citation Index Expanded (SCI-EXPANDED) and
Conference Proceedings Citation Index- Science (CPCI-S) n =
881
• CINAHL Plus with Full text (EBSCO) n = 306
• AMED n = 21
• IEEE Xplore n = 1524
• TROVE n = 0
• Proquest Digital Dissertations n = 23
We excluded 973 references as duplicates.
Handsearching of conference abstracts identified 52 references.
Overall, we identified 265 studies as potentially relevant, and we
obtained full-text copies for assessment according to our inclusion
and exclusion criteria.
We have identified 34 new studies which are currently ongoing,
which includes those identified as conference abstracts but for
which a full-text peer-reviewed publication was not available by
the census date (Characteristics of ongoing studies).
We have identified seven new references as awaiting classification
(Characteristics of studies awaiting classification), as we have con-
tacted the study authors but have not received a reply to assist
with determining the study eligibility, with several remaining in
this category from the 2010 version of this review (Dunlap 2006
(HearT-I); Kulshreshtha 2010; Levine 2006 (Mind My Heart);
Yakushin 2006).
We have now excluded one study (Kielblock 2007) which was
included in the previous version of this review, since, based on
debate and discussion in the literature (Anker 2011) since the
publication of the previous version of this review, we consider it
not to be a randomised controlled trial.
Included studies
We include 41 full-text peer-reviewed studies of either structured
telephone support or home telemonitoring. Two included stud-
ies trialled both structured telephone support and telemonitor-
ing compared to usual care, therefore 43 comparisons are evident.
These include 24 studies published as full-text peer-reviewed pub-
lications included in the 2010 Cochrane review (Inglis 2010);
(Figure 2 and Characteristics of included studies). Twenty-five
studies evaluated structured telephone support (eight new studies,
plus one included study previously classified as telemonitoring;
total of 9332 participants), 18 evaluated telemonitoring (nine new
studies; total of 3860 participants) and two studies evaluated both
interventions (included in listed counts).
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Figure 2. Study flowchart.
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We have excluded one telemonitoring study (Kielblock 2007) in-
cluded in the previous version of this review (Inglis 2010). An-
other study (Capomolla 2004) which used IVR technology and
was previously included as a telemonitoring study in the previous
version of this review we now classify as structured telephone sup-
port.
We have added 17 new studies to the review for this update.
These include eight new studies of structured telephone support
(Angermann 2012 (INH); Baker 2011; Bento 2009; Brandon
2009; Chaudhry 2010 (Tele-HF); Domingues 2011; Krum 2013
(CHAT); Zamanzadeh 2013) and nine new studies of non-
invasive home telemonitoring (Biannic 2012 (SEDIC); Blum
2014 (MCCD); Dendale 2012 (TEMA-HF1); Koehler 2011
(TIM-HF); Lyngå 2012 (WISH); Scherr 2009 (MOBITEL); Seto
2012; Villani 2014 (ICAROS); Vuorinen 2014).
Studies with multiple intervention arms included in this review
are: Cleland 2005 (Struct Tele) (TENS-HMS); Cleland 2005
(Telemon) (TENS-HMS); Mortara 2009 (Struct Tele) (HHH);
Mortara 2009 (Telemon) (HHH).We have separated out the data
from these studies into our two interventions of interest (struc-
tured telephone support and telemonitoring). Structured tele-
phone support (Mortara 2009 (Struct Tele) (HHH)) data are from
the “Strategy 2” study arm, and telemonitoring data (Mortara
2009 (Telemon) (HHH)) are from the “Strategy 3” study arm.
(Wakefield 2008) includes two intervention arms, one using stan-
dard telephone equipment and the other a videophone; for the
purposes of our analyses, we combined these two intervention
arms and classed them as structured telephone support.
Two new structured telephone support studies (Brandon 2009;
Zamanzadeh 2013) did not examine themain outcomes of interest
(all-cause mortality, all-cause hospitalisations and heart failure-
related hospitalisations) but did include data on some secondary
outcomes.
Of the newly-included studies, four had been included in the 2010
review as conference abstracts and have now been included in this
version of the review as they are now available as full-text peer-
reviewed publications. These are: Angermann 2012 (INH); Blum
2014 (MCCD); Krum 2013 (CHAT); Villani 2014 (ICAROS).
Two studies identified in the 2010 version of this review as ongoing
(Chaudhry 2010 (Tele-HF); Koehler 2011 (TIM-HF)) and one
study awaiting assessment in 2010 (Scherr 2009 (MOBITEL)) are
now included in this version of the review.
For the structured telephone support studies (n = 25 studies, in-
cluding two three-armed studies):
• Trials ranged in size from small (34 participants in Barth
2001) to large (1653 participants in Chaudhry 2010 (Tele-HF));
• Mean/median age of participants ranged from 45 years
(Ramachandran 2007) to 75 years (Barth 2001);
• Mean percentage of male participants was 63%, which
ranged from 45% to 99%. Only five out of the 25 included
studies recruited more women than men (Barth 2001; Brandon
2009; DeWalt 2006; Riegel 2002; Riegel 2006);
• 56% (n = 14) of the studies reviewed originated from the
USA; other countries were Australia (1), Argentina (1), Brazil
(2), Canada (1), Germany (1), India (1), Iran (1), Italy (1) and
two studies which were involved several European countries
(Germany, Netherlands, UK, Poland, Italy).
• Ethnic groups: Riegel 2006 examined the effect of
structured telephone support on a Hispanic population;
• 66% of studies had a length of follow-up less than six
months;
• Most studies included participants with symptomatic heart
failure, NYHA Class II - III.
For non-invasive home telemonitoring studies (n = 18, including
two three-armed studies):
• Trials ranged in size from small (20 participants in De
Lusignan 2001) to large (710 participants in Koehler 2011
(TIM-HF));
• Mean/median age of participants ranged from 55 years of
age in Seto 2012 to 78 years of age in Antonicelli 2008;
• Mean percentage of male participants was 72%, and ranged
from 35% to 85%. Only one of the 18 included studies recruited
more women than men (Soran 2008);
• Studies were undertaken in a variety of countries: Italy (3),
USA (3), Canada (2), Austria (1), Belgium (1), Finland (1),
France (1), Germany (1), Sweden (1), The Netherlands (1), UK
(1) and two studies involved several European countries
(Germany, The Netherlands and the UK; UK, Poland and Italy)
• Minority populations: Soran 2008 included older
minorities (elderly women and non-white men);
• 38% of studies had a length of follow-up less than six
months;
• Most studies included participants with symptomatic heart
failure, NYHA Class III.
Structured telephone support studies included in the primary
meta-analysis for the primary outcomes of interest funded by in-
dustry/health insurers (reported in publications):
1. Cleland 2005 (Struct Tele) (TENS-HMS) - Phillips.
2. DeWalt 2006 - Pfizer Inc.
3. Domingues 2011 - FIPE and CNPq.
4. GESICA 2005 (DIAL) - Roche, Boehringer Ingelheim,
Bago. Pharmacia, Novartis, Merck Sharp & Dohme.
5. Krum 2013 (CHAT) - National Health and Medical
Research Council (NHMRC) and National Heart Foundation of
Australia and Medical Benefits Fund.
6. Laramee 2003 - Novartis Pharmaceuticals.
7. Riegel 2002 - Pfizer Inc.
8. Tsuyuki 2004 - Park Davis Canada (Pfizer Canada).
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Non-invasive telemonitoring studies included in the primary
meta-analysis of the primary outcomes of interest funded by in-
dustry (reported in publications):
1. Balk 2008 - Achmea, Philips; provision of the MOTIVA
system.
2. Cleland 2005 (Telemon) (TENS-HMS) - Philips.
3. De Lusignan 2001 - Nexan Telemed Ltd, Cambridge.
4. Dendale 2012 (TEMA-HF1) - Belgium Government
Health Insurance Institute, Leo Pharma.
5. Goldberg 2003 (WHARF) - Alere Medical, Incorporated.
6. Koehler 2011 (TIM-HF) - German Federal Ministry of
Economics and Technology, Robert Bosch Healthcare GmbH,
InterComponentWare AG, Aipermon GmbH & Co KG.
7. Scherr 2009 (MOBITEL) - Novartis Pharma Austria,
Roche Pharma Australia Mobilkom Austria.
8. Woodend 2008 - Merck-Frost Canada.
Excluded studies
We excluded the majority of studies for the following reasons (
Characteristics of excluded studies):
• Not an RCT: n = 54
• Involved home or intensive clinic visits: n = 36
• Review or editorial: n = 35
• Not structured telephone support or telemonitoring: n = 19
• Not heart failure-specific: n = 10
• System design: n = 10
• Invasive telemonitoring: n = 7
• Structured telephone support or telemonitoring exposure in
usual care or both arms: n = 4
Risk of bias in included studies
Overall the heterogeneity ranged from “might not be impor-
tant” to “may represent substantial heterogeneity” according to
the rough guide provided by Deeks 2011:
• 0% to 40%: might not be important;
• 30% to 60%: may represent moderate heterogeneity;
• 50% to 90%: may represent substantial heterogeneity;
• 75% to 100%: considerable heterogeneity.
• All-cause mortality:
◦ Structured telephone support vs usual care:
Heterogeneity: Chi² = 13.56, df = 20 (P = 0.85); I² = 0%
◦ Telemonitoring vs usual care: Heterogeneity: Chi² =
19.70, df = 15 (P = 0.18); I² = 24%
• All-cause hospitalisation:
◦ Structured telephone support vs usual care:
Heterogeneity: Chi² = 28.51, df = 15 (P = 0.02); I² = 47%
◦ Telemonitoring vs usual care: Heterogeneity: Chi² =
41.72, df = 12 (P < 0.0001); I² = 71%
• Heart failure-related hospitalisation:
◦ Structured telephone support vs usual care:
Heterogeneity: Chi² = 19.20, df = 14 (P = 0.16); I² = 27%
◦ Telemonitoring vs usual care: Heterogeneity: Chi² =
8.71, df = 7 (P = 0.27); I² = 20%
Analysis of the distribution in the funnel plots (Figure 3; Figure
4; Figure 5; Figure 6; Figure 7; Figure 8) demonstrates a strong
publication bias in the studies selected for this review.
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Figure 3. Funnel plot of comparison: 1 Impact of structured telephone support and telemonitoring in CHF
on all-cause mortality, outcome: 1.1 All-cause mortality: STS vs UC.
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Figure 4. Funnel plot of comparison: 1 Impact of structured telephone support and telemonitoring in CHF
on all-cause mortality, outcome: 1.2 All-cause mortality: TM vs UC.
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Figure 5. Funnel plot of comparison: 2 Impact of structured telephone or telemonitoring in CHF on risk of
all-cause hospitalisation, outcome: 2.1 All-cause hospitalisation: STS vs UC.
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Figure 6. Funnel plot of comparison: 2 Impact of structured telephone or telemonitoring in CHF on risk of
all-cause hospitalisation, outcome: 2.2 All-cause hospitalisation: TM vs UC.
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Figure 7. Funnel plot of comparison: 3 Impact of structured telephone support or telemonitoring in CHF
on risk of CHF-related hospitalisation, outcome: 3.1 CHF-related hospitalisation: STS vs UC.
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Figure 8. Funnel plot of comparison: 3 Impact of structured telephone support or telemonitoring in CHF
on risk of CHF-related hospitalisation, outcome: 3.2 CHF-related hospitalisation: TM vs UC.
Allocation
We assessed random sequence generation as either low risk of bias
(50% of all studies) or unclear for more than 95% of all studies
included in this review. Many studies did not report the method
of random sequence generation Figure 9; Figure 10.
Figure 9. Risk of bias graph: review authors’ judgements about each methodological quality item presented
as percentages across all included studies.
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Figure 10. Risk of bias summary: review authors’ judgements about each methodological quality item for
each included study.
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Allocation concealment was not clearly reported for more than
50% of all studies included in the review. We rated those that did
report allocation concealment at low risk.
Blinding
We do not consider that blinding of participants and study per-
sonnel delivery was possible for these types of interventions. We
assessed blinding of outcome assessment, and rated the majority
of included studies at unclear risk of detection bias, due to the ab-
sence of details in the publications for outcome assessment (Figure
9; Figure 10).
Incomplete outcome data
Several studies reported losses to follow-up without detailing how
or whether outcome data for these studies were included in an
intention-to-treat analysis (Figure 9; Figure 10).
Selective reporting
We assessedmore than 75% of all studies included in this review to
be at low risk for selective reporting, with a small number assessed
as being at high risk (Figure 9; Figure 10).
Effects of interventions
See: Summary of findings for the main comparison Summary
of findings - structured telephone support or telemonitoring
versus usual care - all-cause mortality; Summary of findings
2 Summary of findings - structured telephone support or
telemonitoring versus usual care - all-cause hospitalisation;
Summary of findings 3 Summary of findings - structured
telephone support or telemonitoring versus usual care - heart
failure-related hospitalisation
All-cause mortality
All-causemortality was available for 22 peer-reviewed studies com-
paring structured telephone support with usual care and for 17
studies comparing telemonitoringwith usual care. Both structured
telephone support (RR 0.87, 95% CI 0.77 to 0.98; participants =
9222; studies = 22; I² = 0%; Analysis 1.1) and non-invasive tele-
monitoring (RR 0.80, 95% CI 0.68 to 0.94; participants = 3740;
studies = 17; I² = 24%; Analysis 1.2) reduced all-cause mortality
in people with heart failure.
GRADE assessment rated all-cause mortality evidence included
in the review as of moderate quality, limited by a strong suspicion
publication bias (Summary of findings for the main comparison).
Subgroup analyses designed to explore heterogeneity in the in-
cluded studies found the following:
1. Technology
Heterogeneity tests between groups were not significant (P = 0.34)
and therefore it is difficult to conclude that the apparent differences
amongst technologies on all-cause mortality are true.
Effective technologies for reducing the risk of all-cause mortality
in people with heart failure were telephone (RR 0.81, 95% CI
0.71 to 0.93; participants = 6629; studies = 17; I² = 0%; Analysis
1.3) and complex telemonitoring (RR 0.81, 95% CI 0.68 to 0.96;
participants = 2885; studies = 12; I² = 31%; Analysis 1.4).
Technology categories that did not individually demonstrate sta-
tistically significant effects on all-cause mortality in people with
heart failure included videophone (RR 1.14, 95%CI 0.65 to 1.99;
participants = 269; studies = 2; I² = 0%; Analysis 1.5), IVR (RR
1.01, 95% CI 0.80 to 1.28; participants = 2445; studies = 4; I² =
0%; Analysis 1.6), and mobile telephone or person digital assis-
tant (PDA) (RR 0.71, 95% CI 0.46 to 1.11; participants = 734;
studies = 4; I² = 25%; Analysis 1.7).
2. Telemonitoring intensity
A heterogeneity test did not show strong statistical evidence of
differences between the two groups (P = 0.21) according to the
intensity of telemonitoring.
When we categorised telemonitoring studies according to data
monitoring intensity, only the first subgroup with monitoring in
conventional office hours showed statistically significant evidence
of an effect (RR 0.69, 95% CI 0.52 to 0.92; participants = 1548;
studies = 10; I² = 0%; Analysis 1.8), while the subgroup of seven
days per week/24 hours per day showed no significant effect: (RR
0.86, 95% CI 0.71 to 1.04; participants = 2192; studies = 7; I² =
44%; Analysis 1.9).
3. Publication year
A test came close to identifying significant heterogeneity between
the two subgroups (P = 0.0760). The linear meta-regression coeffi-
cient for year of publication for telemonitoring studies was 1.0477
(P = 0.0463), providing further support for the view that more
recent studies have shown a smaller impact on mortality.
For structured telephone support studies, full-text peer-reviewed
publications prior to 2000 reported a reduction in all-cause mor-
tality in people with heart failure, but was not statistically signif-
icant. This could be due to the few studies and cases. (RR 0.45,
95% CI 0.14 to 1.40; participants = 219; studies = 2; I² = 0%;
Analysis 1.10). For studies published between 2000 and 2007 the
effect was smaller, but the larger sample size made it (just) sta-
tistically significant (RR 0.86, 95% CI 0.74 to 0.99; participants
= 5668; studies = 13; I² = 0%; Analysis 1.11). Studies published
after 2007 showed an even smaller effect and were clearly statisti-
cally non-significant (RR 0.91, 95% CI 0.75 to 1.10; participants
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= 3335; studies = 7; I² = 0%; Analysis 1.12). Heterogeneity tests
between these three subgroups were non-significant (P = 0.47) and
a meta-regression failed to identify a significant linear trend (slope
= 1.008, P = 0.67).
For non-invasive telemonitoring studies, full-text peer-reviewed
publications during the period 2000 to 2007 reported a reduction
in all-cause mortality in people with heart failure (RR 0.58, 95%
CI 0.39 to 0.86; participants = 553; studies = 3; I² = 0%; Analysis
1.13), but for those published after 2008 the effect did not have
strong statistically significant evidence (RR 0.85, 95% CI 0.72 to
1.02; participants = 3187; studies = 14; I² = 21%; Analysis 1.14).
We did not identify any telemonitoring study published prior to
2000 for inclusion.
4. Mean/median age of participants
Again, a test failed to identify heterogeneity (P = 0.4534) and
the linear regression coefficient for median age of participants was
1.0010 (P = 0.9405).
Whenwe categorised structured telephone support studies accord-
ing to the age of the participants, the benefit of structured tele-
phone support for all-cause mortality was similar for studies where
the mean/median age of participants was less than 70 years (RR
0.88, 95% CI 0.77 to 1.01; participants = 6158; studies = 13; I² =
0%; Analysis 1.15) and for those aged 70 years or older (RR 0.84,
95% CI 0.67 to 1.04; participants = 3064; studies = 9; I² = 0%;
Analysis 1.16).
Tests for heterogeneity were not significant (P = 0.69).The linear
meta-regression coefficient for age of participants for structured
telephone support studies was 0.9886 (P = 0.3871) supporting
the view that age is not a major determinant of the effect of the
intervention.
For non-invasive telemonitoring studies, the effect on mortality
was similar to the above, with studies where the mean/median age
of participants was less than 70 years (RR 0.84, 95% CI 0.68 to
1.04; participants = 2493; studies = 9; I² = 31%; Analysis 1.17),
and for those aged 70 or over (RR 0.74, 95% CI 0.59 to 0.94;
participants = 1247; studies = 8; I² = 30%; Analysis 1.18).
5. Focus of structured telephone support studies
The heterogeneity test was non-significant (P = 0.8921).
Structured telephone support which focused on monitoring of
signs and symptoms of heart failure and provided clinical support
reduced all-cause mortality (RR 0.87, 95% CI 0.77 to 0.98; par-
ticipants = 8094; studies = 18; I² = 0%; Analysis 1.19), to a similar
extent as those that focused on self-management education (RR
0.90, 95% CI 0.55 to 1.45; participants = 1128; studies = 4; I² =
0%; Analysis 1.20).
Sensitivity analyses, performed to explore the influence of length of
follow-up greater than six months on all-cause mortality removed
the statistically significant effect of structured telephone support
(RR 0.88, 95%CI 0.75 to 1.02; participants = 4818; studies = 11;
I² = 0%;Analysis 1.21) and telemonitoring (RR0.89, 95%CI0.74
to 1.06; participants = 2580; studies = 10; I² = 0%; Analysis 1.22),
but reduced heterogeneity for telemonitoring studies. However,
meta-regression tests revealed no heterogeneity according to study
duration.
All-cause hospitalisation
All-cause hospitalisation data were available for 16 studies com-
paring structured telephone support with usual care and 13 stud-
ies comparing telemonitoring with usual care. Both structured
telephone support (RR 0.95, 95% CI 0.90 to 1.00; participants
= 7216; studies = 16; I² = 47%; Analysis 2.1), and non-invasive
telemonitoring (RR 0.95, 95% CI 0.89 to 1.01; participants =
3332; studies = 13; I² = 71%; Analysis 2.2), showed an average
reduction in all-cause hospitalisation of people with heart failure
but statistically significant evidence was not strong in either study
and heterogeneity between trial effects was important.
GRADEassessment rated the evidence for all-cause hospitalisation
as very low, due to serious inconsistency and serious imprecision in
this outcome, and a strong suspicion of publication bias (Summary
of findings 2).
Subgroup analyses designed to explore heterogeneity in the in-
cluded studies found the following:
1. Technology
The heterogeneity test between subgroups was not significant (P
= 0.25), suggesting that observed effect differences between sub-
groups may be due to the play of chance.
Effective technologies for reducing the risk of all-cause hospitali-
sation in people with heart failure was telephone (RR 0.93, 95%
CI 0.86 to 0.99; participants = 4756; studies = 12; I² = 51%;
Analysis 2.3) and mobile phone/PDA (RR 0.76, 95% CI 0.60
to 0.97; participants = 560; studies = 2; I² = 70%; Analysis 2.4).
Technology categories that did not individually demonstrate sta-
tistically significant reductions in all-cause hospitalisation in peo-
ple with heart failure included videophone (RR 0.91, 95% CI
0.80 to 1.04; participants = 269; studies = 2; I² = 92%; Analysis
2.5), IVR (RR 0.99, 95% CI 0.91 to 1.08; participants = 2312;
studies = 3; I² = 76%; Analysis 2.6) and complex telemonitoring
(RR 0.97, 95%CI 0.90 to 1.04; participants = 2651; studies = 10;
I² = 69%; Analysis 2.7). But again, heterogeneity between studies
was important in all these analyses.
2. Telemonitoring intensity
The heterogeneity test identified differences between the two sub-
groups (P = 0.0125) (Figure 11).
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Figure 11.
When we categorised telemonitoring studies according to data
monitoring intensity (office hours or seven days per week/24 hours
per day) only those which operated during standard office hours
reduced the risk of all-cause hospitalisation in people with heart
failure (RR 0.85, 95% CI 0.76 to 0.94; participants = 1140; stud-
ies = 6; I² = 76%; Analysis 2.8), whereas studies that operated
telemonitoring seven days per week or 24 hours per day did not
(RR 1.01, 95% CI 0.93 to 1.09; participants = 2192; studies = 7;
I² = 50%; Analysis 2.9).
3. Publication year
A test did not identify heterogeneity (P = 0.9269) and the linear
meta-regression coefficient for year of publication was 1.0000 (P
= 0.9992).
For structured telephone support studies, only one study (Gattis
1999 (PHARM)) was published as a full-text peer-reviewed report
prior to 2000, and demonstrated a statistically significant effect
on reducing the risk of all-cause hospitalisation for people with
heart failure (RR 0.57, 95% CI 0.34 to 0.96; participants = 181;
studies = 1; Analysis 2.10). Structured telephone support studies
published during the period 2000 to 2007 (RR 0.93, 95% CI
0.86 to 1.01; participants = 3700; studies = 8; I² = 0%; Analysis
2.11) and from 2008 onwards (RR 0.98, 95% CI 0.91 to 1.06;
participants = 3335; studies = 7; I² = 68%; Analysis 2.12) did not
show strong evidence of a reduced risk. However, there was no
strong evidence of heterogeneity between the three subgroups (P
= 0.1031) and the linear meta-regression coefficient for year of
publication was also non-significant (slope = 1.0078, P = 0.3453).
For non-invasive telemonitoring studies, we found no statistically
significant reduction in all-cause hospitalisation for the period
2000 to 2007: (RR 0.94, 95%CI 0.79 to 1.12; participants = 533;
studies = 2; I² = 0%; Analysis 2.13) or for the period from 2008
onward: (RR 0.95, 95% CI 0.89 to 1.02; participants = 2799;
studies = 11; I² = 76%; Analysis 2.14).
4. Mean/median age of participants
Heterogeneity tests (P = 0.1990) and linear meta-regression coef-
ficient for age (slope = 0.9983; P = 0.7271) did not provide sta-
tistically significant evidence of heterogeneity of effect.
The borderline effect of STS on all-cause hospitalisation was sim-
ilar for trials with a median/mean participant age above 70 (RR
0.94, 95% CI 0.85 to 1.04; participants = 1923; studies = 6; I² =
36%; Analysis 2.15), or below 70 years of age (RR 0.95, 95% CI
0.89 to 1.01; participants = 5293; studies = 10; I² = 56%; Analysis
2.16). Neither heterogeneity tests (P = 0.88) nor linear meta-re-
gression coefficient for age (slope = 0.9933; P = 0.2369) identified
significant heterogeneity amongst studies.
Non-invasive telemonitoring studies with a mean/median partic-
ipant age above 70 years demonstrated a marginally significant
reduction in the risk of all-cause hospitalisation for people with
heart failure (RR 0.90, 95% CI 0.82 to 0.99; participants = 1147;
studies = 6; I² = 80%; Analysis 2.17) that we did not observe for
studies with a mean/median age of participants below 70 years of
age (RR 0.98, 95% CI 0.90 to 1.07; participants = 2185; studies
= 7; I² = 57%; Analysis 2.18).
5. Focus of structured telephone support studies
Heterogeneity tests did not find important heterogeneity (P =
0.3052).
Neither structured telephone support which focused on monitor-
ing of signs and symptoms of heart failure and providing clinical
support (RR 0.94, 95% CI 0.89 to 1.00; participants = 6820;
studies = 14; I² = 52%; Analysis 2.19), nor those that focused
on self-management education (RR 1.08, 95% CI 0.84 to 1.38;
participants = 396; studies = 2; I² = 0%; Analysis 2.20) showed
statistically significant reductions in all-cause hospitalisation.
Sensitivity analyses, performed to explore the influence of length
of follow-up greater than six months showed slightly better results
and less heterogeneity for STS (RR 0.89, 95% CI 0.82 to 0.96;
participants = 3451; studies = 7; I² = 37%; Analysis 2.21), but
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had no influence on the results of home telemonitoring (RR 0.94,
95% CI 0.87 to 1.01; participants = 2387; studies = 8; I² = 78%;
Analysis 2.22).
Heart failure-related hospitalisation
Data on heart failure-related hospitalisations were available for
16 studies comparing structured telephone support with usual
care and eight studies comparingnon-invasive telemonitoringwith
usual care.
Both structured telephone support (RR 0.85, 95% CI 0.77 to
0.93; participants = 7030; studies = 16; I² = 27%; Analysis 3.1)
and non-invasive telemonitoring (RR 0.71, 95% CI 0.60 to 0.83;
participants = 2148; studies = 8; I² = 20%; Analysis 3.2) showed a
statistically significant reduction in heart failure-related hospitali-
sations.
GRADE assessment rated the evidence for heart failure-related
hospitalisation evidence as moderate, due to a strong suspicion
publication bias.(Summary of findings 3).
Subgroup analyses designed to explore heterogeneity in the in-
cluded studies found the following:
1. Technology
A heterogeneity test (P = 0.0029) strongly suggested that there are
differences in effect for this outcome amongst these technologies
(Figure 12).
Figure 12.
Effective technologies for reducing the risk of heart failure-related
hospitalisation included telephone (RR 0.76, 95% CI 0.67 to
0.86; participants = 4718; studies = 13; I² = 2%; Analysis 3.3),
mobile phone/PDA (RR0.58, 95%CI 0.44 to 0.77; participants =
674; studies = 3; I² = 0%; Analysis 3.4) and complex non-invasive
telemonitoring (RR 0.78, 95% CI 0.64 to 0.94; participants =
1474; studies = 5; I² = 33%; Analysis 3.5).
IVR was the only technology which did not demonstrate a benefit
for reducing the risk of heart failure-related hospitalisation (RR
0.99, 95% CI 0.86 to 1.14; participants = 2312; studies = 3; I² =
0%; Analysis 3.6).
2. Telemonitoring intensity
The heterogeneity test did not find evidence of differences in the
effect (P = 0.9907).
When we categorised telemonitoring studies according to data
monitoring intensity (office hours or seven days per week/24 hours
per day), we found significant reductions in heart failure-related
hospitalisation (office hours: RR 0.71, 95% CI 0.56 to 0.89; par-
ticipants = 858; studies = 5; I² = 20%; Analysis 3.7; seven days per
week/24 hours per day: RR 0.71, 95% CI 0.57 to 0.87; partici-
pants = 1290; studies = 3; I² = 46%; Analysis 3.8).
3. Publication year
The heterogeneity tests did not demonstrate heterogeneity (P =
0.3978) and the linear meta-regression coefficient for year of pub-
lication was non-significant (0.9694; P = 0.3721).
For structured telephone support studies, the two studies pub-
lished prior to 2000 demonstrated a large reduction in the risk
of heart failure-related hospitalisations (RR 0.24, 95% CI 0.10
to 0.58; participants = 219; studies = 2; I² = 48%; Analysis 3.9).
The effect size was smaller with more recent publications: 2000 to
2007 RR 0.78, 95% CI 0.69 to 0.89; participants = 3784; studies
= 10; I² = 0%; Analysis 3.10; 2008 onwards RR 0.96, 95% CI
0.84 to 1.11; participants = 3027; studies = 4; I² = 0%; Analysis
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3.11. The heterogeneity test strongly suggested differences be-
tween these three groups (P = 0.0019) and the linear meta-regres-
sion coefficient for year of publication was 1.0360 (P = 0.0177),
indicating a reduction in benefit for more recent publications for
this outcome (Figure 13; Figure 14).
Figure 13.
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Figure 14.
Only one non-invasive telemonitoring study reporting heart fail-
ure-related hospitalisations was published during the period 2000
to 2007 (Cleland 2005 (Telemon) (TENS-HMS)), which did not
demonstrate a significant benefit for reducing the risk of heart fail-
ure-related hospitalisations in people with heart failure (RR 0.84,
95% CI 0.55 to 1.30; participants = 253; studies = 1; Analysis
3.12). Telemonitoring studies published from 2008 onwards did
detect a significant reduction in heart failure-related hospitalisa-
tions (RR 0.69, 95% CI 0.58 to 0.82; participants = 1895; studies
= 7; I² = 24%; Analysis 3.13).
4. Mean/median age of participants
A test did not identify heterogeneity between the three groups (
P = 0.0952) and the linear meta-regression coefficient for age of
participants was 0.9915 (P = 0.4784).
Structured telephone support reduced heart failure-related hospi-
talisations in studies where the mean/median age of participants
was below 70 years (RR 0.86, 95% CI 0.77 to 0.96; participants =
5035; studies = 8; I² = 51%; Analysis 3.14) and for those where the
mean/median age was 70 years and above (RR 0.81, 95% CI 0.67
to 0.96; participants = 1995; studies = 8; I² = 0%; Analysis 3.15).
A test did not find evidence of heterogeneity (P = 0.5349). The
linear meta-regression coefficient for median age of participants
was 0.9821 (P = 0.0562). This result does not provide strong ev-
idence that studies with an older median age for participant have
slightly larger effects.
There were similar findings for non-invasive telemonitoring stud-
ies where the mean/median age of participants was below 70 years
(RR 0.75, 95% CI 0.63 to 0.89; participants = 1898; studies = 6;
I² = 14%; Analysis 3.16), and for those where the mean/median
age was 70 years and above (RR 0.53, 95% CI 0.37 to 0.76; par-
ticipants = 250; studies = 2; I² = 0%; Analysis 3.17).
5. Focus of structured telephone support studies
A test did not demonstrate heterogeneity (P 0.5607).
Structured telephone support which focused on monitoring of
signs and symptoms of heart failure and provided clinical support
reduced heart failure-related hospitalisations (RR 0.84, 95% CI
0.76 to 0.93; participants = 6754; studies = 15; I² = 31%; Analysis
3.18). There was only one included structured telephone support
study (Tsuyuki 2004) which focused on self-management educa-
tion and the effect on heart failure-related hospitalisations, and
did not show a significant effect (RR 0.95, 95% CI 0.64 to 1.39;
participants = 276; studies = 1; Analysis 3.19).
The effectwas somewhat greater for studies of structured telephone
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support with a follow-up greater than six months (RR 0.76, 95%
CI 0.66 to 0.88; participants = 3341; studies = 7; I² = 0%; Analysis
3.20), but restricting the analysis to longer duration of follow-up
in studies of non-invasive telemonitoring, did not seem to affect
the results (RR 0.78, 95% CI 0.65 to 0.94; participants = 1684;
studies = 4; I² = 31%; Analysis 3.21).
Length of stay
Of the 25 studies reporting on structured telephone support ver-
sus usual care, seven reported length-of-stay data (Chaudhry 2010
(Tele-HF); Galbreath 2004; Laramee 2003; Riegel 2002; Riegel
2006; Tsuyuki 2004; Wakefield 2008). Only Tsuyuki 2004 re-
ported a statistically significant reduction in length of stay in
hospital. Nine telemonitoring studies reported length of stay
(Balk 2008; Blum 2014 (MCCD); Dendale 2012 (TEMA-HF1);
Koehler 2011 (TIM-HF); Lyngå 2012 (WISH); Scherr 2009
(MOBITEL); Soran 2008; Vuorinen 2014; Wakefield 2008).
Only Scherr 2009 (MOBITEL) reported a significant reduction
in the length of stay with the intervention. One telemonitoring
study (Villani 2014 (ICAROS)) reported a large difference in the
total number of hospitalisations for longer than three days, but
this was not an analysis of length of stay per hospitalisation. Stud-
ies which assessed both telemonitoring and structured telephone
support (Cleland 2005 (Struct Tele) (TENS-HMS); Cleland 2005
(Telemon) (TENS-HMS); Mortara 2009 (Struct Tele) (HHH);
Mortara 2009 (Telemon) (HHH)) reported no significant dif-
ference in length of stay for hospital admissions between groups
(Table 1).
Health-related quality of life
Health-related quality of life (HRQoL) was a secondary outcome
for 22 of the 41 included studies (Table 2). Several different psy-
chometric tools were used for evaluation (Chronic Heart Fail-
ure Symptomatology Questionnaire (CHFSQ); Minnesota Liv-
ing with Heart Failure Questionnaire (MLWHFQ); Kansas City
Cardiomyopathy Questionnaire (KCCQ); Short Form 12 Item
(SF-12); Short Form 36 Item (SF-36); Health Distress Score
(HDS); Improving Chronic Illness Care Evaluation (ICICE);
and Heart Failure Symptom Scale (HFSS)). Eleven structured
telephone support studies measured HRQoL, of which nine
(Angermann 2012 (INH); Baker 2011; Barth 2001; Brandon
2009; Galbreath 2004; Smith 2005; GESICA 2005 (DIAL);
Ramachandran 2007; Sisk 2006; Hebert 2008; Wakefield 2008)
demonstrated significant improvements in component scores or
overall HRQoL measures, and two studies (DeWalt 2006; Riegel
2006) did not. Of the 11 telemonitoring studies that measured
HRQoL, five (45%) (Antonicelli 2008; Blum 2014 (MCCD);
Koehler 2011 (TIM-HF); Seto 2012; Woodend 2008) reported
statistically significant improvements in HRQoL outcomes. Stud-
ies which assessed both telemonitoring and structured telephone
support (Cleland 2005 (Struct Tele) (TENS-HMS); Cleland 2005
(Telemon) (TENS-HMS); Mortara 2009 (Struct Tele) (HHH);
Mortara 2009 (Telemon) (HHH)) have not reportedHRQoLout-
comes.
Healthcare costs and cost effectiveness
Fifteen studies presented detailed cost analysis (cost of the in-
tervention or cost effectiveness) for these two types of technolo-
gies (structured telephone support (Barth 2001; Galbreath 2004
- Smith 2008; Laramee 2003; Ramachandran 2007; Riegel 2002;
Riegel 2006; Sisk 2006 - Hebert 2008; Tsuyuki 2004; Wakefield
2008) and telemonitoring (Balk 2008; Blum 2014 (MCCD);
Dendale 2012 (TEMA-HF1);Giordano 2009; Soran2008 - Soran
2010; Villani 2014 (ICAROS)). Costs varied according to the in-
tensity and technologies used in the intervention. Studies which
reported reduction in the cost of care per admission or overall cost
reduction due to fewer hospitalisations reported cost savings rang-
ing between 14% (Laramee 2003) and 86% (Wakefield 2008).
Three structured telephone support studies (Riegel 2002; Tsuyuki
2004; Wakefield 2008) and one telemonitoring study (Giordano
2009) reported a decrease in costs. Two telemonitoring studies
(Balk 2008; Villani 2014 (ICAROS)) reported increases in cost,
due both to the cost of the intervention and to increased medical
management (Table 3).
Adherence to the intervention
Adherance (compliance) was between 55.1% and 65.8% for struc-
tured telephone support (Chaudhry 2010 (Tele-HF); Krum 2013
(CHAT) - Clark 2007b) and from 75% to 98.5% for telemonitor-
ing (Capomolla 2004; Cleland 2005 (Struct Tele) (TENS-HMS);
Cleland 2005 (Telemon) (TENS-HMS); De Lusignan 2001;
Goldberg 2003 (WHARF); Mortara 2009 (Struct Tele) (HHH);
Mortara 2009 (Telemon) (HHH), Soran 2008) (Table 4).
Acceptability (satisfaction and usability)
Acceptance (satisfaction and usability) of people receiving health
care via technology was rated between 76% and 97% (Balk
2008; Cleland 2005 (Struct Tele) (TENS-HMS); Cleland 2005
(Telemon) (TENS-HMS); Krum 2013 (CHAT) - Clark 2007b;
Vuorinen 2014; Woodend 2008).
The only two videophone studies in this review both had low
satisfaction (De Lusignan 2001) and statistically non-significant
satisfaction ratings (Wakefield 2008) (Table 5).
Heart failure knowledge and self care
Six structured telephone support studies (Baker 2011; Brandon
2009; DeWalt 2006; Domingues 2011; Wakefield 2008;
Zamanzadeh 2013) and one telemonitoring study (Balk 2008)
evaluated the effects of the interventiononparticipants’ knowledge
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of their heart failure. All studies except Wakefield 2008 demon-
strated significant improvements in heart failure knowledge, al-
though Wakefield 2008 did report an improvement in medica-
tion knowledge. Four structured telephone support (Baker 2011;
GESICA 2005 (DIAL); DeWalt 2006; Zamanzadeh 2013) and
one telemonitoring study (Seto 2012) reported significant im-
provements in self-care (Table 6).
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Impact of structured telephone or telemonitoring in heart failure on risk of all-cause hospitalisat ion4
Patient or population: people with heart failure
Setting:
Intervention: structured telephone or telemonitoring
Comparison: usual care
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with usual care Risk with Impact of
structured telephone
or telemonitoring in
CHF on risk of all-
cause hospitalisation
All-cause hospitalisa-
t ion: Structured tele-
phone support verus
usual care
Study populat ion RR 0.95
(0.90 to 1.00)
7216
(16 RCTs) VERY LOW 1,2,3
422 per 1000 401 per 1000
(380 to 422)
Moderate risk populat ion
432 per 1000 411 per 1000
(389 to 432)
All-cause hospitalisa-
t ion: Telemonitoring
versus usual care
Study populat ion RR 0.95
(0.89 to 1.01)
3332
(13 RCTs) VERY LOW 1,2,3
517 per 1000 491 per 1000
(460 to 522)
Moderate risk populat ion
541 per 1000 514 per 1000
(482 to 547)
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* The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95% CI).
CI: Conf idence interval; RR: Risk rat io.
GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
M oderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1Evidence of serious inconsistency in this outcome, due to moderate to substant ial heterogeneity (structured telephone
support I² = 47%; telemonitoring I² = 71%) .
2Evidence of serious imprecision in this outcome, due to wide conf idence intervals around the ef fect measure for individual
studies.
3Publicat ion bias strongly suspected.
4 Length of follow-up ranged f rom 3 months to 16 months for structured telephone support studies and f rom 3 months to 802
days for telemonitoring studies.
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Impact of structured telephone support or telemonitoring in heart failure on risk of heart failure-related hospitalisat ion2
Patient or population: people with heart failure
Setting:
Intervention: structured telephone support or telemonitoring n
Comparison: usual care
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with usual care Risk with Impact of
structured telephone
support or telemonitor-
ing in CHF on risk of
CHF- related hospitali-
sation
CHF-related hospitali-
sat ion: Structured tele-
phone support versus
usual care
Study populat ion RR 0.85
(0.77 to 0.93)
7030
(16 RCTs) MODERATE 1
214 per 1000 182 per 1000
(165 to 199)
Moderate risk populat ion
179 per 1000 152 per 1000
(138 to 167)
CHF-related hospitali-
sat ion: Telemonitoring
versus usual care
Study populat ion RR 0.71
(0.60 to 0.83)
2148
(8 RCTs) MODERATE 1
272 per 1000 193 per 1000
(163 to 225)
Moderate risk populat ion
299 per 1000 212 per 1000
(179 to 248)
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* The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95% CI).
CI: Conf idence interval; RR: Risk rat io.
GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
M oderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1Publicat ion bias strongly suspected.
2Length of follow-up ranged f rom 3 months to 16 months for structured telephone support studies and f rom 3 months to 26
months for telemonitoring studies.
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D I S C U S S I O N
Summary of main results
This review summarises data from 41 trials covering 12,947 par-
ticipants. Two of the included studies trialled both structured tele-
phone support and telemonitoring compared to usual care, there-
fore 43 comparisons are evident. This review demonstrates that
structured telephone support and non-invasive home telemoni-
toring programmes for people with heart failure living in the com-
munity reduce all-cause mortality by 13% (95% CI .0.77 to 0.98)
and 20% (95% CI 0.68 to 0.94) respectively and heart failure-
related hospitalisation by 15% (95% CI 0.77 to 0.93) and 29%
(95% CI 0.60 to 0.83) respectively relative to usual care, but do
not provide evidence of an important effect on all-cause hospitali-
sations. These results confirm those reported in previousCochrane
reviews (Clark 2007a; Inglis 2010), and place in context recent
studies with a neutral outcome that have not materially changed
the point estimates for mortality. However, the reduction in all-
cause hospitalisation for people with heart failure reported in the
previous version of this review (Inglis 2010), was not sustained
in this updated analysis. Several studies reported significant im-
provements in health-related quality of life, as well as heart failure
knowledge and self care. There is also evidence to support some re-
duction in healthcare costs, although this was less consistent across
studies.
The firstRCTsof structured telephone support (compared to usual
care, without home or clinic visits) were published in 1999 (Gattis
1999 (PHARM); Rainville 1999) and the first study of non-inva-
sive telemonitoringwas published in 2001 (De Lusignan 2001). In
the past 15 or more years, information technology has progressed
rapidly alongside the need and demand for chronic disease man-
agement for conditions such as heart failure. The first version of
this review (Clark 2007a) included just nine studies of structured
telephone support and four studies of non-invasive telemonitor-
ing. The first Cochrane review in 2010 (Inglis 2010) included 14
studies of structured telephone support and nine studies of non-
invasive telemonitoring. The current review now includes 25 stud-
ies of structured telephone support and 18 studies of non-invasive
telemonitoring.
Although we found a reduction in the proportion of participants
with a heart failure-related hospitalisation, we did not identify a
consistent effect of structured telephone support or telemonitor-
ing on length of stay for such admissions. Length of stay was in-
consistently reported, thus preventing meta-analysis of this out-
come. It is reasonable to suppose that while remote monitoring
interventions would prevent episodes of hospitalisation through
early detection and management of clinical deterioration, in more
serious episodes of decompensation, hospitalisation would still be
necessary and it cannot be expected that community-based inter-
ventions such as structured telephone support or telemonitoring
would affect the care administered in hospital.
Remote monitoring might be most useful in reducing the risk of
death if it is implemented when patients are unstable or newly
diagnosed, and over a relatively brief period when they need sup-
port and education. We therefore performed sensitivity analyses to
investigate length of follow-up on outcomes. Restricting the anal-
yses only to studies with more than six months follow-up failed to
demonstrate a significant effect of either intervention on all-cause
mortality. However, this might reflect the smaller number of trials
and participants rather than a true lack of effect.
For all-cause mortality there was little heterogeneity amongst pre-
specified subgroups, although we noted a trend of borderline sig-
nificance for a smaller effect of home telemonitoring in more re-
cent studies. Although some technologies appeared inferior, such
as the videophone and IVR, tests for heterogeneity were unable
to confirm differences. Meta-regression tests did not identify het-
erogeneity (P = 0.34) and it is therefore inappropriate to conclude
that apparent differences are well founded.
Neither age group, not the intensity of home telemonitoring, nor
the nature of the structured telephone support proffered had an
influence on the effect of interventions.
For reducing the risks of all-cause hospitalisations, we found no
difference for non-invasive telemonitoring, while for structured
telephone support the effect became barely statistically significant.
When we limited the studies to those with more than six months
follow-up the effect did not change for the telemonitoring inter-
vention, but was improved (and reached statistical significance)
for the structured telephone support intervention.
Both interventions (structured telephone support and non-inva-
sive telemonitoring) showed a consistent and clear reduction in the
risk of heart failure-related hospitalisations. When we used only
studies with more than six months of follow-up, the first effect
improved and the second remained basically unchanged.
We undertook several subgroup analyses to explore heterogeneity
across the included studies. Using data from the previous version
of this review (Inglis 2010), two of these subgroup analyses have
been published (Conway 2014; Inglis 2014).We used heterogene-
ity tests to explore differences across the prespecified subgroups
and meta-regressions to test whether the intervention effect could
depend on the median age of participants or the year of publi-
cation of the trial. We found little conclusive evidence of hetero-
geneity, although in some cases this may have reflected the paucity
of data. These analyses indicate that the effect of the intervention
might change depending on the technologies involved, the inten-
sity of the telemonitoring regimen and also on the year of publi-
cation. For all-cause mortality, only telephone and complex tele-
monitoring studies demonstrated a significant benefit, with mo-
bile/PDA and IVR shown to be ineffective. For both structured
telephone support studies and telemonitoring, studies published
over the period 2000 to 2007 were effective in reducing the risk
of all-cause mortality, but with this effect absent for more recent
studies. Structured telephone support studies focusing on clinical
support demonstrated a significant benefit in reducing the risk of
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all-cause mortality, whereas those which focused on self-manage-
ment education did not. For heart failure-related hospitalisations,
telephone studies, mobile phone/PDA studies and complex tele-
monitoring studies were effective in reducing this risk, while IVR
interventions were ineffective. For structured telephone support
studies, the reduction in the risk of heart failure-related hospital-
isations reduced by year of publication. Assessment of this effect
was limited for telemonitoring studies, as only one study reporting
heart failure-related hospitalisations was published prior to 2008.
The differences between the mean/median age of participants was
most notable for the outcome of heart failure-related hospitalisa-
tions for telemonitoring studies, where studies with a mean/me-
dian age of participants of 70 years or older demonstrated a 43%
reduction in the risk of this outcome (relative to a 25% reduction
for those with a mean/median age below 70 years).
Of the three outcomes included in our primary meta-analysis,
we found the greatest heterogeneity in all-cause hospitalisations
(structured telephone support I² = 47% and telemonitoring stud-
ies I² =71%). Two telemonitoring studies with small numbers of
participants (Antonicelli 2008; Biannic 2012 (SEDIC)) reported
a substantially lower RR for hospitalisation for all-causes (RRs of
0.36 and 0.54 respectively). These two studies account for a large
part of the heterogeneity observed for this outcome, as between
the other studies the heterogeneity is much lower (I² = 40%). The
methodological reasons for this difference in reported outcomes
for these two studies are unclear, but may relate to the intervention
and the clinical management of these participants. There are no
obvious differences in the study participants or study methodol-
ogy that we can identify to account for this difference.
This review demonstrated good evidence for cost effectiveness for
structured telephone support. The expense of telemonitoring has
not been shown to have a cost benefit. Strong evidence is also
emerging for the effect of structured telephone support and tele-
monitoring for improving health-related quality of life, heart fail-
ure knowledge and self-care behaviours.
Adherence was good in most studies reporting this outcome, and
acceptance was strong among the participants in the studies re-
viewed. However, it appears that not all technologies are favoured
by patients exposed to video and IVR. After a decade and a half of
research in this area, what is indisputable from the satisfaction and
quality-of-life evidence was that overall participants liked these
interventions (structured telephone support and telemonitoring).
This is demonstrated by levels of adherence, acceptance, knowl-
edge, self-care behaviours and health-related quality of life. As de-
scribed in the Background, the majority of people with heart fail-
ure do not have access to specialist services. Structured telephone
support and telemonitoring can bridge this gap.
People who use non-invasive home telemonitoring are generally
very positive about their experience. Structured telephone support
and non-invasive home telemonitoring may provide greater ben-
efits when targeting people requiring education about their dis-
ease and optimisation of therapy tailored to their needs. Home
telemonitoring provides the person with the possibility of taking
muchmore informed responsibility for their own care. Integrating
structured telephone support and home telemonitoring into ser-
vicesmay increase their benefits. It may be possible to deliver bene-
fits similar to those of structured telephone support and home tele-
monitoring by intensification of conventional clinic- or commu-
nity-based interventions. However, structured telephone support
or home telemonitoring or both might prove more cost-effective
than intensified conventional care. The possibility of additive or
synergistic benefit from enhanced conventional services and struc-
tured telephone support and home telemonitoring should not be
discounted. For geographically isolated people, remote manage-
ment may be the only feasible means of delivering advice, and
providing monitoring and support. The evidence supports the use
of these interventions.
Overall completeness and applicability of
evidence
Like any systematic review and meta-analysis, our findings are
only as good as the studies which met our inclusion criteria. Fu-
ture updates of this review will incorporate new data along with
the findings of studies which are currently underway but not yet
completed, or only available as a conference abstract or awaiting
classification. We were unable to stratify results according to age,
functional class or sex, as outcomes were not reported in a manner
that allowed us to extract these subgroup-specific data. We were
unable to consider ’patient-years’ as the denominator for ourmeta-
analysis in order to adjust for the differing lengths of follow-up of
the included studies, as these data were very rarely reported.
Correctly identifying all of the outcomes available for each in-
cluded studywas challengingbecause ofmultiple publications aris-
ing from some of the included studies. Many studies published
hospitalisation and mortality findings in one paper, cost findings
in another, and quality of life, acceptability and adherence in an-
other. Often these multiple publications were published with a
different order or list of authors and the study was not always
clearly identified from the title of the paper or the abstract. Future
publications arising from RCTs of structured telephone support
and telemonitoring should be published in a manner which per-
mits easy identification of multiple publications.
Krumholz 2006 has outlined a taxonomy for disease management
which encourages authors to describe their study intervention un-
der eight domains (patient population; intervention recipient; in-
tervention content; delivery personnel; method of communica-
tion; intensity and complexity; environment; and clinical out-
comes). We found that studies inconsistently reported these de-
tails, which in turn did not allow us to explore differences in these
domains as potential explanations for observed heterogeneity be-
tween studies. Many of the included studies were published prior
to publication of the taxonomy. Similarly, Clark 2009 has called
for a more specific evidence base to support the development of
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effective programmes for different populations, and for future re-
views to pool data by sex or age; however, we were unable to do
so in this review as very few of the included studies presented out-
comes in a manner that permitted us to extract these data. Most
studies recruited more men than women. We were also unable to
pool outcomes based on age, other than by using mean/median
age of the study participants. An individual patient data meta-
analysis would be the best method to stratify outcomes according
to important demographic and clinical variables, such as sex, age,
cardiac function and comorbidities.
A major limitation to the studies conducted so far is that the re-
search study is conducted in parallel with the existing service to
patients who are willing to participate in research and by staff that
are usually supernumerary to the service that delivers routine clin-
ical care. This division between research study and clinical service
is likely to make home monitoring less efficient and less effective.
Moreover, the lack of a service means that health professionals will
struggle to get experience and training in conducting home moni-
toring. Ideally, studies should integrate home monitoring into the
routine service. However, until home monitoring, and in particu-
lar telemonitoring, is adopted as a service, this is exceedingly dif-
ficult.
The nature of the control group should be considered with care
when interpreting clinical trials of home telemonitoring. Intensi-
fication of more conventional methods of delivering care, such as
more home or clinic visits, can deliver results similar to those of
home telemonitoring. This may account for the neutral outcome
observed in some studies (Cleland 2009; Dar 2009 (HOME-HF);
Chaudhry 2010 (Tele-HF); Koehler 2011 (TIM-HF)). However,
employing health professionals is by far the largest part of health-
care costs. Technology that can make staff more efficient and ef-
fective may well be cost-neutral or cost-saving.
Participants from socio-economically disadvantaged groups may
have been excluded if they did not have access to a touch-tone
telephone. In the case of telemonitoring the information commu-
nication technology equipment and monitoring devices were pro-
vided by the project, regardless of socioeconomic status.
Quality of the evidence
We assessed the primary outcomes examined in the review using
GRADEPro methodology (Schünemann 2011) to create ’Sum-
mary of findings’ tables. Quality assessment ranged from very low
(all-cause hospitalisation) to moderate (all-cause mortality and
heart failure-related hospitalisation). We downgraded all-cause
mortality and heart failure-related hospitalisation evidence by one
point for strong suspicions of publication bias. We downgraded
all-cause hospitalisation evidence by three points because of evi-
dence of serious inconsistency and imprecision in this outcome,
as well as a strong suspicion of publication bias.
The strong suspicion of publication bias may in some part be due
to the inclusion of only full-text peer-reviewed publications. How-
ever we stand by our decision to exclude studies not yet published
as a full-text peer-reviewed publication and have discussed this
methodological aspect below in the strengths and weaknesses of
this review.
Potential biases in the review process
Our review has adhered to Cochrane methodology, and all review
authors and personnel have at all times tried to avoid or minimise
any biases in the review process. The introduction of several sub-
group analyses in this version of the review was initiated in order
to investigate potential heterogeneity across the included studies.
We classified studies into these categories adhering to clear defi-
nitions and processes; however, minimal details of interventions
and participants reported in some studies may lead to some mi-
nor inaccuracies in these classifications. Of most concern is that
categorisation of studies according to year of publication does not
take into account that for a small number of studies there may be
a substantial time lag between the start of study recruitment and
full-text peer-reviewed publication in a journal.
Publication bias has been noted as an issue in evidence presented
in the review. It may be that the exclusion of studies not yet pub-
lished as a full peer-reviewed publication has given rise to some of
this publication bias. The review captures eight studies currently
awaiting classification and 25 currently ongoing studies. Some of
these currently ongoing studies have not yet reported any study
findings andonly a study protocol was available, for others, interim
results have been presented in the form of conference abstracts,
with very little detail provided to clarify the intervention or usual
care. Our decision to exclude studies not published as a full peer-
reviewed publication was based on research indicating inconsis-
tency between trial findings presented as conference abstracts to
those reported in a full, peer-reviewed publication (Toma 2006).
Another factor which was important in the decision to exclude
studies only available as a conference abstract was the lack of detail
provided regarding the intervention and usual care, thereby not
providing confidence as to the classification of the study in terms
of inclusion/exclusion in the review. Authors of studies available
only as a conference abstract or study protocol were contacted in
order to identify a full peer-reviewed publication for the study. A
response was not received from several studies which are classified
as ongoing or awaiting classification despite multiple attempts to
contact authors.
Agreements and disagreements with other
studies or reviews
This review is novel in that we sought to delineate the benefits
of one form of heart failure disease management on patient out-
comes while controlling for other disease management interven-
tions which may confound the benefits of structured telephone
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support and non-invasive home telemonitoring. It is important to
consider the benefits that these specific interventions can deliver,
as there are some circumstances where such interventions may be
the only option for providing specialised heart failure manage-
ment. Multidisciplinary heart failure management programmes,
designed to improve patient outcomes through structured fol-
low-up with patient education, optimisation of treatment and
psychosocial support, are advocated worldwide as a fundamental
component to the delivery of care. However, because of conflict-
ing trial results, national and international guidelines have so far
not recommended widespread implementation of remote mon-
itoring. The latest European Society of Cardiology Heart Fail-
ure Guidelines (McMurray 2012) state that the effect of inva-
sive (implantable devices) and non-invasive telemonitoring, and
structured telephone support remain unclear, with insufficient evi-
dence to support a guideline recommendation. Similarly the 2013
ACCF/AHA Guidelines for the Management of Heart Failure
(Yancy 2013) acknowledged the problem of the mixed quality of
evidence for specific components of heart failure clinical man-
agement interventions, such as home-based care, disease manage-
ment, and remote telemonitoring programmes. The National In-
stitute for Health and Clinical Excellence (NICE) guidelines in
the United Kingdom (Mant 2011) summarise that telemonitor-
ing reduces mortality and hospitalisation for any reason but does
not seem to improve quality of life or decrease heart failure-re-
lated hospitalisations. For this reason again the guideline did not
include a recommendation for telemonitoring.
Several systematic reviews and meta-analyses have been published
on this topic (Clarke 2011; Kotb 2015; Pandor 2013b; Polisena
2010). Although superficially the recently published reviews ap-
pear similar, there are important differences in inclusion crite-
ria from our review, and particularly the inclusion of home vis-
its or invasive haemodynamic monitoring in their definitions of
’remote monitoring’. Our review focuses solely on non-invasive
monitoring and structured telephone support, and as such we be-
lieve is more relevant for healthcare service planning in resource-
poor environments where access to invasive monitoring or spe-
cially-trained staff to conduct home visits is not an option.
Differences in the inclusion criteria of the recently publishedmeta-
analyses on this topic impair the possibility of directly comparing
our findings with the findings of previous meta-analyses. How-
ever, a critical review of these other reports with our findings high-
lights the uniqueness and importance of our findings. The previ-
ous version of this review included 30 randomised controlled trials
(25 peer-reviewed publications and 5 abstracts) comparing tele-
monitoring or structured telephone support to usual care. Other
recently published systematic reviews and meta-analyses have in-
cluded fewer studies, used different selection criteria, and some
have included cohort studies and/or did not systematically ex-
clude intensified follow-up such as home visits (Clarke 2011; Kotb
2015; Pandor 2013b; Polisena 2010). Nonetheless, overall find-
ings have been consistent in confirming that telemonitoring re-
duces all-cause mortality, especially in those situations where the
quality of usual care is inferior. However, the effect on all-cause or
heart failure-related hospitalisations was more variable.
Strengths and weaknesses of this review
The major strength and advantage of our review is the quantifi-
cation of the benefit of structured telephone support and non-
invasive telemonitoring in the absence of home visits or intensi-
fied clinic follow-up, which identifies for clinicians and healthcare
service planners the value of each of the ’building blocks’ in con-
temporary heart failure disease management programmes, allow-
ing them to be better customised to needs. Another strength of
our systematic review and meta-analysis is that we have consid-
ered and synthesised evidence on many important aspects of heart
failure (mortality, hospitalisations, length of stay, quality of life,
heart failure knowledge and self care, acceptability, and cost).
Weaknesses of this review are due to inadequate reporting by some
studies, which has precluded classification of risks of bias as either
low or high risk, leading to many studies across the categories
being rated as at unclear risk.
Although we have only included studies which were published
as a full-text peer-reviewed publication, we consider that this is a
strength of this review. We do, however, acknowledge that this has
resulted in some studies which are near to reporting final results
not being included in this update. Studies which are yet to report
final results are listed as Studies awaiting classification, and those
which are still ongoing are listed as Ongoing studies.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Compared to usual conventional care, implementation of struc-
tured telephone support and non-invasive home telemonitoring
reduces mortality and heart failure-related hospitalisations, im-
proves quality of life, heart failure knowledge and self-care be-
haviours and therefore should be considered evidence-based strate-
gies to improve the quality of care and outcomes for people with
heart failure.
As the equipment for these interventions was in most cases pro-
vided as part of the study, the implications for purchase, installa-
tion and maintenance of such equipment for use of telemonitor-
ing in particular in the real world needs to be considered as these
may be barriers to the use of telemonitoring.
Implications for research
• Patient preference and engagement is a key factor in
successful delivery of structured telephone support and non-
invasive home telemonitoring services and should be a greater
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focus for future research. Patient approval for these services
appears to be high.
• Structured telephone support and non-invasive home
telemonitoring are a heterogeneous group of interventions.
Further RCTs investigating the benefits of these interventions
would be valuable, but should take into account many factors
including the population to be studied and the intended
interventions for both the active and control groups. Structured
telephone support and non-invasive home telemonitoring may
not be superior to intensive management by conventional means,
and this should be taken into account when planning studies.
Monitoring alone is unlikely to change outcome; actions as a
consequence of monitoring may.
• However, further studies in geographically isolated
communities could be considered unnecessary, as there may be
no satisfactory alternative to structured telephone support and
non-invasive home telemonitoring, and the data in support of
this approach are substantial.
• More consideration should be given to the potential
advantages of cluster-RCTs when evaluating service models,
including structured telephone support and non-invasive home
telemonitoring. This allows structured telephone support and
non-invasive home telemonitoring to be evaluated alongside
other disease management strategies and the ’best’ multi-modal
strategy identified.
• Although there is a plethora of evidence in well-resourced,
high-income countries, consideration should be given to more
studies undertaken in low- and middle-income nations where
the burden of heart failure may increase in the future (Callender
2014b).
• Standard design and reporting criteria for studies of
structured telephone support and non-invasive home
telemonitoring should be developed. The published taxonomy
(Krumholz 2006) should be developed for this purpose.
• Investigators are encouraged to share data. This will enable
individual patient data meta-analysis that can provide insights
into overall effect and in subgroups.
• Future research into ’remote monitoring’ of people with
heart failure should compare the value of remote monitoring
using a variety of different non-invasive technologies as well as
implanted devices.
• The development of closed-loop systems that integrate
physiological measurements into decision-support tools that
allow the patient greater participation in their own disease
management is an exciting area requiring more research. Patient
motivation as well as education may be important.
• More work is required on business models to identify
sustainable, cost-effective services, particularly telemonitoring.
High capital acquisition costs with low running costs argue for
long-term monitoring of individuals. However, renting
equipment argues for monitoring over shorter periods of high
risk with intensive monitoring and education. Business models
will help define how the clinical community use the technology.
• Stratified implementation of technology should be
investigated, according to the severity of illness on the trajectory
of heart failure.
• The potential for remote monitoring in end-of-life care for
heart failure should be investigated.
• Publications relating to studies of these interventions
should clearly identify to which study they relate and where
outcomes are reported across multiple publications, all
publications for a study should detail all of the outcomes and
then indicate which are reported in each publication.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Angermann 2012 (INH)
Methods Open, randomised, 2-armed, parallel-group, multicentre trial
2 groups: nurse co-ordinated disease management programme (HeartNetCare-HF,
HNC) or usual care (UC)
Participants 715 people with heart failure ≥ 18 years of age hospitalised with signs and symptoms of
decompensated heart failure (dyspnoea at rest/minimal exercise plus at least 1 the follow-
ing: raised jugular venous pressure, peripheral oedema, third heart sound or pulmonary
congestion on either clinical examination or radiography) and LVEF ≤ 40%
Mean age 68.6 years.
71% of participants were men.
2%NYHA class I, 58%NYHA class II, 36%NYHA class III, 4%NYHA class IV, mean
LVEF 30%
HNC: n = 352, mean age 67.7 years, 71% men, 3% NYHA class I, 54% NYHA class
II, 40% NYHA class III, 3% NYHA class IV, mean LVEF 30%
UC: n = 363, mean age 69.4 years, 71% men, 2% NYHA class I, 62% NYHA class II,
31% NYHA class III, 5% NYHA class IV, mean LVEF 30%
9 hospitals in Germany.
Interventions Structured telephone support
Electronic scale and BP at participant’s home.
Intervention included: 1) in-hospital face-to-face education; 2) telephone-based struc-
tured monitoring using 19-item questionnaire (assessing indicators of worsening HF,
other cardiac symptoms, medication, health care utilisation, state of mood and general
health and well-being; 3) up titration of HF medication in co-operation with GPs; 4)
needs-adjusted specialist care, which nurses co-ordinated with participant’s physician
All nurses received supervision by cardiologist (weekly) and a psychologist (bimonthly),
and had unrestricted access to their supervisor for questions
Professionals involved: skilled nurses, general practitioners and cardiologist
Frequency of intervention: weekly during the first month, and then individualised ac-
cording to NYHA class at discharge (weekly or fortnightly for NYHA III - IV, monthly
for NYHA I - II) and participant’s needs
Outcomes Follow-up: 180 days
Primary endpoint was time to all-cause rehospitalisation (combined endpoints)
Secondary endpointswere cardiovascular and all-cause death or hospitalisation separately,
time to, number and duration of readmissions, number of days alive and not hospitalised,
changes in NYHA class, HF medication, cardiac function and quality of life
Funding source German Ministry of Education and Research, German Competence Network Heart
Failure, Comprehensive Heart Failure Centre Wurzburg, University of Wurzburg Car-
diovascular Centre
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Angermann 2012 (INH) (Continued)
Comparison Group(s) Usual care: fixed appointment with GP or cardiologist within 7 - 14 days after discharge.
No restrictions were placed on outpatient care
Professionals involved: skilled nurses, general practitioners and cardiologist
Notes New in 2015 review - included as abstract in sensitivity analysis in previous version of
review (Inglis 2010).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Central computer-generated
block random assignment was used (strata:
age (>70 vs. <70 years), sex and type of out-
patient care (cardiologist vs. GP)”
Allocation concealment (selection bias) Low risk Quote: “Patients were randomly assigned
1:1 to either HNC or UC, using sealed en-
velopes”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “An independent committee ad-
judicated the end points (see online-only
Data Supplement Appendix), blinded to
treatment assignment”
Incomplete outcome data (attrition bias)
All outcomes
High risk Quote: “More patients withdrew consent
in HNC; life status at 180 days was ascer-
tained in dropouts and reported as uncen-
sored survival data”
22 UC (6%) and 45 HNC (12%) partic-
ipants withdrew consent. No participants
were lost to follow-up
Comment: Therewere imbalances between
dropouts in the 2 groups. (Uncensored)
survival was assessed but unsure about
other endpoints
Selective reporting (reporting bias) Low risk All prespecified endpoints have been ad-
dressed (except for total duration of read-
missions; duration of first and second hos-
pitalisation has been reported)
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Antonicelli 2008
Methods Randomised controlled trial; intervention arm and control (usual care) arm
Participants 57 people hospitalised for worsening symptoms and signs of CHF with NYHA class
II - IV, evidence of pulmonary congestions on chest x-ray and EF < 40%. People with
NYHA class II - III with an EF > 40% and diastolic LV dysfunction were also included
Mean age 78 years.
61% of participants were men.
Italy
Interventions Telemonitoring
Participants randomised to home telemonitoring-based care were contacted by telephone
at least once a week to collect information on symptoms and treatment adherence as well
as BP,HR, weight and 24h urine output on the previous day. A weekly ECG transmission
was also obtained. Participants were then evaluated and their regimen altered when
necessary based on these data. Additionally, clinic visits were performed when required
based on the data collected or telephone interviews
Outcomes Combined rate of mortality and hospitalisation, these rates considered individually,
quality of life
12-month follow-up.
Funding source Italian Ministry of Health
Comparison Group(s) Usual care involved receiving stand care based on routinely scheduled clinic visits (ev-
ery 4 months) performed by a team specialised in CHF patient management. These
participants were also contacted monthly by telephone to collect data on new hospital
admissions, complications and death. Additional clinic visits were performed whenever
required when clinical status altered
Notes Included previous version of review (Inglis 2010).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of randomisation not stated.
Allocation concealment (selection bias) Unclear risk Not detailed.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not detailed.
Incomplete outcome data (attrition bias)
All outcomes
Low risk No evidence of incomplete outcome data.
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Antonicelli 2008 (Continued)
Selective reporting (reporting bias) Low risk No evidence of selective outcome report-
ing.
Baker 2011
Methods Randomised controlled trial; intervention arm and control (usual care) arm
Participants 605 people with heart failure from general and internal medicine and cardiology clinics
at 4 different sites
Inclusion criteria: diagnosis of heart failure, NYHA Class II - IV symptoms in the past
6 months, current use of a loop diuretic, fluency in English or Spanish and adequate
cognitive function (based on Mini-Cog screening tool)
Mean age 60.7 years.
52% of participants were men.
USA
Interventions Structured telephone support.
Intensive education and self-care training which was based on social cognitive theory
and adult learning theory. This included specific instruction using daily weights to guide
diuretic self adjustment and included an individualised plan developed with the partic-
ipant’s clinician. Over 4 weeks, participants were scheduled to receive 5 - 8 phone calls
from the study educator to reinforce education and to guide the participant towards im-
proved self-care skills. Each call lasted about 10 minutes. The calls focused on reviewing
the content of the initial education session, assessing the participant’s knowledge and
behaviour and providing additional information and encouragement
Outcomes 30 days - Heart failure-related quality of life and heart failure knowledge was assessed
using the Improving Chronic Illness Care Evaulation Heart Failure Symptom Scale
All-cause hospitalisation and mortality at 6 and 12 months.
Funding source Not reported.
Comparison Group(s) Control was a brief educational intervention (BEI), durationof 40minuteswhich covered
daily self assessment and action planning in case of exacerbation, salt avoidance, exercise
andmedication adherence. Participants received an educational manual and a new digital
scale for weighing themselves. All participants in both study arms received this BEI, after
which participants were randomised to the control arm where they continued to receive
usual care, or the intervention
Notes New in 2015 review.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Allocation to study group is done
with concealed, stratified, block random-
ization by the statistical team at UNC.”
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Baker 2011 (Continued)
Allocation concealment (selection bias) Low risk Quote: “Randomization assignments are
placed in sets of opaque envelopes and dis-
tributed to the health educators at each site.
After literacy status is determined and the
BEI is delivered, the health educator opens
the opaque envelope and learns the inter-
vention status of the patient”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Quote: “Patients were called by the UNC
Survey Research Unit (SRU) on day 30 of
the study (with day 1 defined as the day
of the initial in-person educational session)
and a blinded interview conducted.”
Incomplete outcome data (attrition bias)
All outcomes
High risk Quote: “During the 30-day study period..
.72 (11.7%) patients did not complete the
1-month assessment call (41 in the BEI
group and 31 in the TTG group), leaving
259 patients in the BEI group and 272 in
the TTG group”
Selective reporting (reporting bias) Low risk No evidence of selective outcome report-
ing.
Balk 2008
Methods Randomised controlled trial; intervention arm and control (usual care) arm
Participants 214 patients with CHF and NYHA class I - IV.
Mean age 66 years.
70% of participants were men.
The Netherlands.
Interventions Telemonitoring.
Participants in the Intervention group were provided a MOTIVA system (TV-channel
providing educational material, reminders of medication, health-related surveys and mo-
tivational messages to encourage the prescribed lifestyle regimen) in addition to sched-
uled cardiologist appointments. A subgroup of intervention participants also received
automated BP and weight devices that automatically communicated readings via the
telephone (those who had been hospitalised in the prior year for HF). Participaent guid-
ance followed a personalised plan
Outcomes 288 days - mean follow-up.
All-cause hospital days per year, days alive and out of hospital, quality of life, knowledge
of disease, self care
Funding source Study proposed and funded by the healthcare insurance company Achmea
Philips- provision of the MOTIVA system.
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Balk 2008 (Continued)
Comparison Group(s) Control participants were followed by their cardiologists and HF nurses according to
standard local practice
All participants recorded all contacts with healthcare professionals and hospital admis-
sions
Notes Included in previous version of review (Inglis 2010).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Randomisation was performed in
a 1:1 ratio, in randomly permuted blocks
of 30 per participating centre. Randomi-
sation was independently performed...via a
special Web-based application”
Allocation concealment (selection bias) Unclear risk Not detailed.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not detailed.
Incomplete outcome data (attrition bias)
All outcomes
Low risk No evidence of incomplete outcome data.
Selective reporting (reporting bias) Low risk No evidence of selective outcome report-
ing.
Barth 2001
Methods Randomised controlled trial; intervention arm and control (usual care) arm
Participants 34 people discharged from acute care to home with primary diagnosis of CHF
Mean age 75 years.
47% of participants were men.
USA
Interventions Structured telephone support.
Structured nurse-managed telephonic post-discharge programme involving predischarge
education plus post-discharge telephone follow-up. Structured interaction at 72 hours,
144 hours, and then fortnightly
Outcomes Mortality, rehospitalisation, physician and emergency department visits, quality of life,
cost of the intervention
3 months follow-up.
Funding source Not reported.
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Barth 2001 (Continued)
Comparison Group(s) The control group received routine discharge teaching at the time of discharge as per
hospital procedure. Participants were contacted at 2 months for collection of data
Notes Included in previous version of review (Inglis 2010)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of randomisation not stated.
Allocation concealment (selection bias) Unclear risk Not detailed.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not detailed.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not detailed.
Selective reporting (reporting bias) Low risk Not evident.
Bento 2009
Methods Randomised controlled trial. Single-blinded
2 groups: intervention group (nursing consultation and telephone monitoring of edu-
cational nature every 15 days) versus usual care (with monthly telephone monitoring of
epidemiological and administrative nature)
Participants 40 participants with a diagnosis of heart failure and NYHA class I - IV, treated at a heart
failure outpatient clinic with telephone access
Mean age (intervention 54 years; control 61 years, P = 0.046)
70% of participants were men.
IG: n = 20, mean age 54.3 years, 65% men, 5% NYHA I, 65% NYHA II, 30% NYHA
III, 0% NYHA IV
CG: n = 20, mean age 60.7 years, 75% men, 5% NYHA I, 50% NYHA II, 45% NYHA
III, 0% NYHA IV
Brazil
Interventions Structured telephone support
Conventional medical assistance (not otherwise specified), nursing consultation (fort-
nightly or monthly depending on participants’ needs) and telephone monitoring every
15 days (education, recording hospitalisations and emergency treatments). Recomen-
dations on pharmacological treatment, water intake, sodium intake, BP control, body
weight control
Duration: 6 months
Professionals involved: nurses
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Bento 2009 (Continued)
Outcomes Follow-up: 6 months.
All-cause hospitalisations.
Funding source No funding received.
Comparison Group(s) Conventional medical assistance and monthly telephone monitoring of administrative
and epidemiological nature, with no education. The phone calls were aimed at recording
hospitalisations and emergency treatments
Professionals involved: not specified
Notes New in 2015 review.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “The groups were created by simple
random allocation (drawing lots)...”
Allocation concealment (selection bias) Unclear risk Comment: not reported.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Comment: not reported.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: No dropouts reported.
Selective reporting (reporting bias) High risk Comment: Some hospitalisations in the
CGmight have been underreported due to
the fact that some emergency services do
not record these cases
Biannic 2012 (SEDIC)
Methods Randomised controlled trial.
2 groups - classic follow-up group and telemedicine group.
Participants Telemonitoring
Elderly and well-treated population suffering from severe heart failure. Participants older
than 65 years of age, recently hospitalised for HF (EF < 45%)
73 participants (99 randomised); 35 in control group (UC) and 38 in the TM group
TM: mean age 76; 79% men, mean LVEF 31.9%, NYHA II 45.9%, NYHA III 54%
UC: mean age 77.9; 77% men, mean LVEF 31.1%, NYHA II 35.3%, NYHA III 64.
7%
France
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Biannic 2012 (SEDIC) (Continued)
Interventions TM group: TM during 3 months, after which participants all received usual care up
until 1 year
TM: intensity 3 times per week; variables: symptoms, weight and BP
Outcomes Follow-up 3 months (preliminary results; main trial will report on follow up of 1 year)
Primary outcome: number of days in hospital for acute cardiac reasons:
Funding source No funding
Comparison Group(s) Author correspondence: “After an initial consultation with a specialized nurse, all eli-
gible patients participated in therapeutic education sessions, which focused on disease
knowledge and dietetic advice and were part of the French I-Care project endorsed by
the French Society of Cardiology (14). All investigators were asked to treat patients in
accordance with the current guidelines for the management of HF, irrespective of the
group assignment. Automated sphygmomanometers were given to all patients. Patients
assigned to the SOC group were treated in the same manner as those assigned to the
ETM group (including standard therapeutic education), and all subjects were instructed
to contact their physician for HF symptom worsening and weight increase.”
Notes New in 2015 review.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Randomized occurred centrally by
the Unit of Biostatistics and Clinical Re-
search” in Caen.”
Allocation concealment (selection bias) Unclear risk No information provided.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information provided.
Incomplete outcome data (attrition bias)
All outcomes
High risk Both intention-to-treat and per protocol
analysis have been performed.
99 participants were randomized, 11 with-
drew consent after inclusion or refused fur-
ther follow-up, 3 were excluded because of
breach of protocol. 4 never used the TM
system and in 1 participant it was never
installed (because of prolonged hospitali-
sation). 73 participants completed the 3-
month follow-up.
Conflict in the report: “34 patients in the
telemonitoring arm produced at least 1
alert” (Page 43) is in conflict with the num-
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Biannic 2012 (SEDIC) (Continued)
ber of 38 patients reported to be included
in the telemonitoring group
Selective reporting (reporting bias) Low risk Prespecified endpoints were addressed
Blum 2014 (MCCD)
Methods Randomised controlled trial; intervention arm and control (usual care) arm
Participants 204 people with heart failure. Inclusion criteria: hospital admission in the past year; able
to provide informed consent; access to a telephone; systolic or diastolic dysfunction; and
enrolled in Medicare Part A and B
Mean age 72 years.
71% of participants were men.
USA
Interventions Telemonitoring.
All participants were given written material about heart failure and self-management
activities such as daily weights, medication administration, signs and symptoms of wors-
ening heart failure, and were given an opportunity to ask questions or seek clarification
as the handout was discussed
Intervention participants were instructed to use the scale, BP cuff/HR monitor and the
heart rhythm strip monitor at the same time each day. The transmitted data were then
compared to individually assigned parameters based on the participant’s admission and
subsequent evaluations. Readings outside these parameters were flagged for the nurse
practitioner (NP) who did the monitoring. This NP, who had extensive experience in
the management of people with heart failure contacted the participant to gather more
information and, if appropriate, adjusted medications, usually diuretics. There were no
specific protocols as to the management decisions, and decisions were based on the NP’s
experience or consultation with the participant’s cardiologist, or both. If no flags were
noted over the period of 1 month, the participants were called just to maintain contact,
provide encouragement and answer any questions they might have
Outcomes Mean follow-up 802 ± 430 days.
All-cause mortality, hospitalisations (as provided by the authors). Quality of life using
SF-36 and Minnesota Living with Heart Failure Questionnaire at 12 months
Funding source Center for Medicare and Medicaid Services (CMS).
Comparison Group(s) The usual-care group was not contacted again until time to schedule the 6-month follow-
up appointment
Notes New in 2015 review - included as abstract in sensitivity analysis in previous version of
review (Inglis 2010).
Risk of bias
Bias Authors’ judgement Support for judgement
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Blum 2014 (MCCD) (Continued)
Random sequence generation (selection
bias)
Unclear risk Quote: “The subject’s identification infor-
mation was entered into the Mathematica
Policy Research (MPR) randomisation web
site and the designation of participant (tele
monitored group) or control (usual care)
was returned”; author correspondence
Allocation concealment (selection bias) Unclear risk Not detailed.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not detailed.
Incomplete outcome data (attrition bias)
All outcomes
High risk Quote: “Two subjects declined to continue
after signing consent and only partial or
no data were collected on them, one in the
usual care group and one in the monitored
group. Therefore, complete baseline data
was collected on 202 subjects. One subject
completed all of the first visit data and then
declined to accept the monitoring equip-
ment when it was delivered. These sub-
jects were eliminated from the data analysis
leaving 201 subjects; 100 in the usual care
group and 101 in the monitored group”;
author correspondence
Selective reporting (reporting bias) Low risk No evidence of selective outcome report-
ing.
Brandon 2009
Methods Randomised controlled trial using pretest, post-test design.
2 study arms, a control (usual care) and a intervention (advanced-practice nurse-led
telephone intervention)
Participants People with heart failure under the care of 1 cardiologist. Inclusion criteria included
living with heart failure for more than 6 months, capable of self care, telephone access
Mean age of participants was 60 years.
45% men.
USA.
Interventions Structured telephone support.
Advanced Practice Nurse-led intervention was delivered by the same APN throughout
the study. The frequency of the APN-led intervention was weekly for 2 weeks and every
2 weeks for the following 10 weeks. There were 7 telephone appointments for each
participant in the intervention group. The APN-led intervention included education
about the pathophysiology of HF, a low sodium diet, smoking cessation, flu/pneumonia
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Brandon 2009 (Continued)
vaccination, when to call the physician with symptoms of exacerbation and medication
adherence
Outcomes Length of follow-up 3 months.
HF-related hospital admissions; QoL and self-care behaviours
Funding source Not reported.
Comparison Group(s) Participants randomised to the control group received usual care from the cardiologist
clinic. This included education by the physician or a registered nurse about exercise
recommendations, low sodium intake, medications, and when to call the physician with
increased swelling or shortness of breath
Notes HF-hospitalisation data presented only as ANOVA output and unable to be included in
meta-analysis. Authors contacted, but no response received
New in 2015 review.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not detailed: “...participants were ran-
domly assigned to the intervention or usual
care group”
Allocation concealment (selection bias) Unclear risk Not detailed.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not detailed.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not detailed.
Selective reporting (reporting bias) Unclear risk HF-hospitalisation data presented only as
ANOVA output and unable to be included
inmeta-analysis. Authors contacted, but no
response received
Capomolla 2004
Methods Randomised controlled trial; intervention arm and control (usual care) arm
Participants 133 people discharged from specialist CHF unit to home.
Mean age 57 years.
88% of participants were men.
Italy
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Capomolla 2004 (Continued)
Interventions Structured telephone support.
Daily communication of vital signs (including weight, systolic BP, HR) and symptoms
with review by nurses and physicians. Access to medical staff via phone was available as
needed
Outcomes Mortality, re hospitalisation, emergency department visits, compliance with intervention
12 month follow-up.
Funding source Ministero della Salute
Comparison Group(s) Usual care consisted of a referral to the participant’s primary care physician or cardiology
department at discharge. Post-discharge care was governed by the care provider
Notes Included in previous version of this review (Inglis 2010).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of randomisation not stated.
Allocation concealment (selection bias) Unclear risk Not detailed.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not detailed.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not detailed.
Selective reporting (reporting bias) Low risk No evidence of selective outcome report-
ing.
Chaudhry 2010 (Tele-HF)
Methods Randomised controlled trial.
Participants 1653 people who had recently been hospitalised for heart failure enrolled from 2006
through 2009 at 33 cardiology practices across the USA
Median age of the participants was 61 years.
58% of participants were men.
USA.
Interventions Structured telephone support.
All study participants received educational materials developed by the Heart Failure
Society of America, and if needed, a weighing scale
Participants in the intervention group were also provided with detailed instructions and
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Chaudhry 2010 (Tele-HF) (Continued)
a demonstration by site co-ordinators of how to use the system, as well as a touch-tone
telephone, if needed. The intervention was performed using a commercial system, Tel-
Assurance (Pharos Innovations)
The intervention group was instructed to make daily, toll-free calls to the system. Dur-
ing each call, participants, via an interactive voice response system, heard a series of
questions about general health and heart-failure symptoms, and entered responses using
the telephone keypad. Validated depression screening questions were included monthly.
Information from the system was downloaded daily to a secure Internet site and was
reviewed every weekday (except on holidays) by site co-ordinators. All questions had
predetermined responses that triggered “variances” to flag clinicians’ attention. The pro-
tocol required the sites to contact any participant whose response generated variances
and document their management of the variances
Clinicians were instructed to treat participants in accordance with national guidelines
for the management of heart failure
Outcomes Primary endpoint was a composite of readmission for any reason or death from any cause
within 180 days after enrolment. Prespecified secondary endpoints included hospitalisa-
tion for any reason or death from any cause, hospitalisation for heart failure, number of
days in the hospital, number of hospitalisations for any cause, and times to the primary
endpoint and its components
Funding source National Heart, Lung, and Blood Institute.
Comparison Group(s) All study participants received educational materials developed by the Heart Failure
Society of America, and if needed, a weighing scale
Clinicians were instructed to treat participants in accordance with national guidelines
for the management of heart failure
Notes New in 2015 review.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Patientswere randomly assigned to receive usual
care or undergo telemonitoring, according to a sequence
of computer-generated random numbers, with stratifi-
cation on the basis of the study site”
Allocation concealment (selection bias) Low risk Quote: “All patients provided written informed consent
before randomization”
“Randomization is centralized and performed by tele-
phone. Randomization is stratified by study site, and
force randomized within each study site in blocks of
20 (10 intervention, 10 control), to ensure a balance
across study arms within each site. The randomization
sequence is developed by the coordinating center using
a computer random-number generator. The sequence
is unknown to the attending cardiologists and nurses.
86Structured telephone support or non-invasive telemonitoring for patients with heart failure (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Chaudhry 2010 (Tele-HF) (Continued)
The study nurses call the coordinating center when they
enroll a new patient; the coordinating center personnel
then assigns the new patient to intervention or control
group according to the randomization list for that study
site”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “A committee of physicians, all of whom were
unaware of the treatment-group assignments, adjudi-
cated each potential readmission to ensure that the event
qualified as a readmission (and not another clinical en-
counter such as an emergency department visit) and to
determine the primary cause of the readmission”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “A total of 21% of the study patients did not
complete the final telephone interview at 6months. This
rate is not surprising, given the severity of illness in the
study population. Missing data for these patients should
have had minimal influence on our assessment of hospi-
talization and vital status, which were verified through
medical-record review and electronic databases.”
Selective reporting (reporting bias) High risk Comment: The study protocol is available and the pri-
mary endpoint has been adequately reported. However,
following secondary endpoints are missing: number of
office visits with the clinician receiving information from
the telemonitoring system; cost of inpatient and outpa-
tient medical care; health status; participants’ satisfac-
tion with care; and participants’ reported confidence in
their self management of HF
Cleland 2005 (Struct Tele) (TENS-HMS)
Methods Randomised controlled trial; multiple intervention arms and control (usual care) arm
3-armed study with both telephone and telemonitoring.
Participants 426 people with a recent admission for heart failure and LVEF < 40%
Mean age 67 years.
77% of participants were men.
Germany, Netherlands, UK.
Interventions Structured telephone support; telemonitoring.
Participants assigned to the nurse telephone support arm received a telephone call each
month by a heart failure specialist nurse to assess their symptoms and currentmedications
Participants assigned to telemonitoring received the nurse telephone support and had
their weight, BP and ECG monitored twice daily
Outcomes Mortality, rehospitalisation, compliance with intervention.
240-day and 450-day follow-up.
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Cleland 2005 (Struct Tele) (TENS-HMS) (Continued)
Funding source Quote: “The study was funded jointly by the EuropeanUnion’s Trans EuropeanNetwork
(TEN) Telecom programme, which provided most of the financial support for clinical
investigators, data collection, and analysis, and by Philips Medical Systems, which pro-
vided information technology systems, telemonitoring solutions, and support engineers
and contributed to investigator-site staff costs”
Comparison Group(s) Usual care consisted of a management plan forwarded to the participant’s primary care
physician, who was asked to implement it. If the practice involved nurse titration of
drugs this was allowed. Participants were assessed at a research clinic every four months;
contact with the clinic was discouraged between clinic visits
Notes Included in previous review (Inglis 2010).
Results included in meta-analysis are from 240-day follow-up
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random permuted blocks - correspon-
dence from author.
Allocation concealment (selection bias) Low risk After consent and collection of baseline
data an independent statistical centre was
contacted - correspondence from author
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Quote: “Investigators were asked to clas-
sify hospitalizations as due to heart failure,
other cardiovascular, or noncardiovascular.
Deaths were classified as sudden, due to cir-
culatory failure, or due to other causes.”
Incomplete outcome data (attrition bias)
All outcomes
High risk Quote: “...Four were lost to follow-up and
12 declined to comply with regular tele-
monitoring”
Quote: “Analyses were conducted by inten-
tion-to-treat”.
Selective reporting (reporting bias) Low risk Selective outcome reporting not evident.
Cleland 2005 (Telemon) (TENS-HMS)
Methods Randomised controlled trial; multiple intervention arms and control (usual care) arm
3-armed study with both telephone and telemonitoring.
Participants 426 people with a recent admission for heart failure and LVEF < 40%
Mean age 67 years.
77% of participants were men.
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Cleland 2005 (Telemon) (TENS-HMS) (Continued)
Germany, Netherlands, UK.
Interventions Structured telephone support; telemonitoring.
Participants assigned to the nurse telephone support arm received a telephone call each
month by a heart failure specialist nurse to assess their symptoms and currentmedications
Participants assigned to telemonitoring received the nurse telephone support and had
their weight, BP and ECG monitored twice daily
Outcomes Mortality, rehospitalisation, compliance with intervention.
240-day and 450-day follow-up.
Funding source Quote: “The study was funded jointly by the EuropeanUnion’s Trans EuropeanNetwork
(TEN) Telecom programme, which provided most of the financial support for clinical
investigators, data collection, and analysis, and by Philips Medical Systems, which pro-
vided information technology systems, telemonitoring solutions, and support engineers
and contributed to investigator-site staff costs”
Comparison Group(s) Usual care consisted of a management plan forwarded to the participant’s primary care
physician, who was asked to implement it. If the practice involved nurse titration of
drugs this was allowed. Participants were assessed at a research clinic every 4 months;
contact with the clinic was discouraged between clinic visits
Notes Included in previous review (Inglis 2010).
Results included in meta-analysis are from 240-day follow-up
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random permuted blocks; correspondence
from author.
Allocation concealment (selection bias) Unclear risk After consent and collection of baseline
data an independent statistical centre was
contacted; correspondence from author
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Quote: “Investigators were asked to clas-
sify hospitalizations as due to heart failure,
other cardiovascular, or noncardiovascular.
Deaths were classified as sudden, due to cir-
culatory failure, or due to other causes.”
Incomplete outcome data (attrition bias)
All outcomes
High risk Quote: “...Four were lost to follow-up and
12 declined to comply with regular tele-
monitoring”
Quote: “Analyses were conducted by inten-
tion-to-treat”.
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Cleland 2005 (Telemon) (TENS-HMS) (Continued)
Selective reporting (reporting bias) Low risk Selective outcome reporting not evident.
De Lusignan 2001
Methods Randomised controlled trial; intervention arm and control (usual care) arm
Participants 20 people with heart failure confirmed by cardiologist, identified from the database of
an academic general practice
Mean age 75 years.
Number or proportion of men and women not specified.
UK.
Interventions Telemonitoring.
Telemonitoring of vital signs (pulse, BP, weight) and clinical status daily assessed daily
by nurses along with video consultations with a nurse weekly for 3 months, fortnightly
for 3 months, then monthly
Outcomes Mortality, compliance with intervention andmedication, participant satisfaction, quality
of life
12 month follow-up.
Funding source Hewlett Packard now Agilent.MSDPharmaceuticals, Herts who funded the assessments
of the controls
Comparison Group(s) Usual care consisted of standard general practice treatment; in addition they had their
pulse, BP and weight measured quarterly. They were evaluated in the same manner as
the intervention group
Notes Included in previous version of review (Inglis 2010).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “The first 20 patients identified
by random table allocation 10 to the
telemedicine and 10 to the control group..
.”
Allocation concealment (selection bias) Unclear risk Not detailed.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not detailed.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not detailed.
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De Lusignan 2001 (Continued)
Selective reporting (reporting bias) Low risk No evidence of selective outcome report-
ing.
DeBusk 2004
Methods Randomised controlled trial; intervention arm and control (usual care) arm
Participants 462 people hospitalised with a provisional diagnosis of CHF from Kaiser Permanente
Mean age 72 years.
51% of participants were men.
USA.
Interventions Structured telephone support.
Standardised telephonic physician-directed nurse-managed case management, involving
CHF lifestyle education and medication management. Participants contacted weekly for
6 weeks, biweekly for 8 weeks and then monthly and bimonthly
Outcomes Mortality, rehospitalisation, emergency and outpatient department visits, prescription
of recommended pharmacotherapy
12 months follow-up.
Funding source National Heart, Lung, and Blood Institute.
Comparison Group(s) Usual care not clearly defined, but was provided by the participating Kaiser Permanente
medical centres, appeared to involve a high frequency of all of kinds of follow-up clinic
visits (13 in 12 months following hospitalisation)
Notes Included in previous version of review (Inglis 2010).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Equal numbers of patients were
allocated to the 2 groups in each medical
center by using the Efron procedure”.
Allocation concealment (selection bias) Low risk Quote: “Research staff who were not asso-
ciated with delivering the intervention ran-
domly assigned patients to treatment con-
ditions by using sealed assignments.”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “Research staff who were not asso-
ciated with, and were blinded to, the in-
tervention conditionsmeasuredhealth out-
comes at 12 months.”
91Structured telephone support or non-invasive telemonitoring for patients with heart failure (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
DeBusk 2004 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
High risk Quote: “During the first year of follow-up,
23 patients (3%) dropped out of the trial (8
in the treatment group and 15 in the usual
care group)”
The analysis was by intention-to-treat.
Selective reporting (reporting bias) Low risk No evidence of selective reporting.
Dendale 2012 (TEMA-HF1)
Methods Multicentre RCT (all centres located in Belgium).
Follow-up: 6 months
2 arms: Telemonitoring (TM) versus usual care.
Participants 160 people hospitalised with heart failure. Inclusion criteria included: hospitalisation
for fluid overload due to heart failure requiring an increase or initiation of diuretic
treatment. All participants had to be treated with an ACE inhibitor or angiotensin II
receptor antagonist, and with a beta-blocker in the absence of contraindications. Only
people with sufficient cognitive function to operate the telemonitoring equipment
Mean age 76 years.
65% of participants were men.
All: n = 160, mean age 76 years, 65% men, mean LVEF 35%; NYHA class III
TM: n = 80, mean age 77 years, 62% men, mean LVEF 32.5%, mean NYHA class III
UC: n = 80, mean age 77 years, 67% men, mean LVEF 35%, mean NYHA class III
Belgium.
Interventions Telemonitoring.
Daily measurement of weight, BP and HR for 6 months. Participants were seen at the
HF clinic 2 weeks after discharge, and at 3 and 6 months (but were allowed to visit the
clinic sooner or more frequently if necessary)
Professionals involved: GP, heart failure clinic (HF nurse and cardiologist)
Outcomes Primary endpoint was all-cause mortality.
Secondary endpoints were days lost until death, hospitalisation or dialysis and number
of hospitalisations and cost of hospitalisations
6 month follow-up.
Funding source The Belgian Government Health Insurance Institute; Leo Pharma
Comparison Group(s) All participants were seen at the HF clinic 2 weeks after discharge. No intervention by
the study nurse or HF clinic was done thereafter
Professionals involved: GP (who could refer participants to their cardiologist if needed)
Notes New in 2015 review.
Risk of bias
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Dendale 2012 (TEMA-HF1) (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Next, patients were block ran-
domised by sealed envelopes to 6 months
of intense follow-up facilitated by TM or
usual care”
Allocation concealment (selection bias) Low risk Comment: Method of allocation conceal-
ment was sealed envelopes
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “To decrease the risk of bias in an
unblinded study, the data were collected
by a data manager not involved in patient
care, and not stationed in one of the par-
ticipating hospitals. The statistical analy-
sis was done by a statistician not involved
in patient care. The reason for hospital-
ization was determined based on the dis-
charge letter and adjudicated after the end
of the study in a blinded way, and the
primary endpoint was all-cause mortality,
which avoided the difficulty of determin-
ing the cause of death.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “Four patients dropped out prema-
turely because of lack of motivation (tim-
ing and assigned group not specified). Data
from these subjects were included in the
analysis (intention to treat)”
Selective reporting (reporting bias) Low risk Comment: The study protocol is not avail-
able but the results paper reports on all pre-
specified outcomes
DeWalt 2006
Methods Randomised controlled trial; intervention arm and control (usual care) arm
Participants 127 people with confirmed HF, NYHA class II - IV symptoms within the last 3 months
and currently taking furosemide from the University of North Carolina (UNC) General
Internal Medicine Practice
Mean age 62.5 years.
47% of participants were men.
USA.
Interventions Structured telephone support.
Intervention participants received self-care education, picture-based educational mate-
rials with verbal explanation, a digital scale and scheduled follow-up phone calls (days
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DeWalt 2006 (Continued)
3, 7, 14, 21, 28, 56) and monthly during months 3 - 6 for reinforcement of education
and revision of individualised care plan
Outcomes Mortality, all-cause rehospitalisation, HF-related quality of life, HF self efficacy, HF
knowledge, reported weight monitoring (self-management behaviour)
12 month follow-up.
Funding source Pfizer Health Literacy Initiative, the Robert Wood Johnson Clinical Scholars Program,
the University of North Carolina Program on Health Outcomes, and the National In-
stitute of Nursing Research, NIH
Comparison Group(s) Control group participants received a general heart failure education pamphlet and usual
care from their primary physician (not specified). Data collection occurred at 6 and 12
months via in-person interview and medical record review
Notes Included in previous version of review (Inglis 2010).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “..randomised patients by con-
cealed allocation based on a random num-
ber generator”
Allocation concealment (selection bias) Unclear risk Comment: Unclear if randomisation per-
formed before or after consent provided
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Quote: “We assessed outcomes at 6 and 12
months through in-person interviews and
review of the medical record. To be sensi-
tive to low literacy, all interviews were con-
ducted verbally by a trained research assis-
tant. If patients were unable to come to
clinic for the interview, it was conducted
by phone. The research assistant was not
blinded to the patient’s study group.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “Patients who did not return any
phone calls and did not return for follow-
up assessment did not have outcome data
for analysis. Patients who withdrew from
the study were censored at the time of with-
drawal; any data collected prior to with-
drawal were included in the analysis” p5
“Of those randomised to the control group,
1 never returned after the first visit, 1 with-
drew during the study and 4 died during
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the study. Follow-up was completed for all
of the remaining participants (98%)”
Selective reporting (reporting bias) Low risk No evidence of selective reporting.
Domingues 2011
Methods Randomised controlled trial.
2 groups: intervention group (IG): education during hospitalisation followed by tele-
phone monitoring after discharge, and control group (CG): in-hospital education only
Participants 120 people randomised (57 IG and 63 CG). Inclusion criteria included: ≥ 18 years
old with HF regardless of the aetiology and LVEF ≤ 45%. Only patients who had a
telephone number
available for after-discharge contact were included.
After randomisation 9 patients were excluded (2 deaths, 1 stopped treatment and 6
patients difficult to contact)
Mean age 63 years, 68% male, mean LVEF 29%, NYHA not reported (n = 111)
IG: n = 48, mean age 62 years, 67% men, mean LVEF 29%
CG: n = 63, mean age 63 years, 51% men, mean LVEF 29%
Brazil
Interventions Education in hospital (3 - 5 visits).
Systematic telephone contact (study nurse) for a 3-month period
1 telephone contact per week during the 1st month, followed by 1 every 15 days in the
2nd and 3rd month
Outcomes Follow-up: 3 months
Primary outcome was HF awareness and self-care knowledge scores
Secondary outcomes were frequency of visits to the emergency room, rehospitalisations
and death at the end of the 3 month follow-up
Funding source FIPE (Fundação Instituto de Pasquisas Econ micas) and CNPq (Conselho Nacional de
Desenvolvimento Cientico e Tecnologico)
Comparison Group(s) Education in hospital (3 - 5 visits).
Follow-up of the participant at the return appointment to the outpatient clinic without
any telephone contact in between
Notes New in 2015 review.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “After discharge from the hospital,
patients were randomised to receive sys-
tematic telephone contacts for a 3-month
95Structured telephone support or non-invasive telemonitoring for patients with heart failure (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Domingues 2011 (Continued)
investigational period (intervention group-
IG) or to receive the usual care.”
Comment: Method of randomisation not
specified.
Allocation concealment (selection bias) Unclear risk Comment: Not detailed.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Comment: Not detailed.
Incomplete outcome data (attrition bias)
All outcomes
High risk Quote: “After randomisation, 9 patients
were excluded from the IG (n=2 deaths, n=
1 quit treatment, n= 6 could not contact)
. At the end of the study, 87 patients com-
pleted the study protocol, of which 40 were
from the IG and 47 from the CG.”
Comment: Data for 9 participants ex-
cluded after randomisation were not in-
cluded in the analysis
Selective reporting (reporting bias) Low risk Comment: All prespecified outcomes have
been addressed.
Galbreath 2004
Methods Randomised controlled trial; intervention arm and control (usual care) arm
Participants 1069 people with symptoms of CHF and documented systolic (mean EF 35%) or
diastolic dysfunction (echo confirmed)
Mean age 71 years.
71% of participants were men.
USA.
Interventions Structured telephone support.
All intervention participants received bathroom scales and were assigned a disease man-
ager who administered the disease management programme telephonically. Initial call
frequency was weekly then transitioned to monthly for the duration of the study. Call
frequency could be adjusted for acuity or need. After each call a call summary was faxed
to the participant’s primary care provider
An additional randomisation was performed within the intervention arm, with some
participants provided with in-home technology (BP monitor, pulse oximeter). These
measurements were reported by the participant to the disease manager, but the data
were not forwarded to the primary care provider. These participants also wore activity
monitors at regular intervals and had 6-monthly measurement of thoracic bioimpedance
cardiac output; these data were not forwarded to the primary care physician
The authors state: “because data derived from the technology were not used in clinical
management, we combined results from the two treatment groups for the purposes of
this analysis.”
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Traditional-care participants were managed as usual by their physicians
Outcomes All-cause mortality, 6-minute walk performance, functional therapeutic class improve-
ment, total healthcare costs. Improvement in ejection fraction andmedication adherence
were assessed in a subgroup
18-month follow-up.
Funding source US Department of Defense, US Army Medical Research Acquisition Activity. Clinical
space was provided by TEAM Research of Seguin, McKenna.
Neighborhood Clinic, and Hill Country Medical Associates.
Comparison Group(s) Traditional-care participants were managed as usual by their physicians
Notes Included in previous version of review (Inglis 2010).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Participants were randomised in a
2:1 ratio between the treatment and control
groups”
Method of randomisation not detailed.
Allocation concealment (selection bias) Low risk Randomisation performed after informed
consent obtained.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Quote: “To assess economic and utiliza-
tion outcomes, we thoroughly reviewed
patient medical records. Records covering
the period of a patient’s enrollment in
the trial were requested from both PCPs
and specialty physicians. Records of inpa-
tient and outpatient encounters and emer-
gency department visits were culled from
patient self-reported data, reviews of elec-
tronic hospital records, and documents re-
ceived fromphysician and clinic charts. Re-
views were performed by study staff, con-
sisting of physicians, nurses, and ancillary
health providers.”
Incomplete outcome data (attrition bias)
All outcomes
High risk Some evidence of attrition of study partic-
ipants but actual numbers not presented
Selective reporting (reporting bias) Low risk No evidence of selective reporting.
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Gattis 1999 (PHARM)
Methods Randomised controlled trial; intervention arm and control (usual care) arm
Participants 181 people with heart failure being evaluated in cardiology clinic
Mean age 67 years.
68% of participants were men.
USA.
Interventions Structured telephone support.
Clinical pharmacist-led medication review and patient education. Regularly-scheduled
telephone contact (at 2, 12 and 24 weeks) to detect clinical deterioration early
Outcomes Mortality, rehospitalisation, medication prescription.
6-month follow-up.
Funding source American Society of Health-System Pharmacists Research and Education Foundation,
Bethesda, Md and the Duke Clinical Research Institute
Comparison Group(s) The control group received usual care which did not include the pharmacist providing
recommendations regarding drug therapy to the attending physician or providing ed-
ucation to the participant. Participant assessment and education were provided by the
attending physician and/or physician assistant or nurse practitioner. The participant was
contacted by the pharmacist via telephone to identify clinical events
Notes Included in previous version of review (Inglis 2010).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “...patients were randomised ac-
cording to a computer-generated randomi-
sation scheme..”
Allocation concealment (selection bias) Unclear risk Not detailed.
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “...clinical events were adjudicated
by a blinded end point committee”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not detailed.
Selective reporting (reporting bias) Low risk No evidence of selective reporting.
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GESICA 2005 (DIAL)
Methods Randomised controlled trial; intervention arm and control (usual care) arm
Participants 1518 outpatients with stable CHF.
Mean age 65 years.
71% of participants were men.
Argentina.
Interventions Structured telephone support.
Nurses trained in the management of people with CHF performed structured telephone
follow-up based on adherence to diet and treatment, monitoring of symptoms, control
of fluid retention and daily physical activity. Participants were contacted 4 times in the
first fortnight and then as needed
Outcomes Mortality, rehospitalisation, quality of life.
Mean 16-month follow-up.
Funding source GESICA (Grupo de Estudio de Sobrevida en la Insuficiencia Cardíaca en la Argentina)
Foundation with unrestricted collaboration from the following local companies in Ar-
gentina: Roche, Boehringer Ingelheim, Bagó, Pharmacia, Novartis, and Merck Sharp
and Dohme
Comparison Group(s) Participants in the control group were followed by their attending cardiologists and
received care similar to the intervention group
Notes Included in previous version of review (Inglis 2010).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “We then used concealed randomi-
sation lists to do permuted block randomi-
sation stratified by attending cardiologist ”
Allocation concealment (selection bias) Low risk After provision of consent, patient’s cardi-
ologist contacted study centre (BMJ com-
ment)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “The clinical events committee,
which was blinded to the patients’ treat-
ment group assignment, adjudicated all
outcomes.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “Follow-up was completed in 1511
(99.5%) randomised patients”
Quote: “We based all analyses on the in-
tention to treat principle”
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GESICA 2005 (DIAL) (Continued)
Selective reporting (reporting bias) Low risk No evidence of selective reporting.
Giordano 2009
Methods Randomised controlled trial; intervention arm and control (usual care) arm
Participants 460 people with confirmed CHF with LVEF < 40% and at least 1 hospitalisation for
acute HF in the prior year
Mean age 57 years.
85% of participants were men.
Italy.
Interventions Telemonitoring.
Home-Based Telemanagement (HBT) participants received a 1-lead trace portable de-
vice that transferred results via telephone where a nurse was available for interactive
teleconsultation. Scheduled standardised telemonitoring appointments were performed
every week to15 days depending on HF severity discussing symptomology, medications,
self care and, if required, the transmission of the ECG trace
Outcomes Unplanned cardiovascular hospital readmissions, hospitalisation for HF, haemodynamic
instability episode occurrence, cardiovascular mortality
12-month follow-up.
Funding source National Ministry of Health.
Comparison Group(s) Usual care consisted of participants being referred to their primary care physician (PCP)
and cardiologist for clinical management. These participants attended a 2-weeks post-
discharge PCP appointment and a structured follow-up outpatient cardiologist appoint-
ment at 12 months
Notes Included in previous version of review (Inglis 2010).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Randompermuted blocks for each
center were used to allocate patients to
treatment groups”
Allocation concealment (selection bias) Unclear risk Not detailed.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Quote: “The data and the cause of read-
mission were obtained from the GP and
confirmed by hospital records. Episodes of
clinical instability were confirmed by the
GP. Cardiovascular deaths were ascertained
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Giordano 2009 (Continued)
through the GP or hospital records.”
Incomplete outcome data (attrition bias)
All outcomes
High risk Quote: “...one patient in UC group and
four in HBT group were lost to follow-up”
p196
Quote: “Analyses were conducted accord-
ing to the intention-to treat approach”
Selective reporting (reporting bias) Low risk Selective outcome reporting not evident.
Goldberg 2003 (WHARF)
Methods Randomised controlled trial; intervention arm and control (usual care) arm
Participants 280 people hospitalised with NYHA Class III - IV, with a LVEF < 35%
Mean age 59 years.
68% of participants were men.
USA.
Interventions Telemonitoring.
Daily transmission of weight and symptoms using a customised monitor, data was re-
viewed daily by nurses and concerns reported to the physician
Outcomes Mortality, rehospitalisation, emergency department visits, quality of life, participant
satisfaction, compliance with intervention
Mean 6-month follow-up.
Funding source Alere Medical, Incorporated.
Comparison Group(s) Participants in the control group were instructed to contact their physician for weight
increases of more than a prespecified amount or if their symptoms of heart failure wors-
ened. They had a weight log to bring to visits. Follow-up visits, other than study visits
were at the discretion of the treating physician. Telephone contacts were permitted at
the discretion of the treating physician or nurse
Notes Included in previous version of review (Inglis 2010).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: method of randomisation not
detailed.
Allocation concealment (selection bias) Low risk Quote: “After informed consent was ob-
tained and screening laboratory evaluations
were completed, patients were random-
ized”
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Goldberg 2003 (WHARF) (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “To insure that all hospitalizations,
emergency room visits, and deaths were
identified, all patients were contacted by
telephone on a monthly basis by a non
medical surveyor (blinded to patient treat-
ment group randomization), located out-
side of the enrollment sites and Alere mon-
itoring center. Records were obtained for
each of these events, including those occur-
ring outside of the participating health sys-
tems.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “During the study, 32 patients ei-
ther refused follow-up data collection or
were lost to follow-up. Seven patients re-
ceived cardiac transplantation and were
censored on the day of transplant. Exclud-
ing deaths, there was no difference between
groups in the percentage of patients who
failed to complete six months of follow-up”
Selective reporting (reporting bias) Low risk Comment: some nominated outcomes
(satisfaction) were not reported
Koehler 2011 (TIM-HF)
Methods Open, randomised, parallel-group, prospective multicentre clinical trial
Participants A total of 710 people (354 patients RTM group and 356 to the usual care group) with
chronic HF who had signed informed consent were eligible to participate if they were at
least 18 years of age, were in NYHA class II or III, and had a LVEF of 35%
Mean age 66.9 years
80% men
Germany
Interventions Quote: “The telemonitoring system used in the TIM-HF trial is based on a wireless
Bluetooth systemwith a personal digital assistant (PDA) as the central structural element.
The only prerequisite for this system to function once installed is the availability of
a mobile phone network connection. Three measuring devices are integrated into the
system, namely one to collect electrocardiogram (ECG)measurements, one to collect BP
measurements, and one to collect body weight. Each device is equipped with a Bluetooth
chip and connected to the PDA. The patient performs the daily self-assessment of health
status by using the PDA interface. A subgroup of patients in the intervention group
performed a 6-min walk test using a telemedical accelerometer once a month starting 3
months after randomization.”
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Koehler 2011 (TIM-HF) (Continued)
Outcomes Quote: “The primary endpoint is all-cause mortality. The first secondary endpoint is a
composite of the combined rate of cardiovascular death and hospitalization for worsening
heart failure. For this composite endpoint, patientswill be followed for all hospitalizations
for heart failure until death or the end of follow-up thus enabling the possibility to report
event rates for each event. Other secondary endpoints include:
• days lost due to death or heart failure hospitalization,
• cardiovascular mortality,
• rate of cardiovascular hospitalization at 6, 12 and 24 months
• rate of hospitalization for Heart Failure at 6, 12 and 24 months
• hospitalization for any reason,
• cardiovascular hospitalization,
• hospitalization for heart failure,
• duration of all hospitalizations for heart failure,
• NYHA functional class at 12 months and 24 months adjusted for baseline,
• SF-36 physical functioning score at 12 months and 24 months adjusted for
baseline, and
• PHQ-9 depression score, 12 months and 24 months adjusted for baseline.
As for the first secondary endpoint, patients will be followed for all events until death or
the end of follow-up.”
Quote: “Power Calculation: The sample size calculation was based on the assumption of
a mortality rate of 27% in the control group and 17% in the intervention group. This
corresponds to a relative risk (RR) of 0.63, which is comparable to the effect of remote
patient management reported by Cleland et al (2005) (RR=0.65) and more conservative
than the findings of Goldberg et al (2003) (RR=0.44).”
Funding source Quote: “The technology development as well as the clinical trial was funded in a public-
private partnership through a research grant of the German Federal Ministry of Eco-
nomics and Technology (01MG531) and by the following companies: Robert Bosch
Healthcare GmbH, Waiblingen, Germany; InterComponentWare AG, Walldorf, Ger-
many; and Aipermon GmbH & Co KG, Munich, Germany.”
Comparison Group(s) Quote: “Patients randomized to the usual care group were followed by their treating
physician who was instructed to ensure that the patients were optimally treated for their
heart failure in accordance with the current standards and guidelines for treatment of
patients with CHF.”
Notes New in 2015 review.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Patients were then assigned to
one of the two treatment arms by a cen-
tral computerized randomization system.
In order to achieve a balance of potential
risk factors in the treatment arms, Pocock’s
minimization algorithm5 (with 20% resid-
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Koehler 2011 (TIM-HF) (Continued)
ual randomness) was used, with the fol-
lowing variables: NYHA class II or III,
hospitalization for heart failure within 2
years prior to randomization, implanted
defibrillator, region (Berlin-Brandenburg
or Baden-Württemberg), age group (,60 or
60-70 or .70 years), known diabetes mel-
litus, known cerebrovascular disease, living
alone or with partner, gender, presence of
CRT, use of statins, and use of aldosterone
receptor antagonists.”
Allocation concealment (selection bias) Low risk Comment: Investigators were unaware of
the randomisation sequence
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “A Clinical Endpoint Committee
(CEC), blinded to treatment allocation,
will classify all deaths and hospitalizations
using pre-defined criteria as detailed in the
CEC charter”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “The essential features of the
planned statistical analyses are as follows:
two analysis populations will be distin-
guished-the full analysis set (FAS) and the
per protocol analysis population.”
Selective reporting (reporting bias) Low risk Comment: Not all data for changes in
NYHA class, PHQ-9 and SF-36 are re-
ported (but percentages at 12 and 24
months are reported)
Krum 2013 (CHAT)
Methods Cluster-randomised controlled trial. Computer-generated random sequence
GP practices were the unit of randomisation. GPs were not blinded to allocation group
before recruiting and consenting participants
Participants 405 people with a recent hospital discharge due to a primary diagnosis of heart failure
with an EF of 40% and in NYHA class II - IV were randomised to either usual care or
usual care plus telephone monitoring performed at least once per month
Mean age 73 years.
61% of participants were men.
Australia.
Interventions Structured telephone support.
Nurse-led telephone monitoring using the Telewatch System (Baltimore)
Participant responded to computer-generated CHF self-monitoring questions by press-
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Krum 2013 (CHAT) (Continued)
ing the numbers on the touch-phone key pad
Nurse survey incoming calls daily and responded to preset variations to participant’s
parameters
Outcomes The primary endpoint was the change in Packer clinical composite score. HRQOL,
BNP. Secondary endpoints included: all-cause death and all-cause hospitalisation as well
as heart failure-related death and heart failure-specific hospitalisation
Participants were assessed by a blinded reviewer at baseline and then after 6 and 12
months
12 months follow-up.
Funding source NationalHealth andMedical ResearchCouncil, NationalHeart Foundation of Australia,
and Medical Benefits Fund
Comparison Group(s) Usual care discharge follow-up with GP and copy of guidelines
Notes New in 2015 review; included as abstract in sensitivity analysis in previous version of
review (Inglis 2010).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random sequence.
Allocation concealment (selection bias) Unclear risk Quote: “The study involved cluster ran-
domization at the level of the general prac-
titioner (1:1, usual care, usual care plus in-
tervention, stratified by rural, remote and
outer metropolitan area [RRMA] classifi-
cation). This was to minimize contamina-
tion across the two interventions to which
patients were randomized.”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “All patients regardless of treat-
ment allocation were followed up by an in-
dependent reviewer, blinded to treatment
allocation, and asked to complete a tele-
phone survey at baseline and at 6 and 12
months. The survey included questions re-
lating to quality of life (Minnesota Living
with Heart Failure questionnaire), NYHA
class, global health assessment, EQ-5DEu-
roQOL, and questions regarding utiliza-
tion of health services.”
Quote: “All hospitalization data were ad-
judicated by three cardiologists (blinded
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Krum 2013 (CHAT) (Continued)
to randomization allocation) to determine
whether the hospitalizations were related to
heart failure.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “Intention-to-treat analyses were
performed for all endpoints”
Selective reporting (reporting bias) Low risk No evidence of selective outcome report-
ing.
Laramee 2003
Methods Randomised controlled trial; intervention arm and control (usual care) arm
Participants 287 people admitted to hospital with primary or secondary diagnosis of CHF: LVSD <
40% or radiological evidence of pulmonary oedema
Mean age 71 years.
54% of participants were men.
USA.
Interventions Structured telephone support.
Telephonic case management performed by 1 CHF nurse case manager, involving 4
major components: early discharge planning, participant and family CHF education,
promotion of optimal CHF medications and 12 weeks of telephone follow-up.
Outcomes Mortality, rehospitalisation, inpatient and outpatient costs, medication prescription and
adherence
3-month follow-up.
Funding source Novartis Pharmaceuticals.
Comparison Group(s) Usual care consisted of standard care typical of a tertiary-care hospital. It included inpa-
tient social service evaluation (25%), dietary consultation (15%), physiotherapy/occu-
pational therapy (17%) and medication and CHF education by nurses. Post-discharge
was conducted by the participant’s own local physician, 44% received some home-care
services
Notes Included in previous version of this review (Inglis 2010).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “After simple randomisation of the
first 42patients resulted in large amounts of
patients being assigned to one group or the
other, patients were randomised in blocks
of 8 to endure an even group allocation
106Structured telephone support or non-invasive telemonitoring for patients with heart failure (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Laramee 2003 (Continued)
across time”
Allocation concealment (selection bias) Unclear risk Not detailed.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not detailed.
Incomplete outcome data (attrition bias)
All outcomes
High risk Quote: “Patients who withdrew, died or
were otherwise lost before 90 days of fol-
low-up were censored on the day of early
attrition”
Selective reporting (reporting bias) Low risk One secondary outcome not reported:
number of days until first readmission
Lyngå 2012 (WISH)
Methods A multicentre, randomised controlled trial (RCT) involving 6 hospitals in Sweden
Participants Quote: “A total of 344 patients were randomized in the study and, of them, 319 were
included in the final ITT analysis. Twenty-five patients were, after being randomized,
found not to be satisfy the inclusion criteria due to reasons such as having an LVEF .
50%, myocardial infarction within 2 months before inclusion, not being hospitalized
before enrolment, or moved to a nursing home just after randomization. These patients
were excluded from further analysis.”
75% of participants were men.
Mean age 73.9 years
Sweden
Interventions Telemonitoring.
Quote: “Patients randomized to the IG were given an electronic scale (Zenicor Medical
SystemsAB ) to install in their homes. A fewpatients required help to install the electronic
scale. The scale could be placed anywhere in the patients’ home and, after weighing, a
wireless signal was sent from the scale to a modem plugged into the patient’s telephone.
The weight was then automatically transmitted via the telephone network to a central
internet-based data server system (Zenicor Medical Systems AB). Hence, the weight
could be checked from any computer with internet access. The Zenicor system produces
an alarm if patients show a weight gain of .2 kg from the target weight (body weight at
discharge from hospital) and also if there is an upward trend with a weight increase of .
2 kg in 3 days.”
Outcomes Quote: “Primary endpoint, i.e. cardiac re-hospitalization. Information on hospitaliza-
tion, cardiac and other, and death was collected from the medical register at the local
health authorities.”
Quote: “Based on previous research, we assumed a re-admission rate due to a cardiac
cause of 40% in the control group (CG)3 and 25% in the intervention group (IG). To
detect the difference between the groups, with a power of 80% and an alpha-value of 0.
05, a sample size of 152 patients in each group was needed.”
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Lyngå 2012 (WISH) (Continued)
12 month follow-up.
Funding source The Swedish Governmental Agency for Innovation Systems (VINNOVA); the Swedish
Heart and Lung foundation
Comparison Group(s) Quote: “The patients in the CG were informed to contact the HF clinic on a special
telephone in the case of a weight gain of .2 kg in 3 days.”
Notes New in 2015 review.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: method of randomisation not
detailed.
Quote: “Patients were then randomized to
either the CG or the IG, and both groups
were recommended to weigh themselves
daily after emptying their bladder but be-
fore having breakfast.”
Allocation concealment (selection bias) Unclear risk Not detailed.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not detailed.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “The study was based on inten-
tion to treat (ITT) except that randomized
patients not fulfilling the inclusion crite-
ria were excluded from analysis. Baseline
characteristics are presented by descriptive
statistics.”
Quote: “One obvious limitation in the
present study is that 25 patients were ran-
domized before all inclusion criteria were
fully checked (e.g., having an LVEF >50%,
myocardial infarction within 2 months be-
fore inclusion, not being hospitalized be-
fore enrolment, or moved to a nursing
home just after randomization). However,
these patients were equally distributed be-
tween the groups. Also the number of all
eligible patients is unknown”
Selective reporting (reporting bias) Low risk No evidence of selective outcome report-
ing.
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Mortara 2009 (Struct Tele) (HHH)
Methods Randomised controlled trial; multiple intervention arms and control (usual care) arm
Study arms include structured telephone support and telemonitoring
Participants 461 people with heart failure NYHA class II - IV and LVEF ≤ 40%
Mean age 60 years.
85% of participants were men.
UK, Poland, Italy.
Interventions Structured telephone support; telemonitoring.
Strategy 2 is classed as structured telephone support.
Strategy 3 is classed as telemonitoring.
Strategy 2 received monthly supportive telephone contacts from a study nurse to check
on their clinical status and transmitted their vital signs and other data including details
of changes in weight, BP and symptoms weekly by telephone. These participants also
performed monthly 24h cardiorespiratory recordings which were not made available to
the clinical team
Strategy 3 carried out the same measurements as strategy 2 participants, but the monthly
24h cardiorespiratory recordings were made available for clinical management
Outcomes Mortality and hospitalisation due to HF, all-cause mortality, all-cause hospitalisation,
bed-days occupancy (due to cardiovascular cause)
Mean 11.6 month follow-up.
Funding source HHHwas supported byE.C. grant (Action line 10.1 ‘PublicHealth, contract no.QLGA-
CT-2001-02424)
Comparison Group(s) Usual care was only described as usual outpatient care.
Notes Authors provided additional unpublished data.
Included in previous version of this review (Inglis 2010).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “The randomisation list was gener-
ated by the coordinating centre with sepa-
rate blocks held in each country”
Allocation concealment (selection bias) Low risk Quote: “The individual patient allocation
was to be revealed only after the patient
identifiers (name, surname and the date of
birth) hadbeen received at the national ran-
domisation centre”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “All endpoints were adjudicated by
an independent, blinded, Endpoint Com-
mittee.”
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Mortara 2009 (Struct Tele) (HHH) (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Quote: “...18 patients dropped out of the
study...”.
No statement asserting that analyses were
performed as intention-to-treat
Selective reporting (reporting bias) Unclear risk All-cause mortality listed as a secondary
outcome but not reported in publication
according to study group. Author con-
tacted for this information
Bed days occupancy for all cardiovascular
causes listed as secondary outcome. Not
reported, unless “all-causes” is actually all
“cardiovascular causes”
Mortara 2009 (Telemon) (HHH)
Methods Randomised controlled trial; multiple intervention arms and control (usual care) arm
Study arms include structured telephone support and telemonitoring
Participants 461 people with heart failure with NYHA class II - IV and LVEF ≤ 40%
Mean age 60 years.
85% of participants were men.
UK, Poland, Italy.
Interventions Structured telephone support; telemonitoring.
Strategy 2 is classed as structured telephone support.
Strategy 3 is classed as telemonitoring.
Strategy 2 received monthly supportive telephone contacts from a study nurse to check
on their clinical status and transmitted their vital signs and other data including details
of changes in weight, BP and symptoms weekly by telephone. These participants also
performed monthly 24h cardiorespiratory recordings which were not made available to
the clinical team
Strategy 3 carried out the same measurements as strategy 2 participants, but the monthly
24h cardiorespiratory recordings were made available for clinical management
Outcomes Mortality and hospitalisation due to HF, all-cause mortality, all-cause hospitalisation,
bed-days occupancy (due to cardiovascular cause)
Mean 11.6 month follow-up.
Funding source HHHwas supported byE.C. grant (Action line 10.1 ‘PublicHealth, contract no.QLGA-
CT-2001-02424)
Comparison Group(s) Usual care was only described as usual outpatient care.
Notes Authors provided additional unpublished data.
Included in previous version of this review (Inglis 2010).
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Mortara 2009 (Telemon) (HHH) (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “The randomisation list was gener-
ated by the coordinating centre with sepa-
rate blocks held in each country”
Allocation concealment (selection bias) Low risk Quote: “The individual patient allocation
was to be revealed only after the patient
identifiers (name, surname and the date of
birth) hadbeen received at the national ran-
domisation centre”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “All endpoints were adjudicated by
an independent, blinded, Endpoint Com-
mittee.”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk “...18 patients dropped out of the study...
”.
No statement asserting that analyses were
performed as intention-to-treat
Selective reporting (reporting bias) Unclear risk All-cause mortality listed as a secondary
outcome but not reported in publication
according to study group. Author con-
tacted for this information
Bed days occupancy for all cardiovascular
causes listed as secondary outcome. Not
reported, unless “all-causes” is actually all
“cardiovascular causes”
Rainville 1999
Methods Randomised controlled trial; intervention arm and control (usual care) arm
Participants 38 people aged ≥ 50 years discharged from hospital with heart failure
Mean age 70 years.
50% of participants were men.
USA.
Interventions Structured telephone support.
Usual care plus a pharmacist-led medication review, patient education, medication man-
agement prior to discharge and at day 3, day 7, 30 days, 90 days and 12 months via
telephone
Outcomes Mortality, rehospitalisation, functional assessment score. NYHA Functional Class
12-month follow-up.
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Rainville 1999 (Continued)
Funding source Not reported.
Comparison Group(s) Usual care consisted of routine care and preparation for discharge including written
prescriptions, physician discharge instructions and a nurse review of diet, treatment plans
and medications. The nurses provided the participant with computer-generated drug
information sheets. Participants were contacted by a pharmacist at 30 days, 90 days and
12 months to determine readmissions
Notes Included in previous version of this review (Inglis 2010).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of randomisation not detailed.
Allocation concealment (selection bias) Low risk Quote: “Qualified patients were randomly
assigned to a control group or an interven-
tion group, with the patients, nurses, and
physicians blinded to the randomisation re-
sults”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not detailed.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 38 participants randomised; 2 participants
in intervention group and 1 in control
group were excluded during the initial hos-
pitalisation because test results showed nor-
mal LVF, long-term dialysis was initiated
or because the participant was moving out
of state after DC. 1 control participant was
lost to follow-up within the first 30 days
after discharge and was excluded from the
analysis
Final sample included 34 participants
equally divided between the 2 groups
Selective reporting (reporting bias) Low risk Selective outcome reporting not evident.
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Ramachandran 2007
Methods Randomised controlled trial; intervention arm and control (usual care) arm
Participants 50 people attending heart failure clinic with symptoms of CHF and LVEF < 40%
Mean age 44.5 years.
78% of participants were men.
India.
Interventions Structured telephone support.
Intervention group participants were managed in the heart failure clinic and received
disease, medication and self-management education and telephonic disease management
which consisted of reinforcement of information and drug dose modification
Outcomes Functional status, quality of life, hospitalisation rates, quality of care, drug usage, cost
effectiveness. NYHA Functional Class. 6-month follow-up
Funding source Not reported.
Comparison Group(s) The control group was managed as per usual care in the heart failure clinic
Notes Included in previous version of this review (Inglis 2010).
Mortality not reported. No response from authors for further detail
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “An investigator, unaware of the
patients’ demographic and clinical profile,
using a computer-generated list, initiated
randomisation”
Allocation concealment (selection bias) Unclear risk Not detailed.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not detailed.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not detailed.
Selective reporting (reporting bias) Low risk No evidence of selective outcome report-
ing.
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Riegel 2002
Methods Cluster randomised controlled trial; intervention arm and control (usual care) arm
Participants 358 people discharged from hospital with heart failure.
Mean age 74 years.
49% of participants were men.
USA.
Interventions Structured telephone support.
Telephonic case management by a registered nurse using decision support software,
involving patient education and counselling and liaison with primary care physician.
Participants were telephoned within 5 days of discharge and thereafter at a frequency
guided by the software and case manager (mean 17 calls)
Outcomes Mortality, rehospitalisation, physician and emergency department visits, inpatient costs,
participant satisfaction
6-month follow-up.
Funding source Pfizer.
Comparison Group(s) Usual care was not standardised, and no formal telephonic case management was in
existence at these institutions. These participants presumably received some education
regarding HF management prior to hospital discharge
Notes Included in previous version of this review (Inglis 2010).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of randomisation not stated.
(Physicianswere the unit of randomisation)
Allocation concealment (selection bias) Low risk Quote: “Physicians were not informed of
the group to which they were assigned”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not detailed.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not detailed.
Selective reporting (reporting bias) Low risk Selective outcome reporting not evident.
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Riegel 2006
Methods Randomised controlled trial; intervention arm and control (usual care) arm
Participants 135 hospitalised Hispanic people with CHF.
Mean age 72 years.
46% of participants were men.
USA.
Interventions Structured telephone support.
Education, monitoring and guidance by bilingual-bicultural Mexican-American regis-
tered nurses via telephone case management standardised using decision support soft-
ware. Participants were contacted on average within 5 days of discharge and thereafter
at a frequency guided by the software and nurse case manager over a 6-month period
(mean 13.5 calls to participants and 8.4 additional calls to families). Printed educational
material was provided monthly and upon request in the relevant language
Outcomes Mortality, re hospitalisation, cost of care, self-reported health-related quality of life and
depression
6-month follow-up.
Funding source American Heart Association.
Comparison Group(s) Usual care was not standardised and no formal disease management programme existed
at these institutions. The standard of usual care was that participants were educated
regarding HF management before discharge, assuming that the nurse spoke the partic-
ipant’s language or someone bilingual was available to translate. In reality, only a small
proportion of staff were bilingual
Notes Included in previous version of review (Inglis 2010).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “After the baseline data were col-
lected, the nurse case manager opened a
sealed envelope with the random assign-
ment. These envelopes had been prepared
by the project director and attached to
the numbered data collection forms, to be
opened in sequence”
Method of randomisation not detailed.
Allocation concealment (selection bias) Low risk See above.
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “We were unable to strictly blind
staff about which patients were in the in-
tervention group, but a research assistant
uninvolved with the clinical care collected
all follow-up data.”
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Riegel 2006 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk For intervention arm, only 69 participants
were included in analysis as 1 outlier ex-
cluded from analysis
Quote: “One outlier was removed from the
data set before analyses began because he
spent threemonths in the hospital while his
family debated taking him off life support”
Selective reporting (reporting bias) Low risk Selective outcome reporting not evident.
Scherr 2009 (MOBITEL)
Methods A prospective, randomised, open-label study.
Recruitment started on October 1, 2003 - April 29, 2008.
Participants Quote: “Inclusion criteria: acute worsening of heart failure (acute cardiac decompen-
sation) with hospital admission lasting > 24 hours within the last 4 weeks, treatment
according to the guidelines of the European Society of Cardiology (ESC) with an an-
giotensin converting enzyme (ACE) inhibitor or an angiotensin receptor blocker (ARB)
, diuretic, and beta-blocker (except in cases with documented intolerance to beta-block-
ers). Initially, patients older than 18 years and younger than 75 years were eligible; the
latter was amended to 80 years after 4 months of recruitment. For the definition of CHF,
we adopted the ESC guidelines”
Austria.
Interventions Telemonitoring
Quote: “Tele group patients were asked to measure vital parameters (blood pressure,
heart rate, body weight) on a daily basis at the same time, preferably in the morning after
emptying the bladder and before dressing and taking medication. Thereafter, patients
were advised to enter these values as well as their dosage of heart failure medication into
the mobile phone’s Internet browser and send them to the monitoring center provided
by the Austrian Institute of Technology (AIT) - Information Management & eHealth,
Graz. Study physicians had access to a secure website providing both numerical and
graphical depiction of data for each patient.”
Outcomes Quote: “The combined primary endpoint of this study was cardiovascular mortality or
re-hospitalization for worsening heart failure. Besides evaluation of patients’ functional
status according to the NYHA classification and length of stay during re-hospitaliza-
tions, further secondary endpoints focused on technical parameters: system availability,
cumulative transmissions, and transmissions per patient.”
Quote: “For statistical planning, we assumed that patients in the control arm would
show an event rate of 30% over 6 months. For the telemedicine arm, we expected a 50%
reduction of the event rate. To show a statistically significant difference at an error of .
05 with a power of 80%, a sample size of 240 subjects was calculated.”
6 month follow-up.
Funding source Quote: “This study was partly funded by restricted research grants fromNovartis Pharma
Austria, Roche Pharma Austria, and Mobilkom Austria.”
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Scherr 2009 (MOBITEL) (Continued)
Comparison Group(s) Quote: “Baseline demographics and medication were recorded for all patients, and an
appointment for the 6-month follow-up was made. There was no planned interaction
between study site and patients in the control group within the follow-up period of 6
months.”
Notes New in 2015 review.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: method of randomisation not
detailed.
Quote: “Patients were allocated randomly
to pharmacological treatment (control
group) or pharmacological treatment plus
telemedical surveillance (tele group). The
adaptive randomization procedure was
stratified by patient age, New York Heart
Association (NYHA) class, gender, and
study center.”
Allocation concealment (selection bias) Unclear risk Not detailed
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not detailed
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: Baseline demographics data not
presented for intention-to-treat sample
Selective reporting (reporting bias) Low risk Selective outcome reporting not evident.
Seto 2012
Methods Quote: “The primary intent of the trial was to pilot the telemonitoring system in order
to determine the impact of the system on self-care and clinical management.”
Participants Quote: “Eligible participants were ambulatory patients diagnosed with heart failure.
Other eligibility criteria included 18 years of age or older, ability to speak and read in
English, not on the heart transplantation list, an expected survival of greater than one
year, and a left ventricular ejection fraction (LVEF) less than 40%.”
Mean age 55.1 SD(13.7) years
82% male
Canada
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Seto 2012 (Continued)
Interventions Telemonitoring
Quote: “The participants in the telemonitoring group received the telemonitoring system
in addition to standard care. They were asked to use the telemonitoring system for 6
months to take dailymorningweight and blood pressure readings as well as weekly single-
lead electrocardiograms (ECGs) if provided with an ECG recorder. They were also asked
to answer daily morning symptom questions on a mobile phone. Only the 17 patients
who did not have an implantable cardioverter defibrillator (ICD) were provided with an
ECG recorder because the recorder was not certified for use with ICDs. Patients were also
told to report their symptoms through the mobile phone if they did not feel well during
the day. The patients in the telemonitoring group were given an individual training
session on how to use the system during the recruitment session, and were provided
with technical support by telephone throughout the study. The daily measurements took
about 5 minutes each morning.”
Outcomes Quote: “The primary outcomes of this study included a surrogate for heart failure prog-
nosis, specifically brain natriuretic peptide (BNP), self-care as measured by the SCHFI,
and quality of life as measured by theMLHFQ. Hospital readmissions, number of nights
in hospital, and mortality were secondary outcome measures because the study was un-
derpowered to detect differences between groups for these metrics. Other secondary out-
come measures included number of emergency department visits and number of Heart
Function Clinic visits. In addition, LVEF, NYHA class, medication prescriptions, and
blood test results (specifically creatinine, sodium, potassium, hemoglobin, and urate val-
ues) were also subsequently analyzed.”
Quote: “A sample size calculation was based on the Self-Care of Heart Failure Index
(SCHFI), using a population standard deviation of 20 and an effect size of 10 (effect
size represents a clinically significant change of more than half a standard deviation)
as determined in previous studies (alpha = 0.05, power = 0.8) [7,8]. We calculated the
required sample size per group to be 34, and recruited 50 participants for the intervention
group and 50 for the control group to compensate for the patients estimated as lost to
follow-up, including due to mortality, over the six-month trial.”
6 month follow-up.
Funding source Quote: “Funding for this work was in part provided by the Toronto General Hospital
Foundation and the Natural Sciences and Engineering Research Council of Canada
Strategic Research Network Grant entitled Healthcare Support through Information
Technology Enhancements (hSITE).”
Comparison Group(s) Quote: “The standard care group received standard care at the UHN Heart Function
Clinic, which includes visiting the clinic between once every 2 weeks to once every 3
to 6 months, depending on the severity of the patient’s heart failure condition and the
need for optimizing their medication. Standard care also includes heart failure education
during preliminary visits at the Heart Function Clinic and the ability to telephone the
clinic as necessary. Participants in the standard care group were not contacted again
regarding the study until the end of the trial.”
Notes New in 2015 review.
Risk of bias
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Seto 2012 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “The 100 participants were ran-
domized into the telemonitoring (TM)
group and standard care (SC) group using
stratified four-block randomization. Strat-
ification was based on NYHA classifica-
tion (NYHA class II-III and NYHA class
IV). There were no participants in NYHA
class I. An online computer-generated ran-
domization tool, Research Randomizer was
used to determine the order of participants
in the telemonitoring and standard care
groups.”
Allocation concealment (selection bias) Low risk Quote: “The study coordinatorwas blinded
to which group the patient would be as-
signed until each patient consented to par-
ticipate in the trial.”
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Quote from author contact: “We had to
rely on self-reported indications of hospi-
talization and tried to confirm with charts
because it was possible that patients would
be admitted to hospital outside of the clin-
ical setting where the study took place.
Therefore, the denominators are smaller
than the number of participants.”
Incomplete outcome data (attrition bias)
All outcomes
High risk Quote from author contact: “We had to
rely on self-reported indications of hospi-
talization and tried to confirm with charts
because it was possible that patients would
be admitted to hospital outside of the clin-
ical setting where the study took place.
Therefore, the denominators are smaller
than the number of participants.”
Selective reporting (reporting bias) Low risk Selective outcome reporting not evident.
Sisk 2006
Methods Randomised controlled trial; intervention arm and control (usual care) arm
Participants 406 non-Hispanic and Hispanic people with documented systolic dysfunction
Mean age 59 years.
54% of participants were men.
USA.
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Sisk 2006 (Continued)
Interventions Structured telephone support.
An in-person appointment was arranged for each intervention participant, which in-
cluded symptom and disease education and referral to additional patient services (if
required). Follow-up telephone calls consisted of participant assessment, recording of
admission information reinforcement of self monitoring and administration of a food-
frequency questionnaire (at 2, 4, 8, 12 and 24 weeks and a report sent to participants).
Intervention nurses co-ordinated flow of information between participant and clinician
and arranged medication adjustment and required examinations
Outcomes Mortality, hospitalisations, functional status (including quality of life). Cost
12-month follow-up.
Funding source The Agency for Healthcare Research and Quality.
Comparison Group(s) Usual care participants received guidelines for managing systolic dysfunction, but no
other care information was specified
Notes Included in previous version of this review (Inglis 2010).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “The project’s statistician used a
computer-generated, random-number se-
quence without blocking or stratification
to centrally determine randomizations as-
signments and concealed treatment group
assignments in sealed, opaque envelopes”
Allocation concealment (selection bias) Low risk See above.
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “To measure hospitalizations, we
used billing data from the 4 participating
hospitals. At quarterly telephone surveys,
interviewerswhowere blinded to treatment
assignment asked patients about hospital-
izations at nonparticipating hospitals; how-
ever, we present the analysis of billing data
because theymeasure hospitalizations inde-
pendent of possibly socially acceptable re-
sponses or survey non response of the pa-
tients.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk No losses to follow-up in the first 12
months of follow-up.
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Sisk 2006 (Continued)
Selective reporting (reporting bias) Low risk Selective outcome reporting not evident.
Soran 2008
Methods Randomised controlled trial; intervention arm and control (usual care) arm
Participants 315 people with HF diagnosis secondary to systolic dysfunction (LVEF ≤ 40%)
Mean age 76 years.
35% of participants were men.
USA.
Interventions Telemonitoring.
Participants randomised to the Heart Failure Monitoring System (HFMS) cohort re-
ceived a disease management programme using telecommunication equipment includ-
ing an electronic scale and individualised symptom response system linked to a database
staffed by nurses. Participants weighed themselves and answered questions related to
their heart failure. Participants were contacted if any changes were observed in symptoms
or weight
Outcomes Treatment failure (cardiovascular mortality or rehospitalisation for HF within 6months)
, length of hospital stay, 6-month all-cause hospitalisation, 6-month heart failure hos-
pitalisation, number of emergency room visits, Medicare expenditure, total participant
costs, quality of life
6-month follow-up.
Funding source Centers for Medicare & Medicaid Services Baltimore, Maryland
Comparison Group(s) Participants allocated to standard heart failure care (SC) received enhanced patient ed-
ucation, education to clinicians and follow-up. They were provided with a digital home
scale to weigh themselves daily and educational materials related to worsening of HF
and were asked to record heart failure symptoms
All participants were telephoned 30 days and 3 months post-randomisation for blinded
clinical data collection (vital signs, hospital visits, quality of life questionnaires)
Notes Number of participants hospitalised calculated from reported % with any hospital ad-
mission
Included in previous version of this review (Inglis 2010).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “...patients were randomised in a 1:
1 ratio..”.
Method of randomisation not detailed.
Allocation concealment (selection bias) Unclear risk Not detailed.
121Structured telephone support or non-invasive telemonitoring for patients with heart failure (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Soran 2008 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “The HFHC Trial was a multi-
center, randomized controlled clinical trial
with blinded end point evaluation...”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Quote: “Eight patients refused to be re con-
tacted after randomisation and were con-
sidered lost to follow-up”
Quote: “The intention-to-treat principle
was used to compare HFMS to SC”
Selective reporting (reporting bias) Low risk No evidence of selective outcome report-
ing.
Tsuyuki 2004
Methods Randomised controlled trial; intervention arm and control (usual care) arm
Participants 276 people discharged from hospital with heart failure.
Mean age 72 years.
58% of participants were men.
Canada.
Interventions Structured telephone support.
Early discharge planning with provision of adherence aids, patient education, regularly
scheduled telephone contact with local research co-ordinator at 2 and 4 weeks then
monthly thereafter for 6 months. Recommendations to see primary care physician if not
on target dose ACE inhibitor or deterioration
Outcomes Mortality, rehospitalisation, medication adherence, physician and emergency depart-
ment visits, cost analysis
6-month follow-up.
Funding source Parke Davis Canada (now Pfizer Canada) and the University of Alberta Hospital Foun-
dation
Comparison Group(s) Participants assigned to usual care received a general heart disease pamphlet before dis-
charge, but no formal counselling beyond what was routine at the hospital. Participants
were contacted monthly for 6 months to ascertain clinical events
Notes Included in previous version of this review (Inglis 2010).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Randomization was conducted
by a computer-generated sequence using
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Tsuyuki 2004 (Continued)
block randomisation (block size of 4), strat-
ified by study site (hospital)”
Allocation concealment (selection bias) Unclear risk Quote: “...patients were randomised via a
telephone call to the project office”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Quote: “...the primary outcome was medi-
cation adherence, asmeasured by pharmacy
records.”
Quote: “Clinical events, the secondary out-
come, were recorded by patient report and
through examination of hospital records”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Intervention: early withdrawal n = 5; lost
to follow-up n = 3
Control: early withdrawal n = 2; lost to fol-
low-up n = 4.
Selective reporting (reporting bias) Low risk Selective outcome reporting not evident.
Villani 2014 (ICAROS)
Methods Quote: “A randomized, parallel open study was conducted on patients with chronic
heart failure leaving hospital after being treated for clinical instability.”
Power Calculation: No sample size calculation was detailed.
Participants Quote: “...80 agreed to participate and were randomized to the two groups (40 in each
Inclusion criteria (1) NYHA class III/IV during hospital stay (2) Left ventricular systolic
dysfunction (ejection fraction 40%) (3) High risk of early re-hospitalization at discharge
(at least two of ): age>70 years, >2 hospitalizations for heart failure in the last 6 months,
>1 co-pathologies (diabetes, COPD, cerebrovascular disease, renal failure)”
Mean age 72 (SD 3) years.
73.7% men.
Italy.
Interventions Telemonitoring.
Quote: “Integrated Management group, patients and their caregivers had specific train-
ing in the use of the dedicated PDA described above. Each day, the PDA acted as a
reminder of the correct timing for the pills. At a predefined time patients were asked to
send their body weight, blood pressure and heart rate data via the PDA. In some cases pa-
tients were asked to monitor their diuresis. Each month, a psychological assessment was
performed through the PDA software about anxiety (STAI-6; Spielberger’s State Trait
Anxiety Inventory, depression (PHQ-9; Patient Health Questionnaire)18 and perceived
well being (PGWBI; Perception of General Well-Being Inventory).”
Outcomes Quote: “Cardiovascular death or hospitalization for heart failure lastingmore than 3 days
were considered major adverse effects. We considered the following as minor adverse
effects: (1) any hospital stay of less than three days, including Emergency Department
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Villani 2014 (ICAROS) (Continued)
visits; (2) any unplanned investigation and/or blood testing; (3) any unplanned clinical
visit (4) cost.”
12 month follow-up
Funding source The research received a grant from the ItalianMinistry of Research and Public Instruction
(FIRB RBNE01KYE4 2003)
Comparison Group(s) Quote: “In theUsual Care group, patients were dischargedwith appointments for follow-
up every three months at our Heart Failure clinic, in accordance with guidelines for
fragile patients.”
Notes New in 2015 review - included as abstract in sensitivity analysis in previous version of
review (Inglis 2010).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Patients were randomized 1:1 ei-
ther to an Integrated Management group
or to a Usual Care group, using a comput-
erised random number generator.”
Allocation concealment (selection bias) Unclear risk Not detailed.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not detailed.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Not evident.
Selective reporting (reporting bias) Low risk No evidence of selective outcome report-
ing.
Vuorinen 2014
Methods Quote: “Two-arm randomized controlled trial conducted at the Cardiology Outpatient
Clinic of HUCH in 2010-2012.”
Participants 94 people were randomised. 1 from each pair was randomly assigned to receive the usual
care, and the other was assigned to the telemonitoring group (47 per group)
Quote: “The inclusion criteria were (1) diagnosis of systolic heart failure, (2) age of
18-90 years, (3) NYHA class ≥2 (an interview-based classification by the New York
Heart Association concerning limitations to physical activity), (4) left ventricular ejection
fraction ≤35% as measured during hospital visits, (5) need for a regular check-up visit,
and (6) time from the last visit of less than 6 months.”
83% of participants were men.
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Vuorinen 2014 (Continued)
Mean age 58 years.
Finland
Interventions Telemonitoring.
Quote: “Patients regularly reported their most important health parameters to the nurse
using a mobile phone app. At the beginning of the study, the patients were given a home-
care package including a weight scale, a blood pressure meter, a mobile phone, and self-
care instructions. The patients were advised to carry out and report the measurements
together with the assessment of symptoms once a week.”
Outcomes Quote: “The primary outcome was the number of HF-related hospital days during the
follow-up. The data were obtained from the electronic health record system of HUCH.
Secondary outcomes included clinical outcomes, use of health care resources, and user
experience. death from any cause, heart transplant operation or listing for transplant
operation, left ventricular ejection fraction (LVEF, %) measured by echocardiography,
plasma concentration of N-terminal of the prohormone brain natriuretic peptide (NT-
proBNP, ng/l), creatinine (µmol/l), sodium (mmol/l), and potassium (mmol/l). Self-
care behavior was measured using the European Heart Failure Self-Care Behaviour Scale
(EHFSBS). Patients’ acceptance and experience towards home telemonitoring were eval-
uated using a questionnaire delivered to patients in the telemonitoring group at the end-
point visit.”
Quote: “The study was designed to have a power of 90%, an alpha level of .05, and
an effect size of 0.5 determined as the expected difference of 3 HF-related hospital days
between the study groups (SD6). A t test was used as a calculation framework.With these
parameters, we calculated that 44 patients per treatment arm needed to be recruited”
6 month follow-up.
Funding source Quote: “The Finnish Funding Agency for Technology and Innovation and VTT Tech-
nical Research Centre of Finland are acknowledged for funding the study.”
Comparison Group(s) Quote: “A multidisciplinary care approach including patient guidance and support for
self-care has been adopted at the clinic. In the care of these HF patients, the cardiac
team plays a central role in monitoring and interpreting patient symptoms, optimizing
medication, and providing education.”
Notes New in 2015 review.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Quote: “Matched pair design was used in
the randomization. The eligible patients,
who were similar in left ventricular ejec-
tion fraction, NYHA classification, age,
and gender, respectively, were matched in
pairs. One was randomized to the control
group and the other to the intervention
group.”
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Vuorinen 2014 (Continued)
The first 30 intervention participants and
29 control participants started stepwise
from November 2010 to February 2011.
After the first 59 participants had finished
their follow-up, the second group (17 in-
tervention participants and 18 control par-
ticipants) started in May to August 2011.
The nominal follow-up timewas 6months.
The studywas completed in February 2012
Allocation concealment (selection bias) Unclear risk Not detailed.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not detailed.
Incomplete outcome data (attrition bias)
All outcomes
High risk Quote: “There was one dropout in the in-
tervention group. The patient withdrew
from the study shortly after the beginning,
and no endpoint measurements were avail-
able. The patient was excluded in the end-
point analyses.”
Selective reporting (reporting bias) Low risk No evidence of selective outcome report-
ing.
Wakefield 2008
Methods Randomised controlled trial; intervention arm and control (usual care) arm
Telephone and videophone intervention arms were combined and classed as structured
telephone support for this review
Participants 148 people hospitalised for HF exacerbation.
Mean age 69 years.
99% of participants were men.
USA.
Interventions Structured telephone support.
Participants allocated to the intervention group were allocated to 1 of 2 interventions:
telephone follow-up or videophone follow-up. Intervention participants were contacted
by a nurse 3 times in the first week then weekly for 11 weeks. Symptoms and the par-
ticipant’s discharge plan were reviewed and reinforced as well as referrals made if re-
quired. Additionally, the intervention nurses employed behaviour skill training strategies
to maximise self management, self monitoring and self efficacy
Outcomes Mortality, readmissions, hospital days, time to first readmission, urgent care clinic visits,
quality of life, intervention dose and technical issues
12-month follow-up.
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Wakefield 2008 (Continued)
Funding source Department of Veterans Affairs, Veterans Health Administration, Health Services Re-
search and Development (VA HSR&D) Service (#NRI 99-345), a VA HSR&D Career
Development Award to Dr. Wakefield, the VA HSR&D Center for Research in the Im-
plementation of Innovative Strategies in Practice (CRIISP) at the Iowa City VAMedical
Center, Iowa City, IA, and by the Harry S. Truman Memorial Veterans Hospital
Comparison Group(s) Usual care was not specified except to state that ”subjects contacted their primary care
nurse case manager by telephone if needed“
Notes Included in previous version of this review (Inglis 2010).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: ”The project coordinator prepared
sealed envelopes containing group assign-
ments in blocks of 24“
Allocation concealment (selection bias) Low risk Quote: ”Following informed consent and
baseline data collection, study nurses
opened the envelope to assign subjects to
one of three treatment conditions: usual
care, telephone follow-up, or videophone
follow-up”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not detailed.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Qoute: “At 3 months, 85% (n = 126) com-
pleted follow-up; at 6 months, 74% (n =
109) completed follow-up”.
Quote: “All data analyses were conducted
using an intent-to-treat approach”
Selective reporting (reporting bias) Low risk Selective outcome reporting not evident.
Woodend 2008
Methods Randomised controlled trial; intervention arm and control (usual care) arm
Participants 121 people with symptomatic heart failure (NYHA Class II or greater)
Mean age 68 years.
74% of participants were men.
Canada.
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Woodend 2008 (Continued)
Interventions Telemonitoring.
Daily transmission of weight and periodic transmission of ECG and BP. Weekly video
conferences by tele-home care nurse. Video conferences more frequent in first few weeks
and tapered over the 3 months
Outcomes Mortality (3 months), rehospitalisation, quality of life, emergency department visits,
participant satisfaction
12-month follow-up.
Funding source The Richard Ivey Foundation, The Change Foundation and an unrestricted educational
grant from Merck-Frosst Canada
Comparison Group(s) Usual care was not described.
Notes Included in the previous version of this review (Inglis 2010).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of randomisation not detailed.
Allocation concealment (selection bias) Unclear risk Not detailed.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not detailed.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not detailed.
Selective reporting (reporting bias) High risk Some nominated outcomes not reported
(morbidity).
Zamanzadeh 2013
Methods Prospective, randomised trial of a supportive-educational intervention
Participants Quote: “Participants who were included were of 18 years age and older, diagnosed with
New York Heart Association class III or IV HF, had an ejection fraction less than 40%,
agreed to predischarge education and follow-up care, and would be available by phone
after discharge.”
Mean age 65.82 ± 9.87 years
57.9 % men.
Iran
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Zamanzadeh 2013 (Continued)
Interventions Quote: “HF participants randomized to the intervention group received a two-part
intervention aimed at improving self-care behaviours. The first phase consisted of a
one-hour, nurse-led, in-person HF education session that was customized by the nurse
according to the participant’s level of education. An individualized education booklet
was reviewed with literate patients,while for illiterate patients this booklet was reviewed
with the participant as well as a family member
The second phase of the intervention included postdischarge telephone followup. The
objective of this phase was to reiterate and review information covered during the initial
education session and improve the participant’s ability to cope with the disease, as well
as enhance self-care behaviours.The first followup telephone call was made by a nurse
two days after hospital discharge to verify participant information and determine the
next date of contact. The nurse then contacted the participant by phone every two weeks
for 3 months. During these phone calls the nurse asked the participant whether they
were experiencing any signs or symptoms that would suggest worsening HF.The nurse
also reviewed the recommended self-care behaviours and provided support in the form
of advice and encouragement when deemed necessary. These follow-up telephone calls
typically lasted 15 minutes.”
Outcomes Self-care (SCHFI)
Quote: “A sample size of 80 (40 individuals in the intervention group and40 in the
control group)was deemed sufficient based on a preliminary analysis of self-care scores
of 5HF patients. The following parameters guided the present study; the optimal self-
care behaviour score in the study was 70, the mean and standard deviation of self-care
behaviours scores were estimated (Mean = 25, SD= 6.15), alpha = 0.05 and power = 0.
9 were chosen, and no attrition during followup was anticipated”
Funding source Nil disclosed.
Comparison Group(s) Quote: “Participants who were randomized to the control group received usual care
provided by the hospital and attending physician (nonsystematic and informal teaching)
.”
Notes New in 2015 review.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote:“The participants were randomized
into the control and experimental groups
using random number software”
Allocation concealment (selection bias) Unclear risk Not detailed.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not detailed.
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Zamanzadeh 2013 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: 2 participants from the inter-
vention group lost to follow-up in inter-
vention arm, analyses not performed as in-
tention-to-treat
Selective reporting (reporting bias) High risk Comment: No evidence of selective out-
come reporting.
ACE: angiotensin-converting enzyme
BNP: brain natriuretic peptide
CHF: congestive heart failure
CNPq: Conselho Nacional de Desenvolvimento Cientico e Tecnologico
ECG: electrocardiograph
EF: ejection fraction
FIPE: Fundação Instituto de Pasquisas Econ micas
HF: heart failure
HR: heart rate
LVEF: left ventricular ejection fraction
LVSD: left ventricular systolic dysfunction
NYHA: New York Heart Association
SD: standard deviation
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Abu-Awwad 2012 System design paper.
Akosah 2005 Contra to protocol: intervention included frequent clinic visits
Al Khateeb 2012 Contra to protocol: not an RCT.
Albanese 2001 Contra to protocol: invasive impedence monitoring (SCOOP II Trial Evaluating CRT/ICD/Im-
pedence Monitoring)
Albert 2007 Contra to protocol: intervention was an education video.
Aliti 2007 Discussion paper.
Alluhaidan 2015 System design paper.
Alnosayan 2014 Review paper.
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Anderson 2005 Contra to protocol: intervention was a heart failure clinic.
Andrikopoulou 2014 Review paper.
Ansinelli 2013 Contra to protocol: not an RCT.
Archelrod 2014 Review paper.
Artinian 2003 Contra to protocol: web-based intervention, not an RCT.
Artinian 2006 Contra to protocol: intervention specific for hypertension, not heart failure
Arya 2008 Contra to protocol: invasive haemodynamic monitoring.
Austin 2012 Contra to protocol: not an RCT.
Baden 2007a Contra to protocol: not an RCT.
Baden 2007b Contra to protocol: not an RCT.
Baer 1999 Asessment of correlationbetween electronic patientmeasurements andmanual nursemeasurements
Bakhshi 2011 Contra to protocol: not an RCT.
Baldauf 2008 Contra to protocol: not an RCT.
Baldonado 2013 Review paper.
Barber 1999 Contra to protocol: not an RCT, quasi experimental design.
Bekelman 2013 Contra to protocol: telemonitoring was offered to usual care patients
Ben Gal 2013 Contra to protocol: not an RCT.
Benatar 2003 Contra to protocol: comparison was between telemonitoring and home visits (not usual care)
Bennett 2006 Contra to protocol: intervention was a computer-based intervention
Bennett Milburna 2014 Review paper.
Berkley 2010 Review paper.
Blue 2001 Contra to protocol: intervention included home visits.
Bocchi 2007 (REMADHE) Contra to protocol: intervention involved intensive group education sessions and face-to-face
individual/group communication
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Bocchi 2013 Contra to protocol: intervention involved intensive group education sessions and face-to-face
individual/group communication
Bohacik 2014 Contra to protocol: invasive monitoring.
Bohmer 2011 Contra to protocol: intensive clinic follow-up in intervention (monthly)
Bolz 2005 Review paper.
Bondmass 1999 Contra to protocol: not an RCT.
Bondmass 2002 Contra to protocol: not an RCT.
Bondmass 2007 Contra to protocol: not an RCT.
Boriani 2013 Home visits.
Bourge 2008 (COMPASS-HF) Contra to protocol: invasive implantable haemodynamic monitoring
Bowles 2007 Reivew paper.
Bowles 2008 Systematic review.
Bowles 2009 Contra to protocol: home visits in intervention and usual care arms
Bowles 2011 Home visits.
Brennan 2006 Contra to protocol: not an RCT.
Brennan 2010 Contra to protocol: not HF patients.
Browning 2011 Contra to protocol: not an RCT.
Brownsell 2006a Author contacted: primary and secondary outcomes for this review were not measured
Brownsell 2006b Author contacted: primary and secondary outcomes for this review were not measured
Brownsell 2008 Author contacted: primary and secondary outcomes for this review were not measured
Brunetti 2014 Contra to protocol: not an RCT.
Byrnes 2012 Contra to protocol: not HF patients.
Caldwell 2005 Contra to protocol: education session with one follow-up telephone call
Call 2010 Contra to protocol: not an RCT.
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Calvin 2008 Contra to protocol: participants received 18 education sessions aimed to develop self-management
skills. The intervention did not include telemonitoring or structured telephone support
Calò 2013 Contra to protocol: invasive monitoring.
Capomolla 2002 Contra to protocol: intervention was a day hospital.
Chen 2010 Not an RCT
Chen 2014 Contra to protocol: not an RCT.
Cherry 2000 Review article.
Chetney 2003 Contra to protocol: not an RCT.
Chetney 2008 Contra to protocol: not an RCT.
Clappers 2006 Review of abstracts.
Clark 2008 Interviews with carers of patients with heart failure regarding their experiences
Clarke 2005 Conference discussion paper.
Cleland 2012 Not an RCT.
Cleland 2014a Not an RCT.
Cline 1998 Contra to protocol: Intervention group received education on heart failure and self management,
with follow-up at an outpatient clinic
Cole 2006 Contra to protocol: not an RCT.
Coll 2011 Not heart failure-specific.
Conway 2014 Review paper.
Copeland 2010 Home visits.
Cordisco 1999 Contra to protocol: not an RCT.
Courtney 2009 Contra to protocol: intervention was an exercise programme.
Cross 1999 Contra to protocol: not an RCT.
Crundall-Goode 2014 Review paper.
Cruz 2010 Contra to protocol: intensive face to face education sessions
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Dalmiani 2001 Contra to protocol: not an RCT.
Dang 2006 Contra to protocol: not an RCT.
Dansky 2008a Contra to protocol: intervention included home visits.
Dansky 2008b Contra to protocol: not an RCT.
Dansky 2009 Contra to protocol: both groups had telemonitoring exposure. Home visits
Dar 2009 (HOME-HF) Contra to protocol: both study groups received a home visit from study nurse
De Feo 2002 Contra to protocol: not an RCT.
De Vries 2011a Contra to protocol: not an RCT.
De Vries 2011b Not an RCT.
Deckwart 2011 Not an RCT.
Dedier 2008 Contra to protocol: intervention specific for hypertension, not heart failure
Deepak 2008 Contra to protocol: not an RCT.
Del Sindaco 2007 Contra to protocol: intervention included clinic and home visits
Delaney 2013 Previous exposure to telemonitoring.
Demarzo 2006 Contra to protocol: invasive haemodynamic monitoring.
Dickens 2012 Contra to protocol: not an RCT.
Dickerson 2011 Contra to protocol: not an RCT.
Dimmick 2003 Contra to protocol: not an RCT.
Dollard 2004 Review paper.
Dougherty 2005 Contra to protocol: invasive monitoring.
Doughty 2002 Contra to protocol: intervention included regular clinic visits
Downey 2001 Contra to protocol: not an RCT.
Dracup 2012 Contra to protocol: face-to-face education and telephone counselling for intervention and control
groups
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Ducharme 2005 Contra to protocol: intervention was an outpatient clinic.
Duffy 2005 Contra to protocol: intervention included home visits.
Duffy 2008 Discussion paper.
Duffy 2010 Contra to protocol: home visits.
Dunagan 2005 Contra to protocol: intervention included home visits.
Dunn 2006 Contra to protocol: not an RCT, intervention included clinic visits
Dunn 2007 Contra to protocol: not an RCT, intervention included clinic visits
Dwinger 2013 Contra to protocol: education intervention (no monitoring data)
Ekman 1998 Contra to protocol: intervention was a nurse-led outpatient clinic and telephone follow-up
Ellery 2006 Contra to protocol: intervention was invasive monitoring.
Enemuoh 2013 Contra to protocol: not an RCT.
Enjuanes 2013a Contra to protocol: usual care is a HF disease management program
Erich 2013a Contra to protocol: not an RCT.
Erich 2013b Contra to protocol: not an RCT.
Esposito 2008 Not heart failure-specific.
Evangelista 2004 Contra to protocol: web-based education and counselling for patients with heart failure
Fairbrother 2014 Contra to protocol: not an RCT.
Falces 2008 Not structured telephone support or telemonitoring.
Fan 2010 Not an RCT.
Feldman 2004 Contra to protocol: intervention was email-communication to nurses
Feldman 2005 Contra to protocol: intervention was email-communication to nurses
Ferguson 2010 Contra to protocol: not an RCT.
Finkelstein 2004 Contra to protocol: intervention included home visits.
Finkelstein 2006 Contra to protocol: intervention included home visits.
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Finkelstein 2010a System design paper.
Finkelstein 2010b System design paper.
Finkelstein 2011 System design paper.
Florea 2011 Editorial.
Foley 2008 Contra to protocol: not an RCT.
Fragrasso 2007 Not an intervention for management of heart failure, validation of remote clinical examination
Friedberg 2008 Review of COACH study.
Fursse 2008 Contra to protocol: not an RCT.
Gambetta 2007 Contra to protocol: not an RCT.
Garcia 2009 Review paper.
Gellis 2012 Contra to protocol: home visits.
Gellis 2014 Not structured telephone support or telemonitoring.
Giamouzis 2012 Review paper.
Giordano 2013 Contra to protocol: not an RCT.
Goldstein 2014 Contra to protocol: medication adherence only.
Grancelli 2007 Editorial for previous version of this review.
Granger 2013 Not structured telephone support or telemonitoring.
Graves 2013 Review paper.
Gregory 2006 (SPAN-CHF) Contra to protocol: intervention included home visits.
Grustam 2014 Review paper.
Gund 2008 Contra to protocol: not an RCT.
Gurne 2012 Review paper.
Gámez-López 2012 Contra to protocol: home visits in intervention.
Hall 2010 Review paper.
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Hanssen 2007 Contra to protocol: intervention was telephone follow-up of patients following a myocardial in-
farction
Harkness 2006 Review of DIAL Trial.
Harrison 2002 Contra to protocol: intervention included home visits.
Hart-Wright 2006 Contra to protocol: not an RCT.
Hayes, 2008 Contra to protocol: health technology assessment.
Hayes, 2011 Contra to protocol: health technology assessment.
Heidenreich 1999 Contra to protocol: not an RCT.
Heisler 2007 Contra to protocol: not an RCT.
Helms 2007 Discussion / review paper.
Helms 2010 Contra to protocol: not an RCT.
Hennrikus 2012 Contra to protocol: not an RCT.
Hindricks 2014 Contra to protocol: invasive monitoring.
Hinterbuchner 2010 Contra to protocol: not an RCT.
Ho 2007 Contra to protocol: intervention included home visits.
Hoban 2013 Contra to protocol: home visits.
Holland 2014 Contra to protocol: not telemonitoring or telephone support.
Holly 2011 Review paper.
Holst 2007 Contra to protocol: not structured telephone support or telemonitoring, telephone follow-up
following an education intervention
Hoover 2007 Contra to protocol: not an RCT.
Hoover 2009 Contra to protocol: not an RCT.
Howlett 2011 Contra to protocol: usual care in a HF clinic.
Hudson 2005 Contra to protocol: not an RCT.
Huynh 2006 Contra to protocol: intensive education session; not structured telephone support or telemonitoring
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Jaarsma (COACH Study) Contra to protocol: intervention included clinic and home visits
Jaarsma 1999 Review paper.
Jenkins 2001 Contra to protocol: intervention included home visits.
Jerant 2001 Contra to protocol: intervention included home visits.
Jerant 2003 Contra to protocol: intervention included home visits.
Johnston 2000 Intervention not specific to heart failure patients.
Jolly 2007 Home-based exercise intervention.
Jones 2002 Review paper.
Jones 2014 Review paper.
Juan 2011 Not heart failure-specific.
Karlsson 2005 Contra to protocol: intervention was an outpatient clinic.
Kashem 2007 Contra to protocol: web-based intervention.
Kasper 2002 Contra to protocol: intervention included home visits.
Kastner 2010 Contra to protocol: not an RCT.
Khoury 2008 Contra to protocol: invasive haemodynamic monitoring.
Kielblock 2007 Not an RCT.
Kimmelsteil 2004 Contra to protocol: intervention included home visits.
Kirschner 2006 Discussion paper.
Kitsiou 2013 Review paper.
Kleet 2013 Contra to protocol: not an RCT.
Kline 2006 Contra to protocol: not an RCT.
Koehler 2006 Review of TEN-HMS study.
Koelling 2005 Contra to protocol: intervention was a face-to-face education session
Konstam 2012 Review paper.
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Kottmair 2005 Discussion paper.
Koutkias 2003 Contra to protocol: not an RCT.
Kraal 2014 Contra to protocol: cardiac rehabilitation.
Kropf 2014 Contra to protocol: not an RCT.
Krumholz 2002 Contra to protocol: frequent clinic and home visits.
Krumholz 2011 Editorial
Kurtz 2011 Contra to protocol: not an RCT.
Kutzleb 2006 Contra to protocol: not an RCT.
Kwok 2008 Contra to protocol: intervention included home visits.
LaFramboise 2003 Contra to protocol: not an RCT.
Lagido 2014 System design paper.
Lavenberg 2012 Contra to protocol: health technology assessment.
Lehmann 2006 Contra to protocol: not an RCT.
Lemay 2013 Chart review paper.
Leventhal 2011 Contra to protocol: home visit in the intervention.
Lind 2013 System design paper.
Lucas 2007 Contra to protocol: not an RCT.
Machingo 2003 Contra to protocol: not an RCT.
Maddukuri 2006 Contra to protocol: not an RCT.
Madigan 2008 Contra to protocol: not an RCT.
Madigan 2013 Contra to protocol: home visits.
Maglaveras 2002 Contra to protocol:Not RCT
Maglaveras 2003 Contra to protocol: not an RCT
Maglaveras 2006 Contra to protocol: not an RCT
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Mair 2007 Review paper.
Makaya 2008 Contra to protocol: intervention included home visits.
Mansfield 2006 Contra to protocol: not an RCT.
Marangelli 2007 Contra to protocol: not an RCT.
Maric 2010 Contra to protocol: not an RCT.
Martensson 2005 Contra to protocol: intervention included home visits.
Martín-Lesende 2011 Contra to protocol: home visits when required.
Martín-Lesende 2013 Contra to protocol: home visits when required.
Masterson Creber 2014 Home visits.
Mau 2006 Contra to protocol: intervention included home visits.
McCauley 2006 Contra to protocol: intervention included home visits.
McCoy 2007 Contra to protocol: intervention included home visits.
McDonald 2002 Contra to protocol: frequent clinic visits with unstructured telephone follow-up
McEntee 2010 Contra to protocol: not an RCT.
McKinstry 2014 Editorial.
McManus 2004 Contra to protocol: not an RCT.
Mendoza 2002 Contra to protocol: not an RCT.
Meriggi 2009 System development paper.
Metten 2011 Contra to protocol: not an RCT.
Mistiaen 2006 Review paper.
Mitchell 2011 Contra to protocol: health technology assessment.
Mitchell 2014 Contra to protocol: not an RCT.
Moore 2013 Not an RCT.
Morales-Ascencio 2008 Contra to protocol: not an RCT.
140Structured telephone support or non-invasive telemonitoring for patients with heart failure (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
Morcillo 2005 Intervention was a single, home-based educational intervention
Morgan 2014 Contra to protocol: invasive monitoring.
Morguet 2006 Contra to protocol: not an RCT.
Morguet 2007a Contra to protocol: not an RCT.
Morguet 2007b Contra to protocol: not an RCT.
Morguet 2008 Contra to protocol: not RCT.
Mueller 2002 Contra to protocol: not an RCT.
Muller 2013 Contra to protocol: invasive monitoring.
Murtaugh 2005 Contra to protocol: intervention was email-communication to nurses
Myers 2006 Contra to protocol: not an RCT.
Nanevicz 2000 Contra to protocol: not an RCT.
Naylor 1999 Contra to protocol: intervention included home visits.
Naylor 2004 Contra to protocol: intervention included home visits.
Nguyen 2007 Contra to protocol: not an RCT.
Nobel 2003 Contra to protocol: not an RCT.
Noel 2004 Contra to protocol: intervention not specific to patients with heart failure
Nohria 2007 Contra to protocol: intervention was invasive haemodynamic monitoring
Nucifora 2006 Contra to protocol: intervention was not structured telephone support (a telephone number was
available for participants to talk to a nurse)
O’Reilly 1999 Contra to protocol: not an RCT.
Oddone 1999 Contra to protocol: not an RCT.
Odeh 2013 Contra to protocol: not an RCT.
Oeff 2005a Contra to protocol: not an RCT.
Oeff 2005b Discussion paper.
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Ojeda 2005 Contra to protocol: intervention included clinic visits. A telephone number was made available to
participants to contact clinic staff
Oliveira 2013 Contra to protocol: invasive monitoring.
Opasich 2005 Review paper.
Page 2012 Contra to protocol: not an RCT.
Pandor 2013a Review paper.
Pascual 2011 Contra to protocol: education, not monitoring, intensive clinic visits
Pasqualini 2006 Contra to protocol: not an RCT.
Patja 2012 Contra to protocol: education, not monitoring (outcomes of interest not assessed)
Peikes 2009 Review paper.
Philbin 2000 Report on a quality improvement intervention.
Phillips 2008 Report of a 24-hour telephone support programme for patients and caregivers at the end of life
Picard 2008 Review paper.
Piepoli 2006 Contra to protocol: not an RCT.
Pinto 2014 Contra to protocol: not an RCT.
Piorkowski 2006 Contra to protocol: invasive haemodynamic monitoring.
Piotrowicz 2012 Contra to protocol: cardiac rehabilitation, not an RCT.
Pugh 2001 Contra to protocol: nurse visits were part of the intervention
Purcell 2014 Review paper.
Quinn 2006 Contra to protocol: not an RCT.
Quinn 2008 Contra to protocol: not an RCT.
Rabelo 2007 Contra to protocol: not an RCT.
Raborn 2012 Contra to protocol: not an RCT.
Rahimpour 2008 Contra to protocol: not an RCT.
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Ramaekers 2009 Contra to protocol: home visits in usual care.
Raman 2008 Review paper.
Reble 2006 Contra to protocol: not an RCT.
Repoley 2006 Contra to protocol: not an RCT.
Rich 2002 Review paper.
Ross 2004 Comparison of interactive internet electronic record.
Roth 2005 Contra to protocol: not an RCT, not specific to heart failure
Roth 2006 Contra to protocol: not an RCT, not specific to heart failure
Rozenman 2007 Contra to protocol: invasive haemodynamic monitoring.
Saxon 2007 Contra to protocol: invasive haemodynamic monitoring.
Scalvini 2004 Contra to protocol: not an RCT.
Scalvini 2005a Contra to protocol: not an RCT.
Scalvini 2005b Contra to protocol: not an RCT.
Scalvini 2006 Contra to protocol: GP monitoring vs home based monitoring.
Scherr 2006 Contra to protocol:intervention not specific for heart failure patients
Schmidt 2008 Medication box which monitored medication adherence.
Schneider 2004 Contra to protocol: not an RCT.
Schofield 2005 Contra to protocol: not an RCT.
Schofield 2008 Contra to protocol: not an RCT.
Schwamm 2014 Review paper.
Schwarz 2008 Contra to protocol: intervention involved caregivers as well as the person with heart failure
Scott 2004 Contra to protocol: not an RCT.
Seibert 2008a Contra to protocol: not an RCT.
Sen 2014 Contra to protocol: diabetes not HF
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Serxner 1998 Contra to protocol: not an RCT.
Shah 2007 Discussion paper.
Shah 2008 Contra to protocol: intervention based in clinic.
Shearer 2007 Author contacted: primary and secondary outcomes for this review were not measured
Simpson 2006 Heart transplant technology.
Slater 2006 Contra to protocol: not an RCT.
Slater 2008 Contra to protocol: not an RCT.
Smart 2005 Contra to protocol: not an RCT.
Smeulders 2006 Contra to protocol: intervention based in clinic.
Smolis-Bak 2012 Contra to protocol: not an RCT.
Sonntag 2009 Contra to protocol: not an RCT.
Sousa 2014 Review paper.
Spaeder 2006 Contra to protocol: very frequent clinic visits.
Sprenger 2007 Contra to protocol: not an RCT.
Stampehl 2012 Contra to protocol: not an RCT.
Steckler 2008 Contra to protocol: not an RCT.
Steventon 2013 Contra to protocol: not an RCT.
Stoerk 2013 Contra to protocol: not an RCT.
Stone 2009 Editorial.
Stone 2012 Contra to protocol: not an RCT.
Stork 2009 Review paper.
Stromberg 2003 Contra to protocol: intervention based in clinic.
Stromberg 2006 Contra to protocol: intervention based in clinic.
Stut 2011 System development paper.
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Sullivan 2006 Contra to protocol: not an RCT.
Takagawa 2013 System development paper.
Takahashi 2010 Not heart failure-specific.
Takahashi 2012 Not heart failure-specific.
TEHAF Study Contra to protocol: not an RCT, pre- and post-test study design
Terschuren 2007 Contra to protocol: not an RCT.
Thokala 2013a Cost-effectiveness modelling.
Thokala 2013b Not an RCT.
Thompson 2005 Contra to protocol: intervention included home and clinic visits
Thompson 2008 Review of Woodend 2003.
Tompkins 2010 Home visits.
Tramarin 2005 Collection of abstracts, not relating to structured telephone support or telemonitoring in heart
failure
Tran 2008 Review paper.
Trudel 2007 Study included participants with diabetes and hypertension. Intervention not specific to heart
failure
Tsuji 2013 Contra to protocol: not an RCT.
Umeda 2014 Contra to protocol: invasive monitoring.
VA Technology Assessment Report on telemonitoring technologies.
Vaccaro 2001 Contra to protocol: not an RCT. Compared 638 matched controls
Valle 2004 Contra to protocol: intervention consisted of education for participant and family, prescribed
diet and guideline-based pharmacotherapy and did not include structured telephone support or
telemonitoring
Vallina 2008 Contra to protocol: not an RCT.
Vallina 2010 Contra to protocol: not an RCT.
van den Bussche 2004 Contra to protocol: not an RCT, observation study.
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Varon 2014 Contra to protocol: not an RCT.
Vasoncelos 2013 Contra to protocol: not an RCT.
Villalba 2006a Contra to protocol: not an RCT.
Villalba 2006b Contra to protocol: not an RCT.
Vrijhoef 2007 Contra to protocol: not an RCT.
Waldman 2008 Included participants with coronary artery disease, intervention not specific to heart failure
Walsh 2005 Contra to protocol: not an RCT.
Wang 2010 Contra to protocol: not an RCT.
Wang 2012 Not heart failure.
Waywell 2007 Contra to protocol: not an RCT.
Weintraub 2005 Contra to protocol: intervention included home-visits.
West 2013 Editorial paper.
West-Frasier 2008 Contra to protocol: home visits by cardiac nurses to both groups (communication from author)
Westlake 2007 Contra to protocol: intervention was web-based.
Wheeler 2006 Contra to protocol: intervention included home visits.
Whitten 2007 Review.
Wierzchowiecki 2006a Contra to protocol: intervention included home visits.
Wierzchowiecki 2006b Contra to protocol: intervention included home visits.
Willyard 2006 Contra to protocol: not an RCT.
Wong 2005 Intervention for people with chronic obstructive pulmonary disease
Wongpiriyayothar 2008 Contra to protocol: intervention included home visits.
Woodside 2011 Contra to protocol: not an RCT.
Wright 2003 Contra to protocol: intervention consisted of symptom diary, attended three education session and
clinic visits
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(Continued)
Wu 2006 Comparison of internet-based technology.
Xiao 2010 Contra to protocol: not telemonitoring or telephone support.
Zaphiriou 2006 Contra to protocol: intervention included a home visit.
Zentner 2007 Contra to protocol: not an RCT.
Zugck 2006 Contra to protocol: not an RCT.
Characteristics of studies awaiting assessment [ordered by study ID]
Dunlap 2006 (HearT-I)
Methods Randomised controlled trial; Intervention versus usual care.
Participants 455 participants to date (NYHA Class II or greater).
Mean age no data.
% of participants were male - no data.
USA.
Interventions Structured Telephone Support
3 components; 1) computer-initiated medication refill and clinic appointment reminders; 2) IVR access to education
modules; 3) Computer-initiated phone calls with a series of question regarding weight and symptoms
Outcomes All-cause hospitalisation; unscheduled outpatient visits.
KCCQ; satisfaction; adherence to medications; knowledge of self care and heart failure
12-month follow-up.
Notes Unable to contact authors to determine or clarify intervention and usual care arms
Kulshreshtha 2010
Methods Randomised controlled trial.
Participants 150 eligible participants from Massachusetts General Hospital
USA.
Interventions “Participants transmitted daily vital signs data and weight to a nurse who coordinated care with a physician. Timely
interventions and teaching were offered over the course of the 6 month study.”
Outcomes “All cause readmission, HF related admission mortality ER Visits and Length of Stay”
Notes Authors contacted to clarify study methods, but no response received
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Levine 2006 (Mind My Heart)
Methods Randomised controlled trial; intervention arm and control (usual care) arm
Participants 234 participants.
Mean age not reported.
% of participants were male not reported.
USA.
Interventions Telemonitoring.
Intervention group transmitted to monitoring centre via modem vital signs, BP SpO
Usual care no further contact with project staff.
Outcomes Technology use and Satisfaction Survey
Notes No primary outcomes reported. Unable to contact authors.
Suh 2010
Methods “The WANDA B. wireless health technology leverages sensor technology and wireless communication to monitor
heart failure patient activity and to provide tailored guidance. Patients who have cardiovascular system disorders
can measure their weight, blood pressure, activity levels, and other vital signs in a real-time automated fashion. The
system was developed in conjunction with the UCLA Nursing School and the UCLA Wireless Health Institute for
use on actual patients. It is currently in use with real patients in a clinical trial.”
Participants
Interventions
Outcomes
Notes Authors contacted requesting details of clinical trial, no details provided
Wade 2011
Methods Randomised clinical trial.
Participants High-risk people with heart failure.
Interventions Telehealth system with case management (THCM) versus case management (CM) alone
Outcomes Composite of all-cause hospitalisation, ED visit, or death.
Notes Unable to locate valid author contact details.
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Wongpiriyayothar 2011
Methods 2-group pretest-post-test experimental research design with random assignment to groups
Participants 22 people with heart failure.
Interventions Coaching using telephone programme.
“The experimental group received the coaching by telephone program (CTP) from the researcher who is a cardiac
nurse practitioner; the control group received the usual care from the hospital (routine hospital or clinic assessment
and education).”
Outcomes Self management of heart failure symptoms, dyspnoea, physical functioning
Notes Authors contacted, no response received.
Wootton 2010
Methods Randomised controlled trial.
Participants People with heart failure.
Interventions
Outcomes “An evaluation was undertaken on the effectiveness and efficiency of care coordination as a means of delivering health
services to Australian veterans with a diagnosis of congestive heart failure.”
Notes Authors contacted, no response received.
Yakushin 2006
Methods Randomised controlled trial; intervention arm and control (usual care) arm
Participants 78 participants
Mean age 56 years.
% of participants were male not reported.
Russian Federation.
Interventions Unable to determine intervention from abstract.
Some telephone follow-up.
Usual care not described.
Outcomes Hospitalisations and cardiovascular death
Notes Unable to contact authors.
BP: blood pressure
KCCQ: Kansas City cardiomyopathy questionnaire
SpO : Pulse oximetry
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Characteristics of ongoing studies [ordered by study ID]
Andrei 2011
Trial name or title
Methods Randomised controlled trial.
Participants 45 people that have been followed 1 year. All these participants had established diagnosis of chronic congestive
heart failure
Interventions “Two groups: group 1 - patients with worsening CCFH hospitalized for treatment and monitories and group
2 - patients with worsening chronic congestive heart failure treated and monitories at home.”
Outcomes Cost
Starting date
Contact information
Notes Published as conference abstract.
Unable to locate contact details for authors.
Black 2014
Trial name or title
Methods Multicentre, randomised controlled trial.
Participants “1,500 patients aged 50 years and older will be enrolled during a hospitalization for treatment of heart failure.
”
Interventions “Patients in the intervention group will receive intensive patient education using the ‘teach-back’ method and
receive instruction in using the telemonitoring equipment. Following hospital discharge, they will receive a
series of nine scheduled health coaching telephone calls over 6 months from nurses located in a centralized
call center. The nurses also will call patients and patients’ physicians in response to alerts generated by the
telemonitoring system, based on predetermined parameters.”
Outcomes “The primary outcome is readmission for any cause within 180 days. Secondary outcomes include 30-day
readmission, mortality, hospital days, emergency department (ED) visits, hospital cost, and health-related
quality of life.”
Starting date
Contact information
Notes Study protocol only.
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Boxer 2010
Trial name or title
Methods Randomised controlled trial.
Participants
Interventions
Outcomes
Starting date
Contact information
Notes Published as conference abstract.
Authors emailed, no response received.
Cavusoglu 2013 Hit-Point
Trial name or title Hit-Point
Methods Multicentre, randomised, controlled trial.
Participants “Patients who carried the diagnosis of HF secondary to systolic dysfunction, had been hospitalized for HF
within six months of randomization, and had symptoms despite optimal medical therapy.”
Interventions “Enhanced HF education with a 6 month phone follow-up program (EHFP) vs routine care (RC). Education
included information on the adherence to treatment, symptoms recognition, diet and fluid intake, weight
monitoring, activity, exercise training and when to contact cardiologist. Patients were contacted by phone at
1, 3 and 6 month.”
Outcomes “The primary study endpoint was cardiovascular death.”
Starting date
Contact information
Notes Conference abstract, authors contacted, full-text peer-reviewed publication not yet available
De Vries 2011 IN TOUCH
Trial name or title IN-TOUCH
Methods Randomised controlled trial.
Participants 220 participants will be included after worsening of CHF.
Interventions Telemonitoring added to ICT-guided disease management.
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De Vries 2011 IN TOUCH (Continued)
Outcomes “The primary endpoint of this study is a composite score of: 1: death from any cause during the follow-up
of the study, 2: first readmission for HF and 3: change in quality of life compared to baseline, assessed by the
Minnesota Living with Heart failure Questionnaire.”
Starting date 2009
Contact information
Notes Study protocol only.
Dwinger 2013a
Trial name or title
Methods Prospective randomised controlled trial.
Participants
Interventions Telephone-based health coaching with usual care.
Outcomes “Patients are selected based on one of the following chronic conditions: diabetes, coronary artery disease,
asthma, hypertension, heart failure, COPD, chronic depression or schizophrenia”
Starting date
Contact information
Notes Study protocol only.
Enjuanes 2013b
Trial name or title
Methods Prospective, randomised, controlled trial.
Participants
Interventions “Strategies of high risk HF patients: HFP (heart failure programme) or HFP+T heart failure programme based
on telemedicine). Telemedicine management consisted in daily telemonitoring of weight, blood pressure,
heart rate and symptoms that were transmitted to a central station controlled by HF nurses. Teleintervention
was carried out replacing the physical appointments by videoconference, promoting self-care and performing
therapeutic optimization.”
Outcomes “The determination of direct costs was performed using cost accounting methodology. Primary endpoint:
non-fatal HF events by requiring hospital attention at 6 months of inclusion (decompensations requiring
parenteral treatment).”
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Enjuanes 2013b (Continued)
Starting date
Contact information
Notes Conference abstract only, authors contacted, full-text peer-reviewed publication not yet available
Gupta 2013
Trial name or title
Methods Randomised controlled trial.
Participants 40 participants with advanced heart failure.
Interventions “Usual in-hospital care versus telemonitoring-facilitated discharge. Interventions made on the basis of tele-
monitoring data were limited to telephonically communicated advice to adjust medication and to arrange
domiciliary blood samples to monitor renal function and electrolytes.”
Outcomes
Starting date
Contact information
Notes Published as conference abstract.
Unable to locate contact details for authors.
Janssen 2010
Trial name or title
Methods Controlled trial
Participants People with heart failure.
Interventions Telemonitoring.
Outcomes
Starting date
Contact information
Notes Published as conference abstract.
Unable to locate contact details for authors.
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Kalowes 2012
Trial name or title
Methods Multi-site randomised, controlled trial (RCT)
Participants “Recently hospitalized HF patients”.
Interventions “post-discharge, telephone intervention” compared to “usual care group receiving outpatient care by their
primary care physician.”
Outcomes “...self-care/adherence...incidence of all cause mortality or hospital readmissions (30-day /overall)”. “A sec-
ondary aim is to assess the impact of the intervention on patient self-care/adherence by examining the effect
on QoL and the role of multiple variables (socioeconomic, HC setting/system related, condition related,
treatment and patient related)”
Starting date
Contact information
Notes Published as conference abstract.
Authors emailed, no response received.
Karanam 2012
Trial name or title
Methods Unclear.
Participants 61 participants.
Interventions “Mobile phone based case management program for patients with Heart Failure (HF) to monitor, educate,
and improve self-care efficacy.”
Outcomes “Knowledge, behavior, self care efficacy, and quality of life(QoL) at baseline and 12 weeks.”
Starting date
Contact information
Notes Published as conference abstract.
Unable to locate contact details for authors.
Kessing 2011 Telemed-HF
Trial name or title TELEMED-HF
Methods Randomised controlled trial.
Participants People with chronic, systolic HF presenting to the outpatient clinic
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Kessing 2011 Telemed-HF (Continued)
Interventions Medication support device for 6 months in addition to usual care
Outcomes “The efficacy and cost-efficiency of an electronic medication adherence support system in improving and
monitoring HF patients’ medication adherence; (2) the effect of medication adherence on hospitalizations
and health care consumption; as well as on (3) clinical characteristics, and Quality of Life (QoL); and (4)
clinical, sociodemographic, and psychological determinants of medication adherence.”
Starting date
Contact information
Notes Study protocol.
Kotooka 2013 Homes-HF
Trial name or title
Methods Multicentre RCT (Japan).
2 groups: Telemonitoring versus usual care.
Follow-up: 12 months.
Participants n = 420 participants planned.
Interventions “Weight and blood pressure measurements to be performed at least once daily for 12 months
Professionals involved: nurses who monitor the data 7 days a week and patient’s physician who is responsible
for acting on the information.”
Outcomes “Primary endpoints are all-cause death or HF hospitalisation. Secondary endpoints are all-cause death, cardiac
death, all-cause rehospitalisation, CV rehospitalisation, HF rehospitalisation, worsening of symptoms, cost
of care, LVEF, NTpro-BNP, high sensitive CRP, PTX3, high sensitive troponine, high molecular weight
adiponectin, changes in MMSE score, GSES, MLWHF score, PHQ-9 score and adherence to medications.”
Starting date
Contact information
Notes Study protocol only.
Lambrinou 2013 MEETTinCy
Trial name or title MEETTinCy.
Methods Randomised controlled trial, 4 arms.
Participants People hospitalised with HF, NYHA I - IV, were recruited from 4 general hospitals in Cyprus
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Lambrinou 2013 MEETTinCy (Continued)
Interventions “Patients were randomly assigned to receive pre-discharge education or telephone support for 3 months after
discharge or both, while patients in the control group received the usual care.”
Outcomes “Measures of self-care (using the European Heart Failure Selfcare Behavior Scale) and QoL (using the Min-
nesota Living in Heart Failure Questionnaire) were collected at baseline and 3 months.”
Starting date
Contact information
Notes Published as conference abstract.
Authors emailed, no response received.
Mareev 2010 CHANCE-AND
Trial name or title CHANCE-AND
Methods “The aim of this trial was to determine whether a special multidisciplinary, non-pharmacological, intervention
(including pre-discharge patient education and active follow-up with regular bi-lateral telephone contact)
could reduce prevalence of anxiety and depression and morbidity and mortality of patients with heart failure
depending on severity of concomitant anxiety and depression.”
Participants
Interventions
Outcomes
Starting date
Contact information
Notes Authors contacted, a full-text peer-reviewed publication not yet available
McCall 2011
Trial name or title Medicare Health Support Pilot Program
Methods Randomised study of 8 commercial programmes for disease management that used nurse-based call centres
Participants People with heart failure, diabetes, or both to the intervention or to usual care (control)
Interventions
Outcomes “Quality of clinical care, acute care utilization, and Medicare expenditures for Medicare fee-for-service bene-
ficiaries.”
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McCall 2011 (Continued)
Starting date
Contact information
Notes Authors emailed to clarify methods, no response received.
Mizukawa 2014
Trial name or title
Methods Multicentre randomised controlled trial.
Participants People with heart failure.
Interventions “Three groups: A) TM group with a device of noninvasive blood pressure, heart rate, body weight measure-
ments that automatically send data to the monitor center. Nurses gave patients tele-consultation when the
data were out of the optimal values. Patients also received a DM program to gain self-management skills. B)
DM group with the DM program. Patients write the value of blood pressure, heart rate, and body weight to
monitor their conditions. C) UC group with standard self-management education once from a nurse, and
the patients visited the physicians as usual.”
Outcomes Primary outcome was hospital readmissions for heart failure.
Starting date January 2013 and April 2014
Contact information
Notes Conference abstract, authors contacted, full-text peer-reviewed publication not yet available
Moye 2012
Trial name or title
Methods Randomised controlled trial.
Participants Primary or secondary diagnosis of heart failure.
Interventions “Pharmacist-lead education intervention program. The control group received standard of care. The interven-
tion included one-on-one medication/disease management discharge counseling from a pharmacist, patients
were given individualized information regarding their disease state, patients were called on days 14 and 28
post discharge.”
Outcomes Hospital re-admissions
Starting date August 1, 2011
Contact information
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Moye 2012 (Continued)
Notes Published as a conference abstract.
Authors emailed, no response received.
Papadopoulou 2010
Trial name or title
Methods Randomised controlled trial.
Participants 100 outpatients with stable chronic HF (NYHA III and IV) and optimal drug treatment
Interventions “Telephone intervention (a liaison nurse telephoned within seven days of hospital discharge and then at least
weekly for one year).vs. usual care.”
Outcomes Mortality, hospitalisations.
Starting date
Contact information
Notes Published as a conference abstract.
Unable to locate author contact details.
Persson 2011
Trial name or title
Methods Randomised controlled clinical study.
Participants n = 139
Interventions “Patients were invited to meet with a specially trained nurse/care manager for a one-hour structured interview
investigating possible causes of frequent rehospitalizations. Gaps within the patients’ care were identified
and specific actions to alleviate the patient’s situation (e.g. establishing a primary care contact, booking a
specialist or a heart failure nurse appointment, securing home care) were completed. Thereafter regularmedical
telephone support (structured and planned phone calls) by the same nurse was offered to the patients with
the aim to coach and support patients.”
Outcomes Quality of life and hospitalisations.
Starting date
Contact information
Notes Published as a conference abstract.
Authors emailed, no response received.
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Ritchie 2012 E-coach
Trial name or title E-Coach
Methods Randomised controlled trial.
Participants People with congestive heart failure and chronic obstructive pulmonary disease
Interventions “Interactive voice response (IVR)-enhanced care transition intervention that monitors patients
at home using their personal phone.”
Outcomes
Starting date
Contact information
Notes Study protocol.
Authors emailed, no response received.
Voon 2013
Trial name or title
Methods Unclear.
Participants “79 consecutive patients with HF deemed high-risk (hospital admission for acute decompensated HF/IV
diuretic outpatient treatment within 6 months, euvolemic BNP .300pg/mL, non-compliance to therapy).”
Interventions “TM was defined as daily body weight (BW) remote home monitoring using Bluetooth-enabled weighing
scale via mobile phone software to a remote web server. DMP was defined as 24-hour outpatient access via
phone contact with adhoc review. In addition, structured physician review at 2, 6 and 12 weeks post-discharge
and concurrent weekly phone-contacts by nurse, was available.”
Outcomes “Patients weremonitored for clinical deterioration (CD), defined as evidence ofHF decompensation requiring
diuretic therapy or hospitalization as per guidelines.”
Starting date
Contact information
Notes Published as a conference abstract.
Authors contacted, no response received.
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Whole Systems Demonstrator
Trial name or title Whole System Demonstrator
Methods Cluster-randomised trial
Participants 79 general practices in 3 areas of England
Interventions “Telehealth or usual care to eligible patients. Telehealth included remote exchange of vitals signs and symptoms
data between patients and healthcare professionals as part of the continuing management of patients. Usual
care reflected the range of services otherwise available in the sites, excluding telehealth”
Outcomes
Starting date
Contact information
Notes Authors contacted to assess if intervention tailored for people with heart failure and if data available for them.
Authors did not respond
Zhang 2009
Trial name or title
Methods Randomised study
Participants 181 participants with heart failure
Interventions “Nurse 24 hours telephone services group (24h-telephone, n=91) and non-24 hours telephone services (non-
24h-telephone, n=90) group. Telephone services must tell patients how to do next step when patients
have any questions.”
Outcomes “The primary end point of the study was the total number of hospital readmission and dead in the one year
follow-up period”
Starting date
Contact information
Notes Conference abstract, unable to locate author contact details
Zugck 2010 HiTel
Trial name or title HiTel
Methods Randomised controlled trial; intervention arm and control (usual care) arm
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Zugck 2010 HiTel (Continued)
Participants 88 participants recruited from hospital, mean LVEF was 24 ± 7%. Inclusion criteria NYHA II - IV on
optimum therapy and telephone at home
Mean age 58.1 years.
82% of participants were men.
Germany.
Interventions Telemonitoring.
Intervention group transmitted to monitoring centre via modem vital signs, BP SpO and received lifestyle
and medication education. NYHA III and IV transmitted weekly and NYHA II monthly. Medical advice was
available 24/7
Usual care not described.
Outcomes All-cause hospitalisation.
12-month follow-up.
Starting date
Contact information
Notes
BP: blood pressure
SpO : pulse oximetry
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D A T A A N D A N A L Y S E S
Comparison 1. Impact of structured telephone support and telemonitoring in heart failure on all-cause mortality
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 All-cause mortality: STS vs UC 22 9222 Risk Ratio (M-H, Fixed, 95% CI) 0.87 [0.77, 0.98]
2 All-cause mortality: TM vs UC 17 3740 Risk Ratio (M-H, Fixed, 95% CI) 0.80 [0.68, 0.94]
3 Subgroup technology: all-cause
mortality STS vs UC
17 6629 Risk Ratio (M-H, Fixed, 95% CI) 0.81 [0.71, 0.93]
4 Subgroup technology: all-cause
mortality Complex TM vs UC
12 2885 Risk Ratio (M-H, Fixed, 95% CI) 0.81 [0.68, 0.96]
5 Subgroup technology: all-cause
mortality Videophone vs UC
2 269 Risk Ratio (M-H, Fixed, 95% CI) 1.14 [0.65, 1.99]
6 Subgroup technology: all-cause
mortality IVR vs UC
4 2445 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.80, 1.28]
7 Subgroup technology: all-cause
mortality Mobile/PDA vs UC
4 734 Risk Ratio (M-H, Fixed, 95% CI) 0.71 [0.46, 1.11]
8 Subgroup TM intensity:
all-cause mortality Office hours
vs UC
10 1548 Risk Ratio (M-H, Fixed, 95% CI) 0.69 [0.52, 0.92]
9 Subgroup TM intensity:
all-cause mortality 24/7 or 7
days/week vs UC
7 2192 Risk Ratio (M-H, Fixed, 95% CI) 0.86 [0.71, 1.04]
10 Subgroup Publication year:
all-cause mortality STS vs UC
< 2000
2 219 Risk Ratio (M-H, Fixed, 95% CI) 0.45 [0.14, 1.40]
11 Subgroup Publication year:
all-cause mortality STS vs UC
2000 - 2007
13 5668 Risk Ratio (M-H, Fixed, 95% CI) 0.86 [0.74, 0.99]
12 Subgroup Publication year:
all-cause mortality STS vs UC
≥ 2008
7 3335 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.75, 1.10]
13 Subgroup Publication year:
all-cause mortality TM vs UC
2000 - 2007
3 553 Risk Ratio (M-H, Fixed, 95% CI) 0.58 [0.39, 0.86]
14 Subgroup Publication year:
all-cause mortality TM vs UC
≥ 2008
14 3187 Risk Ratio (M-H, Fixed, 95% CI) 0.85 [0.72, 1.02]
15 Subgroup Participant age:
all-cause mortality: STS vs UC
< 70 years of age
13 6158 Risk Ratio (M-H, Fixed, 95% CI) 0.88 [0.77, 1.01]
16 Subgroup Participant age:
all-cause mortality STS vs UC
≥ 70 years of age
9 3064 Risk Ratio (M-H, Fixed, 95% CI) 0.84 [0.67, 1.04]
17 Subgroup Participant age:
all-cause mortality: TM vs UC
< 70 years of age
9 2493 Risk Ratio (M-H, Fixed, 95% CI) 0.84 [0.68, 1.04]
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18 Subgroup Participant age:
all-cause mortality TM vs UC
≥ 70 years of age
8 1247 Risk Ratio (M-H, Fixed, 95% CI) 0.74 [0.59, 0.94]
19 Subgroup STS focus: all-cause
mortality STS (clinical support)
vs UC
18 8094 Risk Ratio (M-H, Fixed, 95% CI) 0.87 [0.77, 0.98]
20 Subgroup STS focus: all-cause
mortality STS (education) vs
UC
4 1128 Risk Ratio (M-H, Fixed, 95% CI) 0.90 [0.55, 1.45]
21 Sensitivity analysis follow-up
period (> 6 months), all-cause
mortality: STS vs UC
11 4818 Risk Ratio (M-H, Fixed, 95% CI) 0.88 [0.75, 1.02]
22 Sensitivity analysis follow-up
period (> 6 months), all-cause
mortality: TM vs UC
10 2580 Risk Ratio (M-H, Fixed, 95% CI) 0.89 [0.74, 1.06]
Comparison 2. Impact of structured telephone or telemonitoring in heart failure on risk of all-cause hospitalisation
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 All-cause hospitalisation: STS vs
UC
16 7216 Risk Ratio (M-H, Fixed, 95% CI) 0.95 [0.90, 1.00]
2 All-cause hospitalisation: TM vs
UC
13 3332 Risk Ratio (M-H, Fixed, 95% CI) 0.95 [0.89, 1.01]
3 Subgroup technology: all-cause
hospitalisation STS vs UC
12 4756 Risk Ratio (M-H, Fixed, 95% CI) 0.93 [0.86, 0.99]
4 Subgroup technology: all-cause
hospitalisation Mobile/PDA vs
UC
2 560 Risk Ratio (M-H, Fixed, 95% CI) 0.76 [0.60, 0.97]
5 Subgroup technology: all-cause
hospitalisation Videophone vs
UC
2 269 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.80, 1.04]
6 Subgroup technology: all-cause
hospitalisation IVR vs UC
3 2312 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.91, 1.08]
7 Subgroup technology: all-cause
hospitalisation Complex TM
vs UC
10 2651 Risk Ratio (M-H, Fixed, 95% CI) 0.97 [0.90, 1.04]
8 Subgroup TM intensity:
all-cause hospitalisation Office
hours vs UC
6 1140 Risk Ratio (M-H, Fixed, 95% CI) 0.85 [0.76, 0.94]
9 Subgroup TM intensity:
all-cause hospitalisation 24/7
or 7 days vs UC
7 2192 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.93, 1.09]
10 Subgroup Publication year:
all-cause hospitalisation STS vs
UC < 2000
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
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11 Subgroup Publication year:
all-cause hospitalisation STS vs
UC 2000 - 2007
8 3700 Risk Ratio (M-H, Fixed, 95% CI) 0.93 [0.86, 1.01]
12 Subgroup Publication year:
all-cause hospitalisation STS vs
UC ≥ 2008
7 3335 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.91, 1.06]
13 Subgroup Publication year:
all-cause hospitalisation TM vs
UC 2000 - 2007
2 533 Risk Ratio (M-H, Fixed, 95% CI) 0.94 [0.79, 1.12]
14 Subgroup Publication year:
all-cause hospitalisation TM vs
UC ≥ 2008
11 2799 Risk Ratio (M-H, Fixed, 95% CI) 0.95 [0.89, 1.02]
15 Subgroup Participant age:
all-cause hospitalisation STS vs
UC ≥ 70 years of age
6 1923 Risk Ratio (M-H, Fixed, 95% CI) 0.94 [0.85, 1.04]
16 Subgroup Participant age:
all-cause hospitalisation: STS
vs UC < 70 years of age
10 5293 Risk Ratio (M-H, Fixed, 95% CI) 0.95 [0.89, 1.01]
17 Subgroup Participant age:
all-cause hospitalisation TM vs
UC ≥ 70 years of age
6 1147 Risk Ratio (M-H, Fixed, 95% CI) 0.90 [0.82, 0.99]
18 Subgroup Participant age:
all-cause hospitalisation: TM vs
UC < 70 years of age
7 2185 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.90, 1.07]
19 Subgroup STS focus: all-cause
hospitalisation: STS (clinical
support) vs UC
14 6820 Risk Ratio (M-H, Fixed, 95% CI) 0.94 [0.89, 1.00]
20 Subgroup STS focus:
all-cause hospitalisation: STS
(education) vs UC
2 396 Risk Ratio (M-H, Fixed, 95% CI) 1.08 [0.84, 1.38]
21 Sensitivity analysis follow-up
period (> 6 months), all-cause
hospitalisation: STS vs UC
7 3451 Risk Ratio (M-H, Fixed, 95% CI) 0.89 [0.82, 0.96]
22 Sensitivity analysis follow-up
period (> 6 months), all-cause
hospitalisation: TM vs UC
8 2387 Risk Ratio (M-H, Fixed, 95% CI) 0.94 [0.87, 1.01]
Comparison 3. Impact of structured telephone support or telemonitoring in heart failure on risk of heart failure-
related hospitalisation
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 CHF-related hospitalisation:
STS vs UC
16 7030 Risk Ratio (M-H, Fixed, 95% CI) 0.85 [0.77, 0.93]
2 CHF-related hospitalisation:
TM vs UC
8 2148 Risk Ratio (M-H, Fixed, 95% CI) 0.71 [0.60, 0.83]
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3 Subgroup technology:
CHF-related hospitalisation
STS vs UC
13 4718 Risk Ratio (M-H, Fixed, 95% CI) 0.76 [0.67, 0.86]
4 Subgroup technology:
CHF-related hospitalisation
Mobile/PDA vs UC
3 674 Risk Ratio (M-H, Fixed, 95% CI) 0.58 [0.44, 0.77]
5 Subgroup technology
CHF-related hospitalisation
Complex TM vs UC
5 1474 Risk Ratio (M-H, Fixed, 95% CI) 0.78 [0.64, 0.94]
6 Subgroup technology:
CHF-related hospitalisation
IVR vs UC
3 2312 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.86, 1.14]
7 Subgroup TM intensity:
CHF-related hospitalisation
Office hours vs UC
5 858 Risk Ratio (M-H, Fixed, 95% CI) 0.71 [0.56, 0.89]
8 Subgroup TM intensity:
CHF-related hospitalisation
24/7 or 7 days vs UC
3 1290 Risk Ratio (M-H, Fixed, 95% CI) 0.71 [0.57, 0.87]
9 Subgroup Publication year:
CHF-related hospitalisation
STS vs UC < 2000
2 219 Risk Ratio (M-H, Fixed, 95% CI) 0.24 [0.10, 0.58]
10 Subgroup Publication year:
CHF-related hospitalisation
STS vs UC 2000 - 2007
10 3784 Risk Ratio (M-H, Fixed, 95% CI) 0.78 [0.69, 0.89]
11 Subgroup Publication year:
CHF-related hospitalisation
STS vs UC ≥ 2008
4 3027 Risk Ratio (M-H, Fixed, 95% CI) 0.96 [0.84, 1.11]
12 Subgroup Publication year:
CHF-related hospitalisation
TM vs UC 2000 - 2007
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
13 Subgroup Publication year:
CHF-related hospitalisation
TM vs UC ≥ 2008
7 1895 Risk Ratio (M-H, Fixed, 95% CI) 0.69 [0.58, 0.82]
14 Subgroup Participant age:
CHF-related hospitalisation:
STS vs UC < 70 years of age
8 5035 Risk Ratio (M-H, Fixed, 95% CI) 0.86 [0.77, 0.96]
15 Subgroup Participant age:
CHF-related hospitalisation:
STS vs UC ≥ 70 years of age
8 1995 Risk Ratio (M-H, Fixed, 95% CI) 0.81 [0.67, 0.96]
16 Subgroup Participant age:
CHF-related hospitalisation:
TM vs UC < 70 years of age
6 1898 Risk Ratio (M-H, Fixed, 95% CI) 0.75 [0.63, 0.89]
17 Subgroup Participant age:
CHF-related hospitalisation:
TM vs UC ≥ 70 years of age
2 250 Risk Ratio (M-H, Fixed, 95% CI) 0.53 [0.37, 0.76]
18 Subgroup STS focus:
CHF-related hospitalisation:
STS (clinical support) vs UC
15 6754 Risk Ratio (M-H, Fixed, 95% CI) 0.84 [0.76, 0.93]
19 Subgroup STS focus:
CHF-related hospitalisation:
STS (education) vs UC
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
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20 Sensitivity analysis follow-up
period (> 6 months),
CHF-related hospitalisation:
STS vs UC
7 3341 Risk Ratio (M-H, Fixed, 95% CI) 0.76 [0.66, 0.88]
21 Sensitivity analysis follow-up
period (> 6 months),
CHF-related hospitalisation:
TM vs UC
4 1684 Risk Ratio (M-H, Fixed, 95% CI) 0.78 [0.65, 0.94]
Analysis 1.1. Comparison 1 Impact of structured telephone support and telemonitoring in heart failure on
all-cause mortality, Outcome 1 All-cause mortality: STS vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 1 Impact of structured telephone support and telemonitoring in heart failure on all-cause mortality
Outcome: 1 All-cause mortality: STS vs UC
Study or subgroup STS Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Angermann 2012 (INH) 32/352 52/363 9.7 % 0.63 [ 0.42, 0.96 ]
Baker 2011 0/303 2/302 0.5 % 0.20 [ 0.01, 4.13 ]
Barth 2001 0/17 0/17 Not estimable
Bento 2009 0/20 1/20 0.3 % 0.33 [ 0.01, 7.72 ]
Capomolla 2004 5/67 7/66 1.3 % 0.70 [ 0.24, 2.11 ]
Chaudhry 2010 (Tele-HF) 92/826 94/827 17.8 % 0.98 [ 0.75, 1.28 ]
Cleland 2005 (Struct Tele) (TENS-HMS) 27/173 20/85 5.1 % 0.66 [ 0.40, 1.11 ]
DeBusk 2004 21/228 29/234 5.4 % 0.74 [ 0.44, 1.26 ]
DeWalt 2006 3/62 4/65 0.7 % 0.79 [ 0.18, 3.37 ]
Domingues 2011 8/57 13/63 2.3 % 0.68 [ 0.30, 1.52 ]
Galbreath 2004 54/710 39/359 9.8 % 0.70 [ 0.47, 1.04 ]
Gattis 1999 (PHARM) 3/90 5/91 0.9 % 0.61 [ 0.15, 2.46 ]
GESICA 2005 (DIAL) 116/760 122/758 23.2 % 0.95 [ 0.75, 1.20 ]
Krum 2013 (CHAT) 17/188 16/217 2.8 % 1.23 [ 0.64, 2.36 ]
Laramee 2003 13/141 15/146 2.8 % 0.90 [ 0.44, 1.82 ]
Mortara 2009 (Struct Tele) (HHH) 7/94 9/160 1.3 % 1.32 [ 0.51, 3.44 ]
Rainville 1999 1/19 4/19 0.8 % 0.25 [ 0.03, 2.04 ]
Riegel 2002 16/130 32/228 4.4 % 0.88 [ 0.50, 1.54 ]
0.01 0.1 1 10 100
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(. . . Continued)
Study or subgroup STS Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Riegel 2006 6/70 8/65 1.6 % 0.70 [ 0.26, 1.90 ]
Sisk 2006 22/203 22/203 4.2 % 1.00 [ 0.57, 1.75 ]
Tsuyuki 2004 16/140 12/136 2.3 % 1.30 [ 0.64, 2.64 ]
Wakefield 2008 25/99 11/49 2.8 % 1.12 [ 0.60, 2.09 ]
Total (95% CI) 4749 4473 100.0 % 0.87 [ 0.77, 0.98 ]
Total events: 484 (STS), 517 (Usual Care)
Heterogeneity: Chi2 = 13.56, df = 20 (P = 0.85); I2 =0.0%
Test for overall effect: Z = 2.38 (P = 0.017)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
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Analysis 1.2. Comparison 1 Impact of structured telephone support and telemonitoring in heart failure on
all-cause mortality, Outcome 2 All-cause mortality: TM vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 1 Impact of structured telephone support and telemonitoring in heart failure on all-cause mortality
Outcome: 2 All-cause mortality: TM vs UC
Study or subgroup Telemonitoring Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Antonicelli 2008 3/28 5/29 1.8 % 0.62 [ 0.16, 2.36 ]
Balk 2008 9/101 8/113 2.8 % 1.26 [ 0.50, 3.14 ]
Biannic 2012 (SEDIC) 8/45 14/45 5.1 % 0.57 [ 0.27, 1.23 ]
Blum 2014 (MCCD) 49/104 45/102 16.6 % 1.07 [ 0.79, 1.44 ]
Cleland 2005 (Telemon) (TENS-HMS) 28/168 20/85 9.7 % 0.71 [ 0.42, 1.18 ]
De Lusignan 2001 2/10 3/10 1.1 % 0.67 [ 0.14, 3.17 ]
Dendale 2012 (TEMA-HF1) 4/80 14/80 5.1 % 0.29 [ 0.10, 0.83 ]
Giordano 2009 21/230 32/230 11.7 % 0.66 [ 0.39, 1.10 ]
0.005 0.1 1 10 200
Favours telemonitoring Favours usual care
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(. . . Continued)
Study or subgroup Telemonitoring Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Goldberg 2003 (WHARF) 11/138 26/142 9.4 % 0.44 [ 0.22, 0.85 ]
Koehler 2011 (TIM-HF) 54/354 55/356 20.0 % 0.99 [ 0.70, 1.39 ]
Lyng 2012 (WISH) 5/166 8/153 3.0 % 0.58 [ 0.19, 1.72 ]
Mortara 2009 (Telemon) (HHH) 8/101 9/160 2.5 % 1.41 [ 0.56, 3.53 ]
Seto 2012 3/50 0/50 0.2 % 7.00 [ 0.37, 132.10 ]
Soran 2008 11/160 17/155 6.3 % 0.63 [ 0.30, 1.29 ]
Villani 2014 (ICAROS) 5/40 9/40 3.3 % 0.56 [ 0.20, 1.51 ]
Vuorinen 2014 0/47 0/47 Not estimable
Woodend 2008 5/62 4/59 1.5 % 1.19 [ 0.34, 4.22 ]
Total (95% CI) 1884 1856 100.0 % 0.80 [ 0.68, 0.94 ]
Total events: 226 (Telemonitoring), 269 (Usual Care)
Heterogeneity: Chi2 = 19.70, df = 15 (P = 0.18); I2 =24%
Test for overall effect: Z = 2.77 (P = 0.0057)
Test for subgroup differences: Not applicable
0.005 0.1 1 10 200
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Analysis 1.3. Comparison 1 Impact of structured telephone support and telemonitoring in heart failure on
all-cause mortality, Outcome 3 Subgroup technology: all-cause mortality STS vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 1 Impact of structured telephone support and telemonitoring in heart failure on all-cause mortality
Outcome: 3 Subgroup technology: all-cause mortality STS vs UC
Study or subgroup STS Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Angermann 2012 (INH) 32/352 52/363 13.1 % 0.63 [ 0.42, 0.96 ]
Baker 2011 0/303 2/302 0.6 % 0.20 [ 0.01, 4.13 ]
Barth 2001 0/17 0/17 Not estimable
Bento 2009 0/20 1/20 0.4 % 0.33 [ 0.01, 7.72 ]
Cleland 2005 (Struct Tele) (TENS-HMS) 27/173 20/85 6.9 % 0.66 [ 0.40, 1.11 ]
DeBusk 2004 21/228 29/234 7.3 % 0.74 [ 0.44, 1.26 ]
DeWalt 2006 3/62 4/65 1.0 % 0.79 [ 0.18, 3.37 ]
Domingues 2011 8/57 13/63 3.2 % 0.68 [ 0.30, 1.52 ]
Galbreath 2004 54/710 39/359 13.3 % 0.70 [ 0.47, 1.04 ]
Gattis 1999 (PHARM) 3/90 5/91 1.3 % 0.61 [ 0.15, 2.46 ]
GESICA 2005 (DIAL) 116/760 122/758 31.3 % 0.95 [ 0.75, 1.20 ]
Laramee 2003 13/141 15/146 3.8 % 0.90 [ 0.44, 1.82 ]
Rainville 1999 1/19 4/19 1.0 % 0.25 [ 0.03, 2.04 ]
Riegel 2002 16/130 32/228 6.0 % 0.88 [ 0.50, 1.54 ]
Riegel 2006 6/70 8/65 2.1 % 0.70 [ 0.26, 1.90 ]
Sisk 2006 22/203 22/203 5.6 % 1.00 [ 0.57, 1.75 ]
Tsuyuki 2004 16/140 12/136 3.1 % 1.30 [ 0.64, 2.64 ]
Total (95% CI) 3475 3154 100.0 % 0.81 [ 0.71, 0.93 ]
Total events: 338 (STS), 380 (Usual Care)
Heterogeneity: Chi2 = 9.43, df = 15 (P = 0.85); I2 =0.0%
Test for overall effect: Z = 2.95 (P = 0.0032)
Test for subgroup differences: Not applicable
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Analysis 1.4. Comparison 1 Impact of structured telephone support and telemonitoring in heart failure on
all-cause mortality, Outcome 4 Subgroup technology: all-cause mortality Complex TM vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 1 Impact of structured telephone support and telemonitoring in heart failure on all-cause mortality
Outcome: 4 Subgroup technology: all-cause mortality Complex TM vs UC
Study or subgroup Complex TM Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Antonicelli 2008 3/28 5/29 2.1 % 0.62 [ 0.16, 2.36 ]
Balk 2008 9/101 8/113 3.3 % 1.26 [ 0.50, 3.14 ]
Biannic 2012 (SEDIC) 8/45 14/45 6.1 % 0.57 [ 0.27, 1.23 ]
Blum 2014 (MCCD) 49/104 45/102 19.9 % 1.07 [ 0.79, 1.44 ]
Cleland 2005 (Telemon) (TENS-HMS) 28/168 20/85 11.6 % 0.71 [ 0.42, 1.18 ]
De Lusignan 2001 2/10 3/10 1.3 % 0.67 [ 0.14, 3.17 ]
Dendale 2012 (TEMA-HF1) 4/80 14/80 6.1 % 0.29 [ 0.10, 0.83 ]
Goldberg 2003 (WHARF) 11/138 26/142 11.2 % 0.44 [ 0.22, 0.85 ]
Koehler 2011 (TIM-HF) 54/354 55/356 24.0 % 0.99 [ 0.70, 1.39 ]
Lyng 2012 (WISH) 5/166 8/153 3.6 % 0.58 [ 0.19, 1.72 ]
Mortara 2009 (Telemon) (HHH) 8/101 9/160 3.0 % 1.41 [ 0.56, 3.53 ]
Soran 2008 11/160 17/155 7.6 % 0.63 [ 0.30, 1.29 ]
Total (95% CI) 1455 1430 100.0 % 0.81 [ 0.68, 0.96 ]
Total events: 192 (Complex TM), 224 (Usual Care)
Heterogeneity: Chi2 = 16.01, df = 11 (P = 0.14); I2 =31%
Test for overall effect: Z = 2.43 (P = 0.015)
Test for subgroup differences: Not applicable
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Analysis 1.5. Comparison 1 Impact of structured telephone support and telemonitoring in heart failure on
all-cause mortality, Outcome 5 Subgroup technology: all-cause mortality Videophone vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 1 Impact of structured telephone support and telemonitoring in heart failure on all-cause mortality
Outcome: 5 Subgroup technology: all-cause mortality Videophone vs UC
Study or subgroup Videophone Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Wakefield 2008 25/99 11/49 78.2 % 1.12 [ 0.60, 2.09 ]
Woodend 2008 5/62 4/59 21.8 % 1.19 [ 0.34, 4.22 ]
Total (95% CI) 161 108 100.0 % 1.14 [ 0.65, 1.99 ]
Total events: 30 (Videophone), 15 (Usual Care)
Heterogeneity: Chi2 = 0.01, df = 1 (P = 0.94); I2 =0.0%
Test for overall effect: Z = 0.46 (P = 0.65)
Test for subgroup differences: Not applicable
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Analysis 1.6. Comparison 1 Impact of structured telephone support and telemonitoring in heart failure on
all-cause mortality, Outcome 6 Subgroup technology: all-cause mortality IVR vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 1 Impact of structured telephone support and telemonitoring in heart failure on all-cause mortality
Outcome: 6 Subgroup technology: all-cause mortality IVR vs UC
Study or subgroup IVR Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Capomolla 2004 5/67 7/66 5.8 % 0.70 [ 0.24, 2.11 ]
Chaudhry 2010 (Tele-HF) 92/826 94/827 76.7 % 0.98 [ 0.75, 1.28 ]
Krum 2013 (CHAT) 17/188 16/217 12.1 % 1.23 [ 0.64, 2.36 ]
Mortara 2009 (Struct Tele) (HHH) 7/94 9/160 5.4 % 1.32 [ 0.51, 3.44 ]
Total (95% CI) 1175 1270 100.0 % 1.01 [ 0.80, 1.28 ]
Total events: 121 (IVR), 126 (Usual Care)
Heterogeneity: Chi2 = 1.11, df = 3 (P = 0.77); I2 =0.0%
Test for overall effect: Z = 0.10 (P = 0.92)
Test for subgroup differences: Not applicable
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Analysis 1.7. Comparison 1 Impact of structured telephone support and telemonitoring in heart failure on
all-cause mortality, Outcome 7 Subgroup technology: all-cause mortality Mobile/PDA vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 1 Impact of structured telephone support and telemonitoring in heart failure on all-cause mortality
Outcome: 7 Subgroup technology: all-cause mortality Mobile/PDA vs UC
Study or subgroup Mobile/PDA Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Giordano 2009 21/230 32/230 77.1 % 0.66 [ 0.39, 1.10 ]
Seto 2012 3/50 0/50 1.2 % 7.00 [ 0.37, 132.10 ]
Villani 2014 (ICAROS) 5/40 9/40 21.7 % 0.56 [ 0.20, 1.51 ]
Vuorinen 2014 0/47 0/47 Not estimable
Total (95% CI) 367 367 100.0 % 0.71 [ 0.46, 1.11 ]
Total events: 29 (Mobile/PDA), 41 (Usual Care)
Heterogeneity: Chi2 = 2.65, df = 2 (P = 0.27); I2 =25%
Test for overall effect: Z = 1.51 (P = 0.13)
Test for subgroup differences: Not applicable
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Analysis 1.8. Comparison 1 Impact of structured telephone support and telemonitoring in heart failure on
all-cause mortality, Outcome 8 Subgroup TM intensity: all-cause mortality Office hours vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 1 Impact of structured telephone support and telemonitoring in heart failure on all-cause mortality
Outcome: 8 Subgroup TM intensity: all-cause mortality Office hours vs UC
Study or subgroup TM - Office hours Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Antonicelli 2008 3/28 5/29 5.2 % 0.62 [ 0.16, 2.36 ]
Balk 2008 9/101 8/113 8.0 % 1.26 [ 0.50, 3.14 ]
Biannic 2012 (SEDIC) 8/45 14/45 14.8 % 0.57 [ 0.27, 1.23 ]
Cleland 2005 (Telemon) (TENS-HMS) 28/168 20/85 28.2 % 0.71 [ 0.42, 1.18 ]
De Lusignan 2001 2/10 3/10 3.2 % 0.67 [ 0.14, 3.17 ]
Dendale 2012 (TEMA-HF1) 4/80 14/80 14.8 % 0.29 [ 0.10, 0.83 ]
Lyng 2012 (WISH) 5/166 8/153 8.8 % 0.58 [ 0.19, 1.72 ]
Mortara 2009 (Telemon) (HHH) 8/101 9/160 7.4 % 1.41 [ 0.56, 3.53 ]
Villani 2014 (ICAROS) 5/40 9/40 9.5 % 0.56 [ 0.20, 1.51 ]
Vuorinen 2014 0/47 0/47 Not estimable
Total (95% CI) 786 762 100.0 % 0.69 [ 0.52, 0.92 ]
Total events: 72 (TM - Office hours), 90 (Usual Care)
Heterogeneity: Chi2 = 7.15, df = 8 (P = 0.52); I2 =0.0%
Test for overall effect: Z = 2.53 (P = 0.011)
Test for subgroup differences: Not applicable
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Analysis 1.9. Comparison 1 Impact of structured telephone support and telemonitoring in heart failure on
all-cause mortality, Outcome 9 Subgroup TM intensity: all-cause mortality 24/7 or 7 days/week vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 1 Impact of structured telephone support and telemonitoring in heart failure on all-cause mortality
Outcome: 9 Subgroup TM intensity: all-cause mortality 24/7 or 7 days/week vs UC
Study or subgroup
TM - 24/7 or
7 days/week Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Blum 2014 (MCCD) 49/104 45/102 25.3 % 1.07 [ 0.79, 1.44 ]
Giordano 2009 21/230 32/230 17.8 % 0.66 [ 0.39, 1.10 ]
Goldberg 2003 (WHARF) 11/138 26/142 14.3 % 0.44 [ 0.22, 0.85 ]
Koehler 2011 (TIM-HF) 54/354 55/356 30.5 % 0.99 [ 0.70, 1.39 ]
Seto 2012 3/50 0/50 0.3 % 7.00 [ 0.37, 132.10 ]
Soran 2008 11/160 17/155 9.6 % 0.63 [ 0.30, 1.29 ]
Woodend 2008 5/62 4/59 2.3 % 1.19 [ 0.34, 4.22 ]
Total (95% CI) 1098 1094 100.0 % 0.86 [ 0.71, 1.04 ]
Total events: 154 (TM - 24/7 or 7 days/week), 179 (Usual Care)
Heterogeneity: Chi2 = 10.67, df = 6 (P = 0.10); I2 =44%
Test for overall effect: Z = 1.59 (P = 0.11)
Test for subgroup differences: Not applicable
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Analysis 1.10. Comparison 1 Impact of structured telephone support and telemonitoring in heart failure on
all-cause mortality, Outcome 10 Subgroup Publication year: all-cause mortality STS vs UC < 2000.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 1 Impact of structured telephone support and telemonitoring in heart failure on all-cause mortality
Outcome: 10 Subgroup Publication year: all-cause mortality STS vs UC < 2000
Study or subgroup STS Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gattis 1999 (PHARM) 3/90 5/91 55.4 % 0.61 [ 0.15, 2.46 ]
Rainville 1999 1/19 4/19 44.6 % 0.25 [ 0.03, 2.04 ]
Total (95% CI) 109 110 100.0 % 0.45 [ 0.14, 1.40 ]
Total events: 4 (STS), 9 (Usual Care)
Heterogeneity: Chi2 = 0.48, df = 1 (P = 0.49); I2 =0.0%
Test for overall effect: Z = 1.38 (P = 0.17)
Test for subgroup differences: Not applicable
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Analysis 1.11. Comparison 1 Impact of structured telephone support and telemonitoring in heart failure on
all-cause mortality, Outcome 11 Subgroup Publication year: all-cause mortality STS vs UC 2000 - 2007.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 1 Impact of structured telephone support and telemonitoring in heart failure on all-cause mortality
Outcome: 11 Subgroup Publication year: all-cause mortality STS vs UC 2000 - 2007
Study or subgroup STS Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Baker 2011 0/303 2/302 0.8 % 0.20 [ 0.01, 4.13 ]
Barth 2001 0/17 0/17 Not estimable
Capomolla 2004 5/67 7/66 2.2 % 0.70 [ 0.24, 2.11 ]
Cleland 2005 (Struct Tele) (TENS-HMS) 27/173 20/85 8.3 % 0.66 [ 0.40, 1.11 ]
DeBusk 2004 21/228 29/234 8.9 % 0.74 [ 0.44, 1.26 ]
DeWalt 2006 3/62 4/65 1.2 % 0.79 [ 0.18, 3.37 ]
Galbreath 2004 54/710 39/359 16.0 % 0.70 [ 0.47, 1.04 ]
GESICA 2005 (DIAL) 116/760 122/758 37.8 % 0.95 [ 0.75, 1.20 ]
Laramee 2003 13/141 15/146 4.6 % 0.90 [ 0.44, 1.82 ]
Riegel 2002 16/130 32/228 7.2 % 0.88 [ 0.50, 1.54 ]
Riegel 2006 6/70 8/65 2.6 % 0.70 [ 0.26, 1.90 ]
Sisk 2006 22/203 22/203 6.8 % 1.00 [ 0.57, 1.75 ]
Tsuyuki 2004 16/140 12/136 3.8 % 1.30 [ 0.64, 2.64 ]
Total (95% CI) 3004 2664 100.0 % 0.86 [ 0.74, 0.99 ]
Total events: 299 (STS), 312 (Usual Care)
Heterogeneity: Chi2 = 5.77, df = 11 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 2.04 (P = 0.041)
Test for subgroup differences: Not applicable
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Analysis 1.12. Comparison 1 Impact of structured telephone support and telemonitoring in heart failure on
all-cause mortality, Outcome 12 Subgroup Publication year: all-cause mortality STS vs UC ≥ 2008.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 1 Impact of structured telephone support and telemonitoring in heart failure on all-cause mortality
Outcome: 12 Subgroup Publication year: all-cause mortality STS vs UC≥ 2008
Study or subgroup STS Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Angermann 2012 (INH) 32/352 52/363 26.2 % 0.63 [ 0.42, 0.96 ]
Bento 2009 0/20 1/20 0.8 % 0.33 [ 0.01, 7.72 ]
Chaudhry 2010 (Tele-HF) 92/826 94/827 48.1 % 0.98 [ 0.75, 1.28 ]
Domingues 2011 8/57 13/63 6.3 % 0.68 [ 0.30, 1.52 ]
Krum 2013 (CHAT) 17/188 16/217 7.6 % 1.23 [ 0.64, 2.36 ]
Mortara 2009 (Struct Tele) (HHH) 7/94 9/160 3.4 % 1.32 [ 0.51, 3.44 ]
Wakefield 2008 25/99 11/49 7.5 % 1.12 [ 0.60, 2.09 ]
Total (95% CI) 1636 1699 100.0 % 0.91 [ 0.75, 1.10 ]
Total events: 181 (STS), 196 (Usual Care)
Heterogeneity: Chi2 = 5.92, df = 6 (P = 0.43); I2 =0.0%
Test for overall effect: Z = 1.00 (P = 0.32)
Test for subgroup differences: Not applicable
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Analysis 1.13. Comparison 1 Impact of structured telephone support and telemonitoring in heart failure on
all-cause mortality, Outcome 13 Subgroup Publication year: all-cause mortality TM vs UC 2000 - 2007.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 1 Impact of structured telephone support and telemonitoring in heart failure on all-cause mortality
Outcome: 13 Subgroup Publication year: all-cause mortality TM vs UC 2000 - 2007
Study or subgroup Telemonitoring Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Cleland 2005 (Telemon) (TENS-HMS) 28/168 20/85 48.1 % 0.71 [ 0.42, 1.18 ]
De Lusignan 2001 2/10 3/10 5.4 % 0.67 [ 0.14, 3.17 ]
Goldberg 2003 (WHARF) 11/138 26/142 46.4 % 0.44 [ 0.22, 0.85 ]
Total (95% CI) 316 237 100.0 % 0.58 [ 0.39, 0.86 ]
Total events: 41 (Telemonitoring), 49 (Usual Care)
Heterogeneity: Chi2 = 1.34, df = 2 (P = 0.51); I2 =0.0%
Test for overall effect: Z = 2.73 (P = 0.0064)
Test for subgroup differences: Not applicable
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Analysis 1.14. Comparison 1 Impact of structured telephone support and telemonitoring in heart failure on
all-cause mortality, Outcome 14 Subgroup Publication year: all-cause mortality TM vs UC ≥ 2008.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 1 Impact of structured telephone support and telemonitoring in heart failure on all-cause mortality
Outcome: 14 Subgroup Publication year: all-cause mortality TM vs UC≥ 2008
Study or subgroup Telemonitoring Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Antonicelli 2008 3/28 5/29 2.2 % 0.62 [ 0.16, 2.36 ]
Balk 2008 9/101 8/113 3.4 % 1.26 [ 0.50, 3.14 ]
Biannic 2012 (SEDIC) 8/45 14/45 6.4 % 0.57 [ 0.27, 1.23 ]
Blum 2014 (MCCD) 49/104 45/102 20.8 % 1.07 [ 0.79, 1.44 ]
Dendale 2012 (TEMA-HF1) 4/80 14/80 6.4 % 0.29 [ 0.10, 0.83 ]
Giordano 2009 21/230 32/230 14.6 % 0.66 [ 0.39, 1.10 ]
Koehler 2011 (TIM-HF) 54/354 55/356 25.1 % 0.99 [ 0.70, 1.39 ]
Lyng 2012 (WISH) 5/166 8/153 3.8 % 0.58 [ 0.19, 1.72 ]
Mortara 2009 (Telemon) (HHH) 8/101 9/160 3.2 % 1.41 [ 0.56, 3.53 ]
Seto 2012 3/50 0/50 0.2 % 7.00 [ 0.37, 132.10 ]
Soran 2008 11/160 17/155 7.9 % 0.63 [ 0.30, 1.29 ]
Villani 2014 (ICAROS) 5/40 9/40 4.1 % 0.56 [ 0.20, 1.51 ]
Vuorinen 2014 0/47 0/47 Not estimable
Woodend 2008 5/62 4/59 1.9 % 1.19 [ 0.34, 4.22 ]
Total (95% CI) 1568 1619 100.0 % 0.85 [ 0.72, 1.02 ]
Total events: 185 (Telemonitoring), 220 (Usual Care)
Heterogeneity: Chi2 = 15.11, df = 12 (P = 0.24); I2 =21%
Test for overall effect: Z = 1.77 (P = 0.077)
Test for subgroup differences: Not applicable
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Analysis 1.15. Comparison 1 Impact of structured telephone support and telemonitoring in heart failure on
all-cause mortality, Outcome 15 Subgroup Participant age: all-cause mortality: STS vs UC < 70 years of age.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 1 Impact of structured telephone support and telemonitoring in heart failure on all-cause mortality
Outcome: 15 Subgroup Participant age: all-cause mortality: STS vs UC < 70 years of age
Study or subgroup STS Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Angermann 2012 (INH) 32/352 52/363 13.8 % 0.63 [ 0.42, 0.96 ]
Baker 2011 0/303 2/302 0.7 % 0.20 [ 0.01, 4.13 ]
Bento 2009 0/20 1/20 0.4 % 0.33 [ 0.01, 7.72 ]
Capomolla 2004 5/67 7/66 1.9 % 0.70 [ 0.24, 2.11 ]
Chaudhry 2010 (Tele-HF) 92/826 94/827 25.4 % 0.98 [ 0.75, 1.28 ]
Cleland 2005 (Struct Tele) (TENS-HMS) 27/173 20/85 7.3 % 0.66 [ 0.40, 1.11 ]
DeWalt 2006 3/62 4/65 1.1 % 0.79 [ 0.18, 3.37 ]
Domingues 2011 8/57 13/63 3.3 % 0.68 [ 0.30, 1.52 ]
Gattis 1999 (PHARM) 3/90 5/91 1.3 % 0.61 [ 0.15, 2.46 ]
GESICA 2005 (DIAL) 116/760 122/758 33.0 % 0.95 [ 0.75, 1.20 ]
Mortara 2009 (Struct Tele) (HHH) 7/94 9/160 1.8 % 1.32 [ 0.51, 3.44 ]
Sisk 2006 22/203 22/203 5.9 % 1.00 [ 0.57, 1.75 ]
Wakefield 2008 25/99 11/49 4.0 % 1.12 [ 0.60, 2.09 ]
Total (95% CI) 3106 3052 100.0 % 0.88 [ 0.77, 1.01 ]
Total events: 340 (STS), 362 (Usual Care)
Heterogeneity: Chi2 = 8.17, df = 12 (P = 0.77); I2 =0.0%
Test for overall effect: Z = 1.79 (P = 0.074)
Test for subgroup differences: Not applicable
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Analysis 1.16. Comparison 1 Impact of structured telephone support and telemonitoring in heart failure on
all-cause mortality, Outcome 16 Subgroup Participant age: all-cause mortality STS vs UC ≥ 70 years of age.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 1 Impact of structured telephone support and telemonitoring in heart failure on all-cause mortality
Outcome: 16 Subgroup Participant age: all-cause mortality STS vs UC≥ 70 years of age
Study or subgroup STS Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Barth 2001 0/17 0/17 Not estimable
DeBusk 2004 21/228 29/234 18.1 % 0.74 [ 0.44, 1.26 ]
Galbreath 2004 54/710 39/359 32.8 % 0.70 [ 0.47, 1.04 ]
Krum 2013 (CHAT) 17/188 16/217 9.4 % 1.23 [ 0.64, 2.36 ]
Laramee 2003 13/141 15/146 9.3 % 0.90 [ 0.44, 1.82 ]
Rainville 1999 1/19 4/19 2.5 % 0.25 [ 0.03, 2.04 ]
Riegel 2002 16/130 32/228 14.7 % 0.88 [ 0.50, 1.54 ]
Riegel 2006 6/70 8/65 5.3 % 0.70 [ 0.26, 1.90 ]
Tsuyuki 2004 16/140 12/136 7.7 % 1.30 [ 0.64, 2.64 ]
Total (95% CI) 1643 1421 100.0 % 0.84 [ 0.67, 1.04 ]
Total events: 144 (STS), 155 (Usual Care)
Heterogeneity: Chi2 = 5.22, df = 7 (P = 0.63); I2 =0.0%
Test for overall effect: Z = 1.61 (P = 0.11)
Test for subgroup differences: Not applicable
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Analysis 1.17. Comparison 1 Impact of structured telephone support and telemonitoring in heart failure on
all-cause mortality, Outcome 17 Subgroup Participant age: all-cause mortality: TM vs UC < 70 years of age.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 1 Impact of structured telephone support and telemonitoring in heart failure on all-cause mortality
Outcome: 17 Subgroup Participant age: all-cause mortality: TM vs UC < 70 years of age
Study or subgroup Telemonitoring Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Balk 2008 9/101 8/113 4.8 % 1.26 [ 0.50, 3.14 ]
Cleland 2005 (Telemon) (TENS-HMS) 28/168 20/85 16.8 % 0.71 [ 0.42, 1.18 ]
Giordano 2009 21/230 32/230 20.2 % 0.66 [ 0.39, 1.10 ]
Goldberg 2003 (WHARF) 11/138 26/142 16.2 % 0.44 [ 0.22, 0.85 ]
Koehler 2011 (TIM-HF) 54/354 55/356 34.7 % 0.99 [ 0.70, 1.39 ]
Mortara 2009 (Telemon) (HHH) 8/101 9/160 4.4 % 1.41 [ 0.56, 3.53 ]
Seto 2012 3/50 0/50 0.3 % 7.00 [ 0.37, 132.10 ]
Vuorinen 2014 0/47 0/47 Not estimable
Woodend 2008 5/62 4/59 2.6 % 1.19 [ 0.34, 4.22 ]
Total (95% CI) 1251 1242 100.0 % 0.84 [ 0.68, 1.04 ]
Total events: 139 (Telemonitoring), 154 (Usual Care)
Heterogeneity: Chi2 = 10.15, df = 7 (P = 0.18); I2 =31%
Test for overall effect: Z = 1.60 (P = 0.11)
Test for subgroup differences: Not applicable
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Analysis 1.18. Comparison 1 Impact of structured telephone support and telemonitoring in heart failure on
all-cause mortality, Outcome 18 Subgroup Participant age: all-cause mortality TM vs UC ≥ 70 years of age.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 1 Impact of structured telephone support and telemonitoring in heart failure on all-cause mortality
Outcome: 18 Subgroup Participant age: all-cause mortality TM vs UC≥ 70 years of age
Study or subgroup Telemonitoring Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Antonicelli 2008 3/28 5/29 4.2 % 0.62 [ 0.16, 2.36 ]
Biannic 2012 (SEDIC) 8/45 14/45 12.1 % 0.57 [ 0.27, 1.23 ]
Blum 2014 (MCCD) 49/104 45/102 39.2 % 1.07 [ 0.79, 1.44 ]
De Lusignan 2001 2/10 3/10 2.6 % 0.67 [ 0.14, 3.17 ]
Dendale 2012 (TEMA-HF1) 4/80 14/80 12.1 % 0.29 [ 0.10, 0.83 ]
Lyng 2012 (WISH) 5/166 8/153 7.2 % 0.58 [ 0.19, 1.72 ]
Soran 2008 11/160 17/155 14.9 % 0.63 [ 0.30, 1.29 ]
Villani 2014 (ICAROS) 5/40 9/40 7.8 % 0.56 [ 0.20, 1.51 ]
Total (95% CI) 633 614 100.0 % 0.74 [ 0.59, 0.94 ]
Total events: 87 (Telemonitoring), 115 (Usual Care)
Heterogeneity: Chi2 = 10.03, df = 7 (P = 0.19); I2 =30%
Test for overall effect: Z = 2.46 (P = 0.014)
Test for subgroup differences: Not applicable
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Analysis 1.19. Comparison 1 Impact of structured telephone support and telemonitoring in heart failure on
all-cause mortality, Outcome 19 Subgroup STS focus: all-cause mortality STS (clinical support) vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 1 Impact of structured telephone support and telemonitoring in heart failure on all-cause mortality
Outcome: 19 Subgroup STS focus: all-cause mortality STS (clinical support) vs UC
Study or subgroup STS (clinical support) Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Angermann 2012 (INH) 32/352 52/363 10.3 % 0.63 [ 0.42, 0.96 ]
Barth 2001 0/17 0/17 Not estimable
Bento 2009 0/20 1/20 0.3 % 0.33 [ 0.01, 7.72 ]
Capomolla 2004 5/67 7/66 1.4 % 0.70 [ 0.24, 2.11 ]
Chaudhry 2010 (Tele-HF) 92/826 94/827 18.9 % 0.98 [ 0.75, 1.28 ]
Cleland 2005 (Struct Tele) (TENS-HMS) 27/173 20/85 5.4 % 0.66 [ 0.40, 1.11 ]
DeBusk 2004 21/228 29/234 5.8 % 0.74 [ 0.44, 1.26 ]
Galbreath 2004 54/710 39/359 10.4 % 0.70 [ 0.47, 1.04 ]
Gattis 1999 (PHARM) 3/90 5/91 1.0 % 0.61 [ 0.15, 2.46 ]
GESICA 2005 (DIAL) 116/760 122/758 24.6 % 0.95 [ 0.75, 1.20 ]
Krum 2013 (CHAT) 17/188 16/217 3.0 % 1.23 [ 0.64, 2.36 ]
Laramee 2003 13/141 15/146 3.0 % 0.90 [ 0.44, 1.82 ]
Mortara 2009 (Struct Tele) (HHH) 7/94 9/160 1.3 % 1.32 [ 0.51, 3.44 ]
Rainville 1999 1/19 4/19 0.8 % 0.25 [ 0.03, 2.04 ]
Riegel 2002 16/130 32/228 4.7 % 0.88 [ 0.50, 1.54 ]
Riegel 2006 6/70 8/65 1.7 % 0.70 [ 0.26, 1.90 ]
Sisk 2006 22/203 22/203 4.4 % 1.00 [ 0.57, 1.75 ]
Wakefield 2008 25/99 11/49 3.0 % 1.12 [ 0.60, 2.09 ]
Total (95% CI) 4187 3907 100.0 % 0.87 [ 0.77, 0.98 ]
Total events: 457 (STS (clinical support)), 486 (Usual Care)
Heterogeneity: Chi2 = 11.07, df = 16 (P = 0.81); I2 =0.0%
Test for overall effect: Z = 2.34 (P = 0.019)
Test for subgroup differences: Not applicable
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Analysis 1.20. Comparison 1 Impact of structured telephone support and telemonitoring in heart failure on
all-cause mortality, Outcome 20 Subgroup STS focus: all-cause mortality STS (education) vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 1 Impact of structured telephone support and telemonitoring in heart failure on all-cause mortality
Outcome: 20 Subgroup STS focus: all-cause mortality STS (education) vs UC
Study or subgroup STS (education) Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Baker 2011 0/303 2/302 8.1 % 0.20 [ 0.01, 4.13 ]
DeWalt 2006 3/62 4/65 12.6 % 0.79 [ 0.18, 3.37 ]
Domingues 2011 8/57 13/63 39.9 % 0.68 [ 0.30, 1.52 ]
Tsuyuki 2004 16/140 12/136 39.4 % 1.30 [ 0.64, 2.64 ]
Total (95% CI) 562 566 100.0 % 0.90 [ 0.55, 1.45 ]
Total events: 27 (STS (education)), 31 (Usual Care)
Heterogeneity: Chi2 = 2.46, df = 3 (P = 0.48); I2 =0.0%
Test for overall effect: Z = 0.44 (P = 0.66)
Test for subgroup differences: Not applicable
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Analysis 1.21. Comparison 1 Impact of structured telephone support and telemonitoring in heart failure on
all-cause mortality, Outcome 21 Sensitivity analysis follow-up period (> 6 months), all-cause mortality: STS vs
UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 1 Impact of structured telephone support and telemonitoring in heart failure on all-cause mortality
Outcome: 21 Sensitivity analysis follow-up period (> 6 months), all-cause mortality: STS vs UC
Study or subgroup STS Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Capomolla 2004 5/67 7/66 2.3 % 0.70 [ 0.24, 2.11 ]
Cleland 2005 (Struct Tele) (TENS-HMS) 27/173 20/85 8.9 % 0.66 [ 0.40, 1.11 ]
DeBusk 2004 21/228 29/234 9.5 % 0.74 [ 0.44, 1.26 ]
DeWalt 2006 3/62 4/65 1.3 % 0.79 [ 0.18, 3.37 ]
Galbreath 2004 54/710 39/359 17.1 % 0.70 [ 0.47, 1.04 ]
GESICA 2005 (DIAL) 116/760 122/758 40.4 % 0.95 [ 0.75, 1.20 ]
Krum 2013 (CHAT) 17/188 16/217 4.9 % 1.23 [ 0.64, 2.36 ]
Mortara 2009 (Struct Tele) (HHH) 7/94 9/160 2.2 % 1.32 [ 0.51, 3.44 ]
Rainville 1999 1/19 4/19 1.3 % 0.25 [ 0.03, 2.04 ]
Sisk 2006 22/203 22/203 7.3 % 1.00 [ 0.57, 1.75 ]
Wakefield 2008 25/99 11/49 4.9 % 1.12 [ 0.60, 2.09 ]
Total (95% CI) 2603 2215 100.0 % 0.88 [ 0.75, 1.02 ]
Total events: 298 (STS), 283 (Usual Care)
Heterogeneity: Chi2 = 7.30, df = 10 (P = 0.70); I2 =0.0%
Test for overall effect: Z = 1.67 (P = 0.094)
Test for subgroup differences: Not applicable
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Analysis 1.22. Comparison 1 Impact of structured telephone support and telemonitoring in heart failure on
all-cause mortality, Outcome 22 Sensitivity analysis follow-up period (> 6 months), all-cause mortality: TM vs
UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 1 Impact of structured telephone support and telemonitoring in heart failure on all-cause mortality
Outcome: 22 Sensitivity analysis follow-up period (> 6 months), all-cause mortality: TM vs UC
Study or subgroup Telemonitoring Usual Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Antonicelli 2008 3/28 5/29 2.5 % 0.62 [ 0.16, 2.36 ]
Balk 2008 9/101 8/113 3.8 % 1.26 [ 0.50, 3.14 ]
Blum 2014 (MCCD) 49/104 45/102 22.9 % 1.07 [ 0.79, 1.44 ]
Cleland 2005 (Telemon) (TENS-HMS) 28/168 20/85 13.4 % 0.71 [ 0.42, 1.18 ]
De Lusignan 2001 2/10 3/10 1.5 % 0.67 [ 0.14, 3.17 ]
Giordano 2009 21/230 32/230 16.1 % 0.66 [ 0.39, 1.10 ]
Koehler 2011 (TIM-HF) 54/354 55/356 27.6 % 0.99 [ 0.70, 1.39 ]
Lyng 2012 (WISH) 5/166 8/153 4.2 % 0.58 [ 0.19, 1.72 ]
Mortara 2009 (Telemon) (HHH) 8/101 9/160 3.5 % 1.41 [ 0.56, 3.53 ]
Villani 2014 (ICAROS) 5/40 9/40 4.5 % 0.56 [ 0.20, 1.51 ]
Total (95% CI) 1302 1278 100.0 % 0.89 [ 0.74, 1.06 ]
Total events: 184 (Telemonitoring), 194 (Usual Care)
Heterogeneity: Chi2 = 7.25, df = 9 (P = 0.61); I2 =0.0%
Test for overall effect: Z = 1.29 (P = 0.20)
Test for subgroup differences: Not applicable
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Analysis 2.1. Comparison 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-
cause hospitalisation, Outcome 1 All-cause hospitalisation: STS vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-cause hospitalisation
Outcome: 1 All-cause hospitalisation: STS vs UC
Study or subgroup STS Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Angermann 2012 (INH) 119/352 112/363 7.3 % 1.10 [ 0.89, 1.35 ]
Bento 2009 2/20 10/20 0.7 % 0.20 [ 0.05, 0.80 ]
Chaudhry 2010 (Tele-HF) 407/826 392/827 26.0 % 1.04 [ 0.94, 1.15 ]
Cleland 2005 (Struct Tele) (TENS-HMS) 85/173 46/85 4.1 % 0.91 [ 0.71, 1.16 ]
DeBusk 2004 116/228 117/234 7.7 % 1.02 [ 0.85, 1.22 ]
Domingues 2011 20/57 23/63 1.4 % 0.96 [ 0.59, 1.55 ]
Gattis 1999 (PHARM) 17/90 30/91 2.0 % 0.57 [ 0.34, 0.96 ]
GESICA 2005 (DIAL) 261/760 296/758 19.6 % 0.88 [ 0.77, 1.00 ]
Krum 2013 (CHAT) 74/188 114/217 7.0 % 0.75 [ 0.60, 0.93 ]
Laramee 2003 49/141 46/146 3.0 % 1.10 [ 0.79, 1.53 ]
Mortara 2009 (Struct Tele) (HHH) 34/94 48/160 2.4 % 1.21 [ 0.84, 1.72 ]
Riegel 2002 56/130 114/228 5.5 % 0.86 [ 0.68, 1.09 ]
Riegel 2006 39/70 37/65 2.5 % 0.98 [ 0.73, 1.32 ]
Sisk 2006 62/203 74/203 4.9 % 0.84 [ 0.64, 1.10 ]
Tsuyuki 2004 59/140 51/136 3.4 % 1.12 [ 0.84, 1.50 ]
Wakefield 2008 41/99 29/49 2.6 % 0.70 [ 0.50, 0.97 ]
Total (95% CI) 3571 3645 100.0 % 0.95 [ 0.90, 1.00 ]
Total events: 1441 (STS), 1539 (Control)
Heterogeneity: Chi2 = 28.51, df = 15 (P = 0.02); I2 =47%
Test for overall effect: Z = 1.92 (P = 0.055)
Test for subgroup differences: Not applicable
0.05 0.2 1 5 20
Favours STS Favours usual care
189Structured telephone support or non-invasive telemonitoring for patients with heart failure (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 2.2. Comparison 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-
cause hospitalisation, Outcome 2 All-cause hospitalisation: TM vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-cause hospitalisation
Outcome: 2 All-cause hospitalisation: TM vs UC
Study or subgroup Telemonitoring Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Antonicelli 2008 9/28 26/29 3.0 % 0.36 [ 0.21, 0.62 ]
Biannic 2012 (SEDIC) 19/45 35/45 4.1 % 0.54 [ 0.37, 0.79 ]
Blum 2014 (MCCD) 80/104 74/102 8.7 % 1.06 [ 0.90, 1.24 ]
Cleland 2005 (Telemon) (TENS-HMS) 80/168 46/85 7.1 % 0.88 [ 0.68, 1.13 ]
Dendale 2012 (TEMA-HF1) 64/80 66/80 7.7 % 0.97 [ 0.84, 1.13 ]
Giordano 2009 67/230 96/230 11.2 % 0.70 [ 0.54, 0.90 ]
Goldberg 2003 (WHARF) 65/138 67/142 7.7 % 1.00 [ 0.78, 1.28 ]
Koehler 2011 (TIM-HF) 192/354 179/356 20.8 % 1.08 [ 0.94, 1.24 ]
Lyng 2012 (WISH) 79/166 84/153 10.2 % 0.87 [ 0.70, 1.07 ]
Mortara 2009 (Telemon) (HHH) 35/101 48/160 4.3 % 1.16 [ 0.81, 1.65 ]
Seto 2012 14/50 10/50 1.2 % 1.40 [ 0.69, 2.85 ]
Soran 2008 75/160 66/155 7.8 % 1.10 [ 0.86, 1.41 ]
Woodend 2008 60/62 54/59 6.4 % 1.06 [ 0.97, 1.16 ]
Total (95% CI) 1686 1646 100.0 % 0.95 [ 0.89, 1.01 ]
Total events: 839 (Telemonitoring), 851 (Control)
Heterogeneity: Chi2 = 41.72, df = 12 (P = 0.00004); I2 =71%
Test for overall effect: Z = 1.61 (P = 0.11)
Test for subgroup differences: Not applicable
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Analysis 2.3. Comparison 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-
cause hospitalisation, Outcome 3 Subgroup technology: all-cause hospitalisation STS vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-cause hospitalisation
Outcome: 3 Subgroup technology: all-cause hospitalisation STS vs UC
Study or subgroup STS Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Angermann 2012 (INH) 119/352 112/363 11.6 % 1.10 [ 0.89, 1.35 ]
Bento 2009 5/20 20/20 2.2 % 0.27 [ 0.13, 0.55 ]
Cleland 2005 (Struct Tele) (TENS-HMS) 85/173 46/85 6.5 % 0.91 [ 0.71, 1.16 ]
DeBusk 2004 116/228 117/234 12.2 % 1.02 [ 0.85, 1.22 ]
Domingues 2011 20/57 23/63 2.3 % 0.96 [ 0.59, 1.55 ]
Gattis 1999 (PHARM) 17/90 30/91 3.1 % 0.57 [ 0.34, 0.96 ]
GESICA 2005 (DIAL) 261/760 296/758 31.3 % 0.88 [ 0.77, 1.00 ]
Laramee 2003 49/141 46/146 4.8 % 1.10 [ 0.79, 1.53 ]
Riegel 2002 56/130 114/228 8.7 % 0.86 [ 0.68, 1.09 ]
Riegel 2006 39/70 37/65 4.0 % 0.98 [ 0.73, 1.32 ]
Sisk 2006 62/203 74/203 7.8 % 0.84 [ 0.64, 1.10 ]
Tsuyuki 2004 59/140 51/136 5.5 % 1.12 [ 0.84, 1.50 ]
Total (95% CI) 2364 2392 100.0 % 0.93 [ 0.86, 0.99 ]
Total events: 888 (STS), 966 (Control)
Heterogeneity: Chi2 = 22.50, df = 11 (P = 0.02); I2 =51%
Test for overall effect: Z = 2.13 (P = 0.033)
Test for subgroup differences: Not applicable
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Analysis 2.4. Comparison 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-
cause hospitalisation, Outcome 4 Subgroup technology: all-cause hospitalisation Mobile/PDA vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-cause hospitalisation
Outcome: 4 Subgroup technology: all-cause hospitalisation Mobile/PDA vs UC
Study or subgroup Mobile/PDA Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Giordano 2009 67/230 96/230 90.6 % 0.70 [ 0.54, 0.90 ]
Seto 2012 14/50 10/50 9.4 % 1.40 [ 0.69, 2.85 ]
Total (95% CI) 280 280 100.0 % 0.76 [ 0.60, 0.97 ]
Total events: 81 (Mobile/PDA), 106 (Control)
Heterogeneity: Chi2 = 3.28, df = 1 (P = 0.07); I2 =70%
Test for overall effect: Z = 2.23 (P = 0.026)
Test for subgroup differences: Not applicable
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Analysis 2.5. Comparison 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-
cause hospitalisation, Outcome 5 Subgroup technology: all-cause hospitalisation Videophone vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-cause hospitalisation
Outcome: 5 Subgroup technology: all-cause hospitalisation Videophone vs UC
Study or subgroup Videophone Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Wakefield 2008 41/99 29/49 41.2 % 0.70 [ 0.50, 0.97 ]
Woodend 2008 60/62 54/59 58.8 % 1.06 [ 0.97, 1.16 ]
Total (95% CI) 161 108 100.0 % 0.91 [ 0.80, 1.04 ]
Total events: 101 (Videophone), 83 (Control)
Heterogeneity: Chi2 = 13.13, df = 1 (P = 0.00029); I2 =92%
Test for overall effect: Z = 1.40 (P = 0.16)
Test for subgroup differences: Not applicable
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Analysis 2.6. Comparison 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-
cause hospitalisation, Outcome 6 Subgroup technology: all-cause hospitalisation IVR vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-cause hospitalisation
Outcome: 6 Subgroup technology: all-cause hospitalisation IVR vs UC
Study or subgroup IVR Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Chaudhry 2010 (Tele-HF) 407/826 392/827 73.5 % 1.04 [ 0.94, 1.15 ]
Krum 2013 (CHAT) 74/188 114/217 19.9 % 0.75 [ 0.60, 0.93 ]
Mortara 2009 (Struct Tele) (HHH) 34/94 48/160 6.7 % 1.21 [ 0.84, 1.72 ]
Total (95% CI) 1108 1204 100.0 % 0.99 [ 0.91, 1.08 ]
Total events: 515 (IVR), 554 (Control)
Heterogeneity: Chi2 = 8.36, df = 2 (P = 0.02); I2 =76%
Test for overall effect: Z = 0.16 (P = 0.87)
Test for subgroup differences: Not applicable
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Analysis 2.7. Comparison 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-
cause hospitalisation, Outcome 7 Subgroup technology: all-cause hospitalisation Complex TM vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-cause hospitalisation
Outcome: 7 Subgroup technology: all-cause hospitalisation Complex TM vs UC
Study or subgroup Complex TM Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Antonicelli 2008 9/28 26/29 3.7 % 0.36 [ 0.21, 0.62 ]
Biannic 2012 (SEDIC) 19/45 35/45 5.0 % 0.54 [ 0.37, 0.79 ]
Blum 2014 (MCCD) 80/104 74/102 10.7 % 1.06 [ 0.90, 1.24 ]
Cleland 2005 (Telemon) (TENS-HMS) 80/168 46/85 8.7 % 0.88 [ 0.68, 1.13 ]
Dendale 2012 (TEMA-HF1) 64/80 66/80 9.4 % 0.97 [ 0.84, 1.13 ]
Goldberg 2003 (WHARF) 65/138 67/142 9.5 % 1.00 [ 0.78, 1.28 ]
Koehler 2011 (TIM-HF) 192/354 179/356 25.6 % 1.08 [ 0.94, 1.24 ]
Lyng 2012 (WISH) 79/166 84/153 12.5 % 0.87 [ 0.70, 1.07 ]
Mortara 2009 (Telemon) (HHH) 35/101 48/160 5.3 % 1.16 [ 0.81, 1.65 ]
Soran 2008 75/160 66/155 9.6 % 1.10 [ 0.86, 1.41 ]
Total (95% CI) 1344 1307 100.0 % 0.97 [ 0.90, 1.04 ]
Total events: 698 (Complex TM), 691 (Control)
Heterogeneity: Chi2 = 28.67, df = 9 (P = 0.00074); I2 =69%
Test for overall effect: Z = 0.90 (P = 0.37)
Test for subgroup differences: Not applicable
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Analysis 2.8. Comparison 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-
cause hospitalisation, Outcome 8 Subgroup TM intensity: all-cause hospitalisation Office hours vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-cause hospitalisation
Outcome: 8 Subgroup TM intensity: all-cause hospitalisation Office hours vs UC
Study or subgroup TM - Office Hours Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Antonicelli 2008 9/28 26/29 8.2 % 0.36 [ 0.21, 0.62 ]
Biannic 2012 (SEDIC) 19/45 35/45 11.2 % 0.54 [ 0.37, 0.79 ]
Cleland 2005 (Telemon) (TENS-HMS) 80/168 46/85 19.6 % 0.88 [ 0.68, 1.13 ]
Dendale 2012 (TEMA-HF1) 64/80 66/80 21.1 % 0.97 [ 0.84, 1.13 ]
Lyng 2012 (WISH) 79/166 84/153 28.0 % 0.87 [ 0.70, 1.07 ]
Mortara 2009 (Telemon) (HHH) 35/101 48/160 11.9 % 1.16 [ 0.81, 1.65 ]
Total (95% CI) 588 552 100.0 % 0.85 [ 0.76, 0.94 ]
Total events: 286 (TM - Office Hours), 305 (Control)
Heterogeneity: Chi2 = 20.87, df = 5 (P = 0.00086); I2 =76%
Test for overall effect: Z = 2.98 (P = 0.0029)
Test for subgroup differences: Not applicable
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Analysis 2.9. Comparison 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-
cause hospitalisation, Outcome 9 Subgroup TM intensity: all-cause hospitalisation 24/7 or 7 days vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-cause hospitalisation
Outcome: 9 Subgroup TM intensity: all-cause hospitalisation 24/7 or 7 days vs UC
Study or subgroup
TM - 24/7 -
7 days/week Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Blum 2014 (MCCD) 80/104 74/102 13.6 % 1.06 [ 0.90, 1.24 ]
Giordano 2009 67/230 96/230 17.5 % 0.70 [ 0.54, 0.90 ]
Goldberg 2003 (WHARF) 65/138 67/142 12.1 % 1.00 [ 0.78, 1.28 ]
Koehler 2011 (TIM-HF) 192/354 179/356 32.6 % 1.08 [ 0.94, 1.24 ]
Seto 2012 14/50 10/50 1.8 % 1.40 [ 0.69, 2.85 ]
Soran 2008 75/160 66/155 12.2 % 1.10 [ 0.86, 1.41 ]
Woodend 2008 60/62 54/59 10.1 % 1.06 [ 0.97, 1.16 ]
Total (95% CI) 1098 1094 100.0 % 1.01 [ 0.93, 1.09 ]
Total events: 553 (TM - 24/7 - 7 days/week), 546 (Control)
Heterogeneity: Chi2 = 11.91, df = 6 (P = 0.06); I2 =50%
Test for overall effect: Z = 0.15 (P = 0.88)
Test for subgroup differences: Not applicable
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Analysis 2.10. Comparison 2 Impact of structured telephone or telemonitoring in heart failure on risk of
all-cause hospitalisation, Outcome 10 Subgroup Publication year: all-cause hospitalisation STS vs UC < 2000.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-cause hospitalisation
Outcome: 10 Subgroup Publication year: all-cause hospitalisation STS vs UC < 2000
Study or subgroup STS Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gattis 1999 (PHARM) 17/90 30/91 0.57 [ 0.34, 0.96 ]
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Analysis 2.11. Comparison 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-
cause hospitalisation, Outcome 11 Subgroup Publication year: all-cause hospitalisation STS vs UC 2000 - 2007.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-cause hospitalisation
Outcome: 11 Subgroup Publication year: all-cause hospitalisation STS vs UC 2000 - 2007
Study or subgroup STS Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Cleland 2005 (Struct Tele) (TENS-HMS) 85/173 46/85 8.1 % 0.91 [ 0.71, 1.16 ]
DeBusk 2004 116/228 117/234 15.1 % 1.02 [ 0.85, 1.22 ]
GESICA 2005 (DIAL) 261/760 296/758 38.7 % 0.88 [ 0.77, 1.00 ]
Laramee 2003 49/141 46/146 5.9 % 1.10 [ 0.79, 1.53 ]
Riegel 2002 56/130 114/228 10.8 % 0.86 [ 0.68, 1.09 ]
Riegel 2006 39/70 37/65 5.0 % 0.98 [ 0.73, 1.32 ]
Sisk 2006 62/203 74/203 9.7 % 0.84 [ 0.64, 1.10 ]
Tsuyuki 2004 59/140 51/136 6.8 % 1.12 [ 0.84, 1.50 ]
Total (95% CI) 1845 1855 100.0 % 0.93 [ 0.86, 1.01 ]
Total events: 727 (STS), 781 (Control)
Heterogeneity: Chi2 = 5.38, df = 7 (P = 0.61); I2 =0.0%
Test for overall effect: Z = 1.79 (P = 0.074)
Test for subgroup differences: Not applicable
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Analysis 2.12. Comparison 2 Impact of structured telephone or telemonitoring in heart failure on risk of
all-cause hospitalisation, Outcome 12 Subgroup Publication year: all-cause hospitalisation STS vs UC ≥ 2008.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-cause hospitalisation
Outcome: 12 Subgroup Publication year: all-cause hospitalisation STS vs UC≥ 2008
Study or subgroup STS Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Angermann 2012 (INH) 119/352 112/363 15.4 % 1.10 [ 0.89, 1.35 ]
Bento 2009 2/20 10/20 1.4 % 0.20 [ 0.05, 0.80 ]
Chaudhry 2010 (Tele-HF) 407/826 392/827 54.9 % 1.04 [ 0.94, 1.15 ]
Domingues 2011 20/57 23/63 3.1 % 0.96 [ 0.59, 1.55 ]
Krum 2013 (CHAT) 74/188 114/217 14.8 % 0.75 [ 0.60, 0.93 ]
Mortara 2009 (Struct Tele) (HHH) 34/94 48/160 5.0 % 1.21 [ 0.84, 1.72 ]
Wakefield 2008 41/99 29/49 5.4 % 0.70 [ 0.50, 0.97 ]
Total (95% CI) 1636 1699 100.0 % 0.98 [ 0.91, 1.06 ]
Total events: 697 (STS), 728 (Control)
Heterogeneity: Chi2 = 18.58, df = 6 (P = 0.005); I2 =68%
Test for overall effect: Z = 0.49 (P = 0.63)
Test for subgroup differences: Not applicable
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Analysis 2.13. Comparison 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-
cause hospitalisation, Outcome 13 Subgroup Publication year: all-cause hospitalisation TM vs UC 2000 - 2007.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-cause hospitalisation
Outcome: 13 Subgroup Publication year: all-cause hospitalisation TM vs UC 2000 - 2007
Study or subgroup Telemonitoring Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Cleland 2005 (Telemon) (TENS-HMS) 80/168 46/85 48.1 % 0.88 [ 0.68, 1.13 ]
Goldberg 2003 (WHARF) 65/138 67/142 51.9 % 1.00 [ 0.78, 1.28 ]
Total (95% CI) 306 227 100.0 % 0.94 [ 0.79, 1.12 ]
Total events: 145 (Telemonitoring), 113 (Control)
Heterogeneity: Chi2 = 0.49, df = 1 (P = 0.48); I2 =0.0%
Test for overall effect: Z = 0.67 (P = 0.50)
Test for subgroup differences: Not applicable
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Analysis 2.14. Comparison 2 Impact of structured telephone or telemonitoring in heart failure on risk of
all-cause hospitalisation, Outcome 14 Subgroup Publication year: all-cause hospitalisation TM vs UC ≥ 2008.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-cause hospitalisation
Outcome: 14 Subgroup Publication year: all-cause hospitalisation TM vs UC≥ 2008
Study or subgroup Telemonitoring Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Antonicelli 2008 9/28 26/29 3.5 % 0.36 [ 0.21, 0.62 ]
Biannic 2012 (SEDIC) 19/45 35/45 4.8 % 0.54 [ 0.37, 0.79 ]
Blum 2014 (MCCD) 80/104 74/102 10.2 % 1.06 [ 0.90, 1.24 ]
Dendale 2012 (TEMA-HF1) 64/80 66/80 9.0 % 0.97 [ 0.84, 1.13 ]
Giordano 2009 67/230 96/230 13.1 % 0.70 [ 0.54, 0.90 ]
Koehler 2011 (TIM-HF) 192/354 179/356 24.4 % 1.08 [ 0.94, 1.24 ]
Lyng 2012 (WISH) 79/166 84/153 11.9 % 0.87 [ 0.70, 1.07 ]
Mortara 2009 (Telemon) (HHH) 35/101 48/160 5.1 % 1.16 [ 0.81, 1.65 ]
Seto 2012 14/50 10/50 1.4 % 1.40 [ 0.69, 2.85 ]
Soran 2008 75/160 66/155 9.2 % 1.10 [ 0.86, 1.41 ]
Woodend 2008 60/62 54/59 7.6 % 1.06 [ 0.97, 1.16 ]
Total (95% CI) 1380 1419 100.0 % 0.95 [ 0.89, 1.02 ]
Total events: 694 (Telemonitoring), 738 (Control)
Heterogeneity: Chi2 = 41.06, df = 10 (P = 0.00001); I2 =76%
Test for overall effect: Z = 1.47 (P = 0.14)
Test for subgroup differences: Not applicable
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Analysis 2.15. Comparison 2 Impact of structured telephone or telemonitoring in heart failure on risk of
all-cause hospitalisation, Outcome 15 Subgroup Participant age: all-cause hospitalisation STS vs UC ≥ 70 years
of age.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-cause hospitalisation
Outcome: 15 Subgroup Participant age: all-cause hospitalisation STS vs UC≥ 70 years of age
Study or subgroup STS Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
DeBusk 2004 116/228 117/234 26.3 % 1.02 [ 0.85, 1.22 ]
Krum 2013 (CHAT) 74/188 114/217 24.1 % 0.75 [ 0.60, 0.93 ]
Laramee 2003 49/141 46/146 10.3 % 1.10 [ 0.79, 1.53 ]
Riegel 2002 56/130 114/228 18.8 % 0.86 [ 0.68, 1.09 ]
Riegel 2006 39/70 37/65 8.7 % 0.98 [ 0.73, 1.32 ]
Tsuyuki 2004 59/140 51/136 11.8 % 1.12 [ 0.84, 1.50 ]
Total (95% CI) 897 1026 100.0 % 0.94 [ 0.85, 1.04 ]
Total events: 393 (STS), 479 (Control)
Heterogeneity: Chi2 = 7.85, df = 5 (P = 0.16); I2 =36%
Test for overall effect: Z = 1.19 (P = 0.23)
Test for subgroup differences: Not applicable
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Analysis 2.16. Comparison 2 Impact of structured telephone or telemonitoring in heart failure on risk of
all-cause hospitalisation, Outcome 16 Subgroup Participant age: all-cause hospitalisation: STS vs UC < 70
years of age.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-cause hospitalisation
Outcome: 16 Subgroup Participant age: all-cause hospitalisation: STS vs UC < 70 years of age
Study or subgroup STS Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Angermann 2012 (INH) 119/352 112/363 10.3 % 1.10 [ 0.89, 1.35 ]
Bento 2009 2/20 10/20 0.9 % 0.20 [ 0.05, 0.80 ]
Chaudhry 2010 (Tele-HF) 407/826 392/827 36.6 % 1.04 [ 0.94, 1.15 ]
Cleland 2005 (Struct Tele) (TENS-HMS) 85/173 46/85 5.8 % 0.91 [ 0.71, 1.16 ]
Domingues 2011 20/57 23/63 2.0 % 0.96 [ 0.59, 1.55 ]
Gattis 1999 (PHARM) 17/90 30/91 2.8 % 0.57 [ 0.34, 0.96 ]
GESICA 2005 (DIAL) 261/760 296/758 27.7 % 0.88 [ 0.77, 1.00 ]
Mortara 2009 (Struct Tele) (HHH) 34/94 48/160 3.3 % 1.21 [ 0.84, 1.72 ]
Sisk 2006 62/203 74/203 6.9 % 0.84 [ 0.64, 1.10 ]
Wakefield 2008 41/99 29/49 3.6 % 0.70 [ 0.50, 0.97 ]
Total (95% CI) 2674 2619 100.0 % 0.95 [ 0.89, 1.01 ]
Total events: 1048 (STS), 1060 (Control)
Heterogeneity: Chi2 = 20.60, df = 9 (P = 0.01); I2 =56%
Test for overall effect: Z = 1.52 (P = 0.13)
Test for subgroup differences: Not applicable
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Analysis 2.17. Comparison 2 Impact of structured telephone or telemonitoring in heart failure on risk of
all-cause hospitalisation, Outcome 17 Subgroup Participant age: all-cause hospitalisation TM vs UC ≥ 70 years
of age.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-cause hospitalisation
Outcome: 17 Subgroup Participant age: all-cause hospitalisation TM vs UC≥ 70 years of age
Study or subgroup Telemonitoring Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Antonicelli 2008 9/28 26/29 7.2 % 0.36 [ 0.21, 0.62 ]
Biannic 2012 (SEDIC) 19/45 35/45 9.8 % 0.54 [ 0.37, 0.79 ]
Blum 2014 (MCCD) 80/104 74/102 21.0 % 1.06 [ 0.90, 1.24 ]
Dendale 2012 (TEMA-HF1) 64/80 66/80 18.6 % 0.97 [ 0.84, 1.13 ]
Lyng 2012 (WISH) 79/166 84/153 24.6 % 0.87 [ 0.70, 1.07 ]
Soran 2008 75/160 66/155 18.8 % 1.10 [ 0.86, 1.41 ]
Total (95% CI) 583 564 100.0 % 0.90 [ 0.82, 0.99 ]
Total events: 326 (Telemonitoring), 351 (Control)
Heterogeneity: Chi2 = 25.24, df = 5 (P = 0.00013); I2 =80%
Test for overall effect: Z = 2.14 (P = 0.033)
Test for subgroup differences: Not applicable
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Analysis 2.18. Comparison 2 Impact of structured telephone or telemonitoring in heart failure on risk of
all-cause hospitalisation, Outcome 18 Subgroup Participant age: all-cause hospitalisation: TM vs UC < 70 years
of age.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-cause hospitalisation
Outcome: 18 Subgroup Participant age: all-cause hospitalisation: TM vs UC < 70 years of age
Study or subgroup Telemonitoring Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Cleland 2005 (Telemon) (TENS-HMS) 80/168 46/85 12.1 % 0.88 [ 0.68, 1.13 ]
Giordano 2009 67/230 96/230 19.0 % 0.70 [ 0.54, 0.90 ]
Goldberg 2003 (WHARF) 65/138 67/142 13.1 % 1.00 [ 0.78, 1.28 ]
Koehler 2011 (TIM-HF) 192/354 179/356 35.4 % 1.08 [ 0.94, 1.24 ]
Mortara 2009 (Telemon) (HHH) 35/101 48/160 7.4 % 1.16 [ 0.81, 1.65 ]
Seto 2012 14/50 10/50 2.0 % 1.40 [ 0.69, 2.85 ]
Woodend 2008 60/62 54/59 11.0 % 1.06 [ 0.97, 1.16 ]
Total (95% CI) 1103 1082 100.0 % 0.98 [ 0.90, 1.07 ]
Total events: 513 (Telemonitoring), 500 (Control)
Heterogeneity: Chi2 = 13.86, df = 6 (P = 0.03); I2 =57%
Test for overall effect: Z = 0.43 (P = 0.67)
Test for subgroup differences: Not applicable
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Analysis 2.19. Comparison 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-
cause hospitalisation, Outcome 19 Subgroup STS focus: all-cause hospitalisation: STS (clinical support) vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-cause hospitalisation
Outcome: 19 Subgroup STS focus: all-cause hospitalisation: STS (clinical support) vs UC
Study or subgroup STS (clinical support) Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Angermann 2012 (INH) 119/352 112/363 7.7 % 1.10 [ 0.89, 1.35 ]
Bento 2009 2/20 10/20 0.7 % 0.20 [ 0.05, 0.80 ]
Chaudhry 2010 (Tele-HF) 407/826 392/827 27.3 % 1.04 [ 0.94, 1.15 ]
Cleland 2005 (Struct Tele) (TENS-HMS) 85/173 46/85 4.3 % 0.91 [ 0.71, 1.16 ]
DeBusk 2004 116/228 117/234 8.0 % 1.02 [ 0.85, 1.22 ]
Gattis 1999 (PHARM) 17/90 30/91 2.1 % 0.57 [ 0.34, 0.96 ]
GESICA 2005 (DIAL) 261/760 296/758 20.6 % 0.88 [ 0.77, 1.00 ]
Krum 2013 (CHAT) 74/188 114/217 7.4 % 0.75 [ 0.60, 0.93 ]
Laramee 2003 49/141 46/146 3.1 % 1.10 [ 0.79, 1.53 ]
Mortara 2009 (Struct Tele) (HHH) 34/94 48/160 2.5 % 1.21 [ 0.84, 1.72 ]
Riegel 2002 56/130 114/228 5.8 % 0.86 [ 0.68, 1.09 ]
Riegel 2006 39/70 37/65 2.7 % 0.98 [ 0.73, 1.32 ]
Sisk 2006 62/203 74/203 5.2 % 0.84 [ 0.64, 1.10 ]
Wakefield 2008 41/99 29/49 2.7 % 0.70 [ 0.50, 0.97 ]
Total (95% CI) 3374 3446 100.0 % 0.94 [ 0.89, 1.00 ]
Total events: 1362 (STS (clinical support)), 1465 (Control)
Heterogeneity: Chi2 = 27.23, df = 13 (P = 0.01); I2 =52%
Test for overall effect: Z = 2.12 (P = 0.034)
Test for subgroup differences: Not applicable
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Analysis 2.20. Comparison 2 Impact of structured telephone or telemonitoring in heart failure on risk of
all-cause hospitalisation, Outcome 20 Subgroup STS focus: all-cause hospitalisation: STS (education) vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-cause hospitalisation
Outcome: 20 Subgroup STS focus: all-cause hospitalisation: STS (education) vs UC
Study or subgroup STS (education) Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Domingues 2011 20/57 23/63 29.7 % 0.96 [ 0.59, 1.55 ]
Tsuyuki 2004 59/140 51/136 70.3 % 1.12 [ 0.84, 1.50 ]
Total (95% CI) 197 199 100.0 % 1.08 [ 0.84, 1.38 ]
Total events: 79 (STS (education)), 74 (Control)
Heterogeneity: Chi2 = 0.30, df = 1 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 0.57 (P = 0.57)
Test for subgroup differences: Not applicable
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Analysis 2.21. Comparison 2 Impact of structured telephone or telemonitoring in heart failure on risk of
all-cause hospitalisation, Outcome 21 Sensitivity analysis follow-up period (> 6 months), all-cause
hospitalisation: STS vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-cause hospitalisation
Outcome: 21 Sensitivity analysis follow-up period (> 6 months), all-cause hospitalisation: STS vs UC
Study or subgroup STS Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Cleland 2005 (Struct Tele) (TENS-HMS) 85/173 46/85 8.5 % 0.91 [ 0.71, 1.16 ]
DeBusk 2004 116/228 117/234 15.9 % 1.02 [ 0.85, 1.22 ]
GESICA 2005 (DIAL) 261/760 296/758 40.7 % 0.88 [ 0.77, 1.00 ]
Krum 2013 (CHAT) 74/188 114/217 14.5 % 0.75 [ 0.60, 0.93 ]
Mortara 2009 (Struct Tele) (HHH) 34/94 48/160 4.9 % 1.21 [ 0.84, 1.72 ]
Sisk 2006 62/203 74/203 10.2 % 0.84 [ 0.64, 1.10 ]
Wakefield 2008 41/99 29/49 5.3 % 0.70 [ 0.50, 0.97 ]
Total (95% CI) 1745 1706 100.0 % 0.89 [ 0.82, 0.96 ]
Total events: 673 (STS), 724 (Control)
Heterogeneity: Chi2 = 9.54, df = 6 (P = 0.15); I2 =37%
Test for overall effect: Z = 2.91 (P = 0.0036)
Test for subgroup differences: Not applicable
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Analysis 2.22. Comparison 2 Impact of structured telephone or telemonitoring in heart failure on risk of
all-cause hospitalisation, Outcome 22 Sensitivity analysis follow-up period (> 6 months), all-cause
hospitalisation: TM vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 2 Impact of structured telephone or telemonitoring in heart failure on risk of all-cause hospitalisation
Outcome: 22 Sensitivity analysis follow-up period (> 6 months), all-cause hospitalisation: TM vs UC
Study or subgroup Telemonitoring Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Antonicelli 2008 9/28 26/29 4.1 % 0.36 [ 0.21, 0.62 ]
Blum 2014 (MCCD) 80/104 74/102 12.1 % 1.06 [ 0.90, 1.24 ]
Cleland 2005 (Telemon) (TENS-HMS) 80/168 46/85 9.9 % 0.88 [ 0.68, 1.13 ]
Giordano 2009 67/230 96/230 15.6 % 0.70 [ 0.54, 0.90 ]
Koehler 2011 (TIM-HF) 192/354 179/356 29.0 % 1.08 [ 0.94, 1.24 ]
Lyng 2012 (WISH) 79/166 84/153 14.2 % 0.87 [ 0.70, 1.07 ]
Mortara 2009 (Telemon) (HHH) 35/101 48/160 6.0 % 1.16 [ 0.81, 1.65 ]
Woodend 2008 60/62 54/59 9.0 % 1.06 [ 0.97, 1.16 ]
Total (95% CI) 1213 1174 100.0 % 0.94 [ 0.87, 1.01 ]
Total events: 602 (Telemonitoring), 607 (Control)
Heterogeneity: Chi2 = 31.54, df = 7 (P = 0.00005); I2 =78%
Test for overall effect: Z = 1.59 (P = 0.11)
Test for subgroup differences: Not applicable
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Analysis 3.1. Comparison 3 Impact of structured telephone support or telemonitoring in heart failure on
risk of heart failure-related hospitalisation, Outcome 1 CHF-related hospitalisation: STS vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 3 Impact of structured telephone support or telemonitoring in heart failure on risk of heart failure-related hospitalisation
Outcome: 1 CHF-related hospitalisation: STS vs UC
Study or subgroup STS Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Angermann 2012 (INH) 36/352 46/363 6.1 % 0.81 [ 0.54, 1.22 ]
Barth 2001 0/17 0/17 Not estimable
Chaudhry 2010 (Tele-HF) 227/826 223/827 29.8 % 1.02 [ 0.87, 1.19 ]
Cleland 2005 (Struct Tele) (TENS-HMS) 34/173 24/85 4.3 % 0.70 [ 0.44, 1.10 ]
DeBusk 2004 38/228 43/234 5.7 % 0.91 [ 0.61, 1.35 ]
Gattis 1999 (PHARM) 1/90 11/91 1.5 % 0.09 [ 0.01, 0.70 ]
GESICA 2005 (DIAL) 128/760 169/758 22.7 % 0.76 [ 0.61, 0.93 ]
Krum 2013 (CHAT) 23/188 35/217 4.4 % 0.76 [ 0.47, 1.24 ]
Laramee 2003 18/141 21/146 2.8 % 0.89 [ 0.49, 1.59 ]
Mortara 2009 (Struct Tele) (HHH) 17/94 28/160 2.8 % 1.03 [ 0.60, 1.78 ]
Rainville 1999 4/19 10/19 1.3 % 0.40 [ 0.15, 1.05 ]
Ramachandran 2007 6/25 4/25 0.5 % 1.50 [ 0.48, 4.68 ]
Riegel 2002 23/130 63/228 6.1 % 0.64 [ 0.42, 0.98 ]
Riegel 2006 21/70 22/65 3.1 % 0.89 [ 0.54, 1.45 ]
Sisk 2006 18/203 29/203 3.9 % 0.62 [ 0.36, 1.08 ]
Tsuyuki 2004 37/140 38/136 5.2 % 0.95 [ 0.64, 1.39 ]
Total (95% CI) 3456 3574 100.0 % 0.85 [ 0.77, 0.93 ]
Total events: 631 (STS), 766 (Control)
Heterogeneity: Chi2 = 19.20, df = 14 (P = 0.16); I2 =27%
Test for overall effect: Z = 3.50 (P = 0.00047)
Test for subgroup differences: Not applicable
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Analysis 3.2. Comparison 3 Impact of structured telephone support or telemonitoring in heart failure on
risk of heart failure-related hospitalisation, Outcome 2 CHF-related hospitalisation: TM vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 3 Impact of structured telephone support or telemonitoring in heart failure on risk of heart failure-related hospitalisation
Outcome: 2 CHF-related hospitalisation: TM vs UC
Study or subgroup Telemonitoring Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Biannic 2012 (SEDIC) 12/45 24/45 8.3 % 0.50 [ 0.29, 0.87 ]
Cleland 2005 (Telemon) (TENS-HMS) 40/168 24/85 11.0 % 0.84 [ 0.55, 1.30 ]
Dendale 2012 (TEMA-HF1) 19/80 34/80 11.7 % 0.56 [ 0.35, 0.89 ]
Giordano 2009 43/230 73/230 25.2 % 0.59 [ 0.42, 0.82 ]
Koehler 2011 (TIM-HF) 64/354 74/356 25.4 % 0.87 [ 0.64, 1.17 ]
Mortara 2009 (Telemon) (HHH) 18/101 28/160 7.5 % 1.02 [ 0.60, 1.74 ]
Scherr 2009 (MOBITEL) 11/66 17/54 6.4 % 0.53 [ 0.27, 1.03 ]
Vuorinen 2014 8/47 13/47 4.5 % 0.62 [ 0.28, 1.35 ]
Total (95% CI) 1091 1057 100.0 % 0.71 [ 0.60, 0.83 ]
Total events: 215 (Telemonitoring), 287 (Control)
Heterogeneity: Chi2 = 8.71, df = 7 (P = 0.27); I2 =20%
Test for overall effect: Z = 4.36 (P = 0.000013)
Test for subgroup differences: Not applicable
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Analysis 3.3. Comparison 3 Impact of structured telephone support or telemonitoring in heart failure on
risk of heart failure-related hospitalisation, Outcome 3 Subgroup technology: CHF-related hospitalisation STS
vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 3 Impact of structured telephone support or telemonitoring in heart failure on risk of heart failure-related hospitalisation
Outcome: 3 Subgroup technology: CHF-related hospitalisation STS vs UC
Study or subgroup STS Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Angermann 2012 (INH) 36/352 46/363 9.6 % 0.81 [ 0.54, 1.22 ]
Barth 2001 0/17 0/17 Not estimable
Cleland 2005 (Struct Tele) (TENS-HMS) 34/173 24/85 6.8 % 0.70 [ 0.44, 1.10 ]
DeBusk 2004 38/228 43/234 9.0 % 0.91 [ 0.61, 1.35 ]
Gattis 1999 (PHARM) 1/90 11/91 2.3 % 0.09 [ 0.01, 0.70 ]
GESICA 2005 (DIAL) 128/760 169/758 35.9 % 0.76 [ 0.61, 0.93 ]
Laramee 2003 18/141 21/146 4.4 % 0.89 [ 0.49, 1.59 ]
Rainville 1999 4/19 10/19 2.1 % 0.40 [ 0.15, 1.05 ]
Ramachandran 2007 6/25 4/25 0.8 % 1.50 [ 0.48, 4.68 ]
Riegel 2002 23/130 63/228 9.7 % 0.64 [ 0.42, 0.98 ]
Riegel 2006 21/70 22/65 4.8 % 0.89 [ 0.54, 1.45 ]
Sisk 2006 18/203 29/203 6.2 % 0.62 [ 0.36, 1.08 ]
Tsuyuki 2004 37/140 38/136 8.2 % 0.95 [ 0.64, 1.39 ]
Total (95% CI) 2348 2370 100.0 % 0.76 [ 0.67, 0.86 ]
Total events: 364 (STS), 480 (Control)
Heterogeneity: Chi2 = 11.21, df = 11 (P = 0.43); I2 =2%
Test for overall effect: Z = 4.32 (P = 0.000016)
Test for subgroup differences: Not applicable
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Analysis 3.4. Comparison 3 Impact of structured telephone support or telemonitoring in heart failure on
risk of heart failure-related hospitalisation, Outcome 4 Subgroup technology: CHF-related hospitalisation
Mobile/PDA vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 3 Impact of structured telephone support or telemonitoring in heart failure on risk of heart failure-related hospitalisation
Outcome: 4 Subgroup technology: CHF-related hospitalisation Mobile/PDA vs UC
Study or subgroup Mobile/PDA Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Giordano 2009 43/230 73/230 69.7 % 0.59 [ 0.42, 0.82 ]
Scherr 2009 (MOBITEL) 11/66 17/54 17.9 % 0.53 [ 0.27, 1.03 ]
Vuorinen 2014 8/47 13/47 12.4 % 0.62 [ 0.28, 1.35 ]
Total (95% CI) 343 331 100.0 % 0.58 [ 0.44, 0.77 ]
Total events: 62 (Mobile/PDA), 103 (Control)
Heterogeneity: Chi2 = 0.10, df = 2 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 3.84 (P = 0.00012)
Test for subgroup differences: Not applicable
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Analysis 3.5. Comparison 3 Impact of structured telephone support or telemonitoring in heart failure on
risk of heart failure-related hospitalisation, Outcome 5 Subgroup technology CHF-related hospitalisation
Complex TM vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 3 Impact of structured telephone support or telemonitoring in heart failure on risk of heart failure-related hospitalisation
Outcome: 5 Subgroup technology CHF-related hospitalisation Complex TM vs UC
Study or subgroup Complex TM Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Biannic 2012 (SEDIC) 12/45 24/45 12.9 % 0.50 [ 0.29, 0.87 ]
Cleland 2005 (Telemon) (TENS-HMS) 40/168 24/85 17.2 % 0.84 [ 0.55, 1.30 ]
Dendale 2012 (TEMA-HF1) 19/80 34/80 18.3 % 0.56 [ 0.35, 0.89 ]
Koehler 2011 (TIM-HF) 64/354 74/356 39.8 % 0.87 [ 0.64, 1.17 ]
Mortara 2009 (Telemon) (HHH) 18/101 28/160 11.7 % 1.02 [ 0.60, 1.74 ]
Total (95% CI) 748 726 100.0 % 0.78 [ 0.64, 0.94 ]
Total events: 153 (Complex TM), 184 (Control)
Heterogeneity: Chi2 = 5.97, df = 4 (P = 0.20); I2 =33%
Test for overall effect: Z = 2.60 (P = 0.0092)
Test for subgroup differences: Not applicable
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Analysis 3.6. Comparison 3 Impact of structured telephone support or telemonitoring in heart failure on
risk of heart failure-related hospitalisation, Outcome 6 Subgroup technology: CHF-related hospitalisation IVR
vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 3 Impact of structured telephone support or telemonitoring in heart failure on risk of heart failure-related hospitalisation
Outcome: 6 Subgroup technology: CHF-related hospitalisation IVR vs UC
Study or subgroup IVR Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Chaudhry 2010 (Tele-HF) 227/826 223/827 80.7 % 1.02 [ 0.87, 1.19 ]
Krum 2013 (CHAT) 23/188 35/217 11.8 % 0.76 [ 0.47, 1.24 ]
Mortara 2009 (Struct Tele) (HHH) 17/94 28/160 7.5 % 1.03 [ 0.60, 1.78 ]
Total (95% CI) 1108 1204 100.0 % 0.99 [ 0.86, 1.14 ]
Total events: 267 (IVR), 286 (Control)
Heterogeneity: Chi2 = 1.30, df = 2 (P = 0.52); I2 =0.0%
Test for overall effect: Z = 0.14 (P = 0.89)
Test for subgroup differences: Not applicable
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Analysis 3.7. Comparison 3 Impact of structured telephone support or telemonitoring in heart failure on
risk of heart failure-related hospitalisation, Outcome 7 Subgroup TM intensity: CHF-related hospitalisation
Office hours vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 3 Impact of structured telephone support or telemonitoring in heart failure on risk of heart failure-related hospitalisation
Outcome: 7 Subgroup TM intensity: CHF-related hospitalisation Office hours vs UC
Study or subgroup TM - Office hours Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Biannic 2012 (SEDIC) 12/45 24/45 19.3 % 0.50 [ 0.29, 0.87 ]
Cleland 2005 (Telemon) (TENS-HMS) 40/168 24/85 25.6 % 0.84 [ 0.55, 1.30 ]
Dendale 2012 (TEMA-HF1) 19/80 34/80 27.3 % 0.56 [ 0.35, 0.89 ]
Mortara 2009 (Telemon) (HHH) 18/101 28/160 17.4 % 1.02 [ 0.60, 1.74 ]
Vuorinen 2014 8/47 13/47 10.4 % 0.62 [ 0.28, 1.35 ]
Total (95% CI) 441 417 100.0 % 0.71 [ 0.56, 0.89 ]
Total events: 97 (TM - Office hours), 123 (Control)
Heterogeneity: Chi2 = 4.99, df = 4 (P = 0.29); I2 =20%
Test for overall effect: Z = 2.93 (P = 0.0034)
Test for subgroup differences: Not applicable
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Analysis 3.8. Comparison 3 Impact of structured telephone support or telemonitoring in heart failure on
risk of heart failure-related hospitalisation, Outcome 8 Subgroup TM intensity: CHF-related hospitalisation
24/7 or 7 days vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 3 Impact of structured telephone support or telemonitoring in heart failure on risk of heart failure-related hospitalisation
Outcome: 8 Subgroup TM intensity: CHF-related hospitalisation 24/7 or 7 days vs UC
Study or subgroup
TM - 24/7 -
7 days/week Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Giordano 2009 43/230 73/230 44.1 % 0.59 [ 0.42, 0.82 ]
Koehler 2011 (TIM-HF) 64/354 74/356 44.6 % 0.87 [ 0.64, 1.17 ]
Scherr 2009 (MOBITEL) 11/66 17/54 11.3 % 0.53 [ 0.27, 1.03 ]
Total (95% CI) 650 640 100.0 % 0.71 [ 0.57, 0.87 ]
Total events: 118 (TM - 24/7 - 7 days/week), 164 (Control)
Heterogeneity: Chi2 = 3.73, df = 2 (P = 0.16); I2 =46%
Test for overall effect: Z = 3.24 (P = 0.0012)
Test for subgroup differences: Not applicable
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Analysis 3.9. Comparison 3 Impact of structured telephone support or telemonitoring in heart failure on
risk of heart failure-related hospitalisation, Outcome 9 Subgroup Publication year: CHF-related hospitalisation
STS vs UC < 2000.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 3 Impact of structured telephone support or telemonitoring in heart failure on risk of heart failure-related hospitalisation
Outcome: 9 Subgroup Publication year: CHF-related hospitalisation STS vs UC < 2000
Study or subgroup STS Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gattis 1999 (PHARM) 1/90 11/91 52.2 % 0.09 [ 0.01, 0.70 ]
Rainville 1999 4/19 10/19 47.8 % 0.40 [ 0.15, 1.05 ]
Total (95% CI) 109 110 100.0 % 0.24 [ 0.10, 0.58 ]
Total events: 5 (STS), 21 (Control)
Heterogeneity: Chi2 = 1.94, df = 1 (P = 0.16); I2 =48%
Test for overall effect: Z = 3.16 (P = 0.0016)
Test for subgroup differences: Not applicable
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Analysis 3.10. Comparison 3 Impact of structured telephone support or telemonitoring in heart failure on
risk of heart failure-related hospitalisation, Outcome 10 Subgroup Publication year: CHF-related
hospitalisation STS vs UC 2000 - 2007.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 3 Impact of structured telephone support or telemonitoring in heart failure on risk of heart failure-related hospitalisation
Outcome: 10 Subgroup Publication year: CHF-related hospitalisation STS vs UC 2000 - 2007
Study or subgroup STS Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Barth 2001 0/17 0/17 Not estimable
Cleland 2005 (Struct Tele) (TENS-HMS) 34/173 24/85 8.0 % 0.70 [ 0.44, 1.10 ]
DeBusk 2004 38/228 43/234 10.5 % 0.91 [ 0.61, 1.35 ]
GESICA 2005 (DIAL) 128/760 169/758 41.8 % 0.76 [ 0.61, 0.93 ]
Laramee 2003 18/141 21/146 5.1 % 0.89 [ 0.49, 1.59 ]
Ramachandran 2007 6/25 4/25 1.0 % 1.50 [ 0.48, 4.68 ]
Riegel 2002 23/130 63/228 11.3 % 0.64 [ 0.42, 0.98 ]
Riegel 2006 21/70 22/65 5.6 % 0.89 [ 0.54, 1.45 ]
Sisk 2006 18/203 29/203 7.2 % 0.62 [ 0.36, 1.08 ]
Tsuyuki 2004 37/140 38/136 9.5 % 0.95 [ 0.64, 1.39 ]
Total (95% CI) 1887 1897 100.0 % 0.78 [ 0.69, 0.89 ]
Total events: 323 (STS), 413 (Control)
Heterogeneity: Chi2 = 5.02, df = 8 (P = 0.76); I2 =0.0%
Test for overall effect: Z = 3.64 (P = 0.00027)
Test for subgroup differences: Not applicable
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Analysis 3.11. Comparison 3 Impact of structured telephone support or telemonitoring in heart failure on
risk of heart failure-related hospitalisation, Outcome 11 Subgroup Publication year: CHF-related
hospitalisation STS vs UC ≥ 2008.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 3 Impact of structured telephone support or telemonitoring in heart failure on risk of heart failure-related hospitalisation
Outcome: 11 Subgroup Publication year: CHF-related hospitalisation STS vs UC≥ 2008
Study or subgroup STS Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Angermann 2012 (INH) 36/352 46/363 14.1 % 0.81 [ 0.54, 1.22 ]
Chaudhry 2010 (Tele-HF) 227/826 223/827 69.3 % 1.02 [ 0.87, 1.19 ]
Krum 2013 (CHAT) 23/188 35/217 10.1 % 0.76 [ 0.47, 1.24 ]
Mortara 2009 (Struct Tele) (HHH) 17/94 28/160 6.4 % 1.03 [ 0.60, 1.78 ]
Total (95% CI) 1460 1567 100.0 % 0.96 [ 0.84, 1.11 ]
Total events: 303 (STS), 332 (Control)
Heterogeneity: Chi2 = 2.19, df = 3 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 0.53 (P = 0.60)
Test for subgroup differences: Not applicable
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Analysis 3.12. Comparison 3 Impact of structured telephone support or telemonitoring in heart failure on
risk of heart failure-related hospitalisation, Outcome 12 Subgroup Publication year: CHF-related
hospitalisation TM vs UC 2000 - 2007.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 3 Impact of structured telephone support or telemonitoring in heart failure on risk of heart failure-related hospitalisation
Outcome: 12 Subgroup Publication year: CHF-related hospitalisation TM vs UC 2000 - 2007
Study or subgroup Telemonitoring Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Cleland 2005 (Telemon) (TENS-HMS) 40/168 24/85 0.84 [ 0.55, 1.30 ]
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Analysis 3.13. Comparison 3 Impact of structured telephone support or telemonitoring in heart failure on
risk of heart failure-related hospitalisation, Outcome 13 Subgroup Publication year: CHF-related
hospitalisation TM vs UC ≥ 2008.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 3 Impact of structured telephone support or telemonitoring in heart failure on risk of heart failure-related hospitalisation
Outcome: 13 Subgroup Publication year: CHF-related hospitalisation TM vs UC≥ 2008
Study or subgroup Telemonitoring Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Biannic 2012 (SEDIC) 12/45 24/45 9.3 % 0.50 [ 0.29, 0.87 ]
Dendale 2012 (TEMA-HF1) 19/80 34/80 13.2 % 0.56 [ 0.35, 0.89 ]
Giordano 2009 43/230 73/230 28.3 % 0.59 [ 0.42, 0.82 ]
Koehler 2011 (TIM-HF) 64/354 74/356 28.6 % 0.87 [ 0.64, 1.17 ]
Mortara 2009 (Telemon) (HHH) 18/101 28/160 8.4 % 1.02 [ 0.60, 1.74 ]
Scherr 2009 (MOBITEL) 11/66 17/54 7.2 % 0.53 [ 0.27, 1.03 ]
Vuorinen 2014 8/47 13/47 5.0 % 0.62 [ 0.28, 1.35 ]
Total (95% CI) 923 972 100.0 % 0.69 [ 0.58, 0.82 ]
Total events: 175 (Telemonitoring), 263 (Control)
Heterogeneity: Chi2 = 7.94, df = 6 (P = 0.24); I2 =24%
Test for overall effect: Z = 4.35 (P = 0.000013)
Test for subgroup differences: Not applicable
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Analysis 3.14. Comparison 3 Impact of structured telephone support or telemonitoring in heart failure on
risk of heart failure-related hospitalisation, Outcome 14 Subgroup Participant age: CHF-related
hospitalisation: STS vs UC < 70 years of age.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 3 Impact of structured telephone support or telemonitoring in heart failure on risk of heart failure-related hospitalisation
Outcome: 14 Subgroup Participant age: CHF-related hospitalisation: STS vs UC < 70 years of age
Study or subgroup STS Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Angermann 2012 (INH) 36/352 46/363 8.5 % 0.81 [ 0.54, 1.22 ]
Chaudhry 2010 (Tele-HF) 227/826 223/827 41.7 % 1.02 [ 0.87, 1.19 ]
Cleland 2005 (Struct Tele) (TENS-HMS) 34/173 24/85 6.0 % 0.70 [ 0.44, 1.10 ]
Gattis 1999 (PHARM) 1/90 11/91 2.0 % 0.09 [ 0.01, 0.70 ]
GESICA 2005 (DIAL) 128/760 169/758 31.7 % 0.76 [ 0.61, 0.93 ]
Mortara 2009 (Struct Tele) (HHH) 17/94 28/160 3.9 % 1.03 [ 0.60, 1.78 ]
Ramachandran 2007 6/25 4/25 0.7 % 1.50 [ 0.48, 4.68 ]
Sisk 2006 18/203 29/203 5.4 % 0.62 [ 0.36, 1.08 ]
Total (95% CI) 2523 2512 100.0 % 0.86 [ 0.77, 0.96 ]
Total events: 467 (STS), 534 (Control)
Heterogeneity: Chi2 = 14.23, df = 7 (P = 0.05); I2 =51%
Test for overall effect: Z = 2.65 (P = 0.0080)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours STS Favours usual care
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Analysis 3.15. Comparison 3 Impact of structured telephone support or telemonitoring in heart failure on
risk of heart failure-related hospitalisation, Outcome 15 Subgroup Participant age: CHF-related
hospitalisation: STS vs UC ≥ 70 years of age.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 3 Impact of structured telephone support or telemonitoring in heart failure on risk of heart failure-related hospitalisation
Outcome: 15 Subgroup Participant age: CHF-related hospitalisation: STS vs UC≥ 70 years of age
Study or subgroup STS Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Barth 2001 0/17 0/17 Not estimable
DeBusk 2004 38/228 43/234 20.0 % 0.91 [ 0.61, 1.35 ]
Krum 2013 (CHAT) 23/188 35/217 15.3 % 0.76 [ 0.47, 1.24 ]
Laramee 2003 18/141 21/146 9.7 % 0.89 [ 0.49, 1.59 ]
Rainville 1999 4/19 10/19 4.7 % 0.40 [ 0.15, 1.05 ]
Riegel 2002 23/130 63/228 21.5 % 0.64 [ 0.42, 0.98 ]
Riegel 2006 21/70 22/65 10.7 % 0.89 [ 0.54, 1.45 ]
Tsuyuki 2004 37/140 38/136 18.1 % 0.95 [ 0.64, 1.39 ]
Total (95% CI) 933 1062 100.0 % 0.81 [ 0.67, 0.96 ]
Total events: 164 (STS), 232 (Control)
Heterogeneity: Chi2 = 4.43, df = 6 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 2.35 (P = 0.019)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
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Analysis 3.16. Comparison 3 Impact of structured telephone support or telemonitoring in heart failure on
risk of heart failure-related hospitalisation, Outcome 16 Subgroup Participant age: CHF-related
hospitalisation: TM vs UC < 70 years of age.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 3 Impact of structured telephone support or telemonitoring in heart failure on risk of heart failure-related hospitalisation
Outcome: 16 Subgroup Participant age: CHF-related hospitalisation: TM vs UC < 70 years of age
Study or subgroup Telemonitoring Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Cleland 2005 (Telemon) (TENS-HMS) 40/168 24/85 13.7 % 0.84 [ 0.55, 1.30 ]
Giordano 2009 43/230 73/230 31.5 % 0.59 [ 0.42, 0.82 ]
Koehler 2011 (TIM-HF) 64/354 74/356 31.8 % 0.87 [ 0.64, 1.17 ]
Mortara 2009 (Telemon) (HHH) 18/101 28/160 9.3 % 1.02 [ 0.60, 1.74 ]
Scherr 2009 (MOBITEL) 11/66 17/54 8.1 % 0.53 [ 0.27, 1.03 ]
Vuorinen 2014 8/47 13/47 5.6 % 0.62 [ 0.28, 1.35 ]
Total (95% CI) 966 932 100.0 % 0.75 [ 0.63, 0.89 ]
Total events: 184 (Telemonitoring), 229 (Control)
Heterogeneity: Chi2 = 5.82, df = 5 (P = 0.32); I2 =14%
Test for overall effect: Z = 3.25 (P = 0.0011)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
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Analysis 3.17. Comparison 3 Impact of structured telephone support or telemonitoring in heart failure on
risk of heart failure-related hospitalisation, Outcome 17 Subgroup Participant age: CHF-related
hospitalisation: TM vs UC ≥ 70 years of age.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 3 Impact of structured telephone support or telemonitoring in heart failure on risk of heart failure-related hospitalisation
Outcome: 17 Subgroup Participant age: CHF-related hospitalisation: TM vs UC≥ 70 years of age
Study or subgroup Telemonitoring Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Biannic 2012 (SEDIC) 12/45 24/45 41.4 % 0.50 [ 0.29, 0.87 ]
Dendale 2012 (TEMA-HF1) 19/80 34/80 58.6 % 0.56 [ 0.35, 0.89 ]
Total (95% CI) 125 125 100.0 % 0.53 [ 0.37, 0.76 ]
Total events: 31 (Telemonitoring), 58 (Control)
Heterogeneity: Chi2 = 0.09, df = 1 (P = 0.76); I2 =0.0%
Test for overall effect: Z = 3.43 (P = 0.00061)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
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Analysis 3.18. Comparison 3 Impact of structured telephone support or telemonitoring in heart failure on
risk of heart failure-related hospitalisation, Outcome 18 Subgroup STS focus: CHF-related hospitalisation: STS
(clinical support) vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 3 Impact of structured telephone support or telemonitoring in heart failure on risk of heart failure-related hospitalisation
Outcome: 18 Subgroup STS focus: CHF-related hospitalisation: STS (clinical support) vs UC
Study or subgroup STS (clinical support) Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Angermann 2012 (INH) 36/352 46/363 6.4 % 0.81 [ 0.54, 1.22 ]
Barth 2001 0/17 0/17 Not estimable
Chaudhry 2010 (Tele-HF) 227/826 223/827 31.5 % 1.02 [ 0.87, 1.19 ]
Cleland 2005 (Struct Tele) (TENS-HMS) 34/173 24/85 4.5 % 0.70 [ 0.44, 1.10 ]
DeBusk 2004 38/228 43/234 6.0 % 0.91 [ 0.61, 1.35 ]
Gattis 1999 (PHARM) 1/90 11/91 1.5 % 0.09 [ 0.01, 0.70 ]
GESICA 2005 (DIAL) 128/760 169/758 23.9 % 0.76 [ 0.61, 0.93 ]
Krum 2013 (CHAT) 23/188 35/217 4.6 % 0.76 [ 0.47, 1.24 ]
Laramee 2003 18/141 21/146 2.9 % 0.89 [ 0.49, 1.59 ]
Mortara 2009 (Struct Tele) (HHH) 17/94 28/160 2.9 % 1.03 [ 0.60, 1.78 ]
Rainville 1999 4/19 10/19 1.4 % 0.40 [ 0.15, 1.05 ]
Ramachandran 2007 6/25 4/25 0.6 % 1.50 [ 0.48, 4.68 ]
Riegel 2002 23/130 63/228 6.5 % 0.64 [ 0.42, 0.98 ]
Riegel 2006 21/70 22/65 3.2 % 0.89 [ 0.54, 1.45 ]
Sisk 2006 18/203 29/203 4.1 % 0.62 [ 0.36, 1.08 ]
Total (95% CI) 3316 3438 100.0 % 0.84 [ 0.76, 0.93 ]
Total events: 594 (STS (clinical support)), 728 (Control)
Heterogeneity: Chi2 = 18.96, df = 13 (P = 0.12); I2 =31%
Test for overall effect: Z = 3.52 (P = 0.00043)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
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Analysis 3.19. Comparison 3 Impact of structured telephone support or telemonitoring in heart failure on
risk of heart failure-related hospitalisation, Outcome 19 Subgroup STS focus: CHF-related hospitalisation: STS
(education) vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 3 Impact of structured telephone support or telemonitoring in heart failure on risk of heart failure-related hospitalisation
Outcome: 19 Subgroup STS focus: CHF-related hospitalisation: STS (education) vs UC
Study or subgroup STS (education) Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Tsuyuki 2004 37/140 38/136 0.95 [ 0.64, 1.39 ]
0.01 0.1 1 10 100
Favours STS (education) Favours usual care
Analysis 3.20. Comparison 3 Impact of structured telephone support or telemonitoring in heart failure on
risk of heart failure-related hospitalisation, Outcome 20 Sensitivity analysis follow-up period (> 6 months),
CHF-related hospitalisation: STS vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 3 Impact of structured telephone support or telemonitoring in heart failure on risk of heart failure-related hospitalisation
Outcome: 20 Sensitivity analysis follow-up period (> 6 months), CHF-related hospitalisation: STS vs UC
Study or subgroup STS Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Cleland 2005 (Struct Tele) (TENS-HMS) 34/173 24/85 9.6 % 0.70 [ 0.44, 1.10 ]
DeBusk 2004 38/228 43/234 12.6 % 0.91 [ 0.61, 1.35 ]
GESICA 2005 (DIAL) 128/760 169/758 50.4 % 0.76 [ 0.61, 0.93 ]
Krum 2013 (CHAT) 23/188 35/217 9.7 % 0.76 [ 0.47, 1.24 ]
Mortara 2009 (Struct Tele) (HHH) 17/94 28/160 6.2 % 1.03 [ 0.60, 1.78 ]
Rainville 1999 4/19 10/19 3.0 % 0.40 [ 0.15, 1.05 ]
Sisk 2006 18/203 29/203 8.6 % 0.62 [ 0.36, 1.08 ]
Total (95% CI) 1665 1676 100.0 % 0.76 [ 0.66, 0.88 ]
Total events: 262 (STS), 338 (Control)
0.01 0.1 1 10 100
Favours STS Favours usual care
(Continued . . . )
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(. . . Continued)
Study or subgroup STS Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Heterogeneity: Chi2 = 4.32, df = 6 (P = 0.63); I2 =0.0%
Test for overall effect: Z = 3.60 (P = 0.00031)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours STS Favours usual care
Analysis 3.21. Comparison 3 Impact of structured telephone support or telemonitoring in heart failure on
risk of heart failure-related hospitalisation, Outcome 21 Sensitivity analysis follow-up period (> 6 months),
CHF-related hospitalisation: TM vs UC.
Review: Structured telephone support or non-invasive telemonitoring for patients with heart failure
Comparison: 3 Impact of structured telephone support or telemonitoring in heart failure on risk of heart failure-related hospitalisation
Outcome: 21 Sensitivity analysis follow-up period (> 6 months), CHF-related hospitalisation: TM vs UC
Study or subgroup Telemonitoring Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Cleland 2005 (Telemon) (TENS-HMS) 40/168 24/85 15.9 % 0.84 [ 0.55, 1.30 ]
Giordano 2009 43/230 73/230 36.4 % 0.59 [ 0.42, 0.82 ]
Koehler 2011 (TIM-HF) 64/354 74/356 36.8 % 0.87 [ 0.64, 1.17 ]
Mortara 2009 (Telemon) (HHH) 18/101 28/160 10.8 % 1.02 [ 0.60, 1.74 ]
Total (95% CI) 853 831 100.0 % 0.78 [ 0.65, 0.94 ]
Total events: 165 (Telemonitoring), 199 (Control)
Heterogeneity: Chi2 = 4.37, df = 3 (P = 0.22); I2 =31%
Test for overall effect: Z = 2.65 (P = 0.0082)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
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A D D I T I O N A L T A B L E S
Table 1. Secondary Outcomes - Length of Stay (LOS)
Study Length of Stay P value
Structured telephone support
Chaudhry 2010 (Tele-HF) Mean total hospital days: Intervention vs
Control: 7.2 ± 14.6 vs 7.0 ± 14.9
NS
P = 0.27
Galbreath 2004 No statistical changes in participant bed
days between groups
NS
P = 0.899 (Group effect)
P = 0.117 (Time effect)
Laramee 2003 Intervention vs Control: mean (SD) days
of hospitalisation: 6.9 (6.5) vs 9.5 (9.8)
NS
P = 0.15
Riegel 2002 Heart failure hospital days (6 months): In-
tervention vs Control: mean (SD): 1.1 (3.
1) vs 2.1 (4.6)
All-cause days (6 months): Intervention vs.
Control: mean (SD): 3.5 (6.6) vs 4.8 (8.3)
NS
P = 0.05 (with covariate)
P = 0.23 (with covariate)
Riegel 2006 Heart failure hospital days (6 months): In-
tervention vs Control: mean (SD, 95%CI)
3.40 (7.1, CI 1.6 to 5.2) vs 3.65 (7.8, 1.9
to 5.4)
NS
P value not reported
Tsuyuki 2004 Cardiovascular hospital days (6 months):
Intervention vs Usual care: mean (SD) 6.4
(6.0) vs 11.6 (10.3)
Total days 341 vs 812
All-cause days (6 months): Intervention vs
Usual care: Total days 627 vs 1082 days
LOS
P = 0.003
P = 0.003
P = 0.001
Wakefield 2008 Quote: “No statistically significant differ-
ences in the mean number of hospital days
or the mean number of urgent care vis-
its among the three groups, or between
the combined intervention and control
groups”
NS
Telemonitoring
Balk 2008 Total days in hospital: Intervention vsCon-
trol 759 (0 - 116) vs 762 (0 - 132): Mean
7.4 vs 7.9 days
NS
P value not reported
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Table 1. Secondary Outcomes - Length of Stay (LOS) (Continued)
Blum 2014 (MCCD) Total mean days in hospital (all-cause): In-
tervention vs Control 40 ± 74 vs. 24 ± 35
Total mean days in hospital (heart failure-
related): Intervention vs Control 21 ± 26
vs. 18 ± 17
NS
P = 0.12
P = 0.75
Dendale 2012 (TEMA-HF1) Heart failure-related hospitalisation LOS:
Intervention vs Control: 2.5 vs 4.6
All-cause hospitalisation LOS: Interven-
tion vs. Control: 7.1 vs 8.0
NS
P = 0.10
P = 0.65
Koehler 2011 (TIM-HF) Number of days in hospital (all-cause): In-
tervention vs Control: 16.7 ± 32.3 vs 13.7
± 22.7
Number of days in hospital (heart failure-
related): Intevention vs Control: 5.3 ± 18.
1 vs 4.9 ± 13.2
NS
P = 0.15
P = 0.71
Lyngå 2012 (WISH) Mean total days in hospital for cardiac dis-
ease: Intervention vs Control: 7.5 vs 7.7
NS
P=0.90
Scherr 2009 (MOBITEL) Length of stay: Intervention vs Control:
median 6.5 days (IQR 5.5 - 8.3) vs 10 days
(IQR 7.0 - 13.0)
LOS with intervention
P = 0.04
Soran 2008 Heart failure hospital days (6 months): In-
tervention vs Control Mean (SD) 9.3 (12.
2) vs 10.0 (7.3)
NS
P = 0.22
Villani 2014 (ICAROS) Hospitalisation > 3 days for heart failure:
Intervention vs Control: 23 v 12
number of hospitalisations > 3 days
P < 0.03
Vuorinen 2014 Heart failure-related hospital days: Inter-
vention vsControl: 0.7 (SD2.4) vs 1.4 (SD
3.5)
Quote: “No difference was found in the
number of HF-related hospital days (inci-
dence rate ratio [IRR]=0.812).”
NS
P = 0.351
Woodend 2008 Mean total days in hospital: Intervention
vs. Control (1 year): 7.13 vs 6.71 days
NS
P value not reported
Structured telephone support and telemonitoring
Cleland 2005 (Struct Tele) (TENS-
HMS)
Heart failure hospitalisations (240 days)
median (IQR) usual care = 11 (6 - 20) nurse
telephone support = 15 (7 - 29) home tele-
monitoring = 11 (6 - 19)
NS
P value not reported
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Table 1. Secondary Outcomes - Length of Stay (LOS) (Continued)
Mortara 2009 (Struct Tele) (HHH) No significant effect of home telemonitor-
ing in reducing bed-days occupancy
Quote: “ There was no significant effect
of HT in reducing bed-days occupancy for
HF”
Total days in hospital for heart failure:
Usual care 584 days (1.0%) vs Home tele-
monitoring 1175 Days (1.1%), Strategy 1:
477 (1.2%), Strategy 2: 374(1.2%), Strat-
egy 3: 324 (1.0%)
NS
P value not reported
IQR: inter-quartile range; LOS: length of stay; NS: not significant; SD: standard deviation.
Table 2. Secondary Outcomes - Health-related quality of life (HRQoL)
Study HRQoL outcomes P value
Structured telephone support
Angermann 2012 (INH) SF-36 (SF-36PhysicalHealthComponent
and Physical Functioning)
QoL
P = 0.03 (both components)
Baker 2011 Improving Chronic Illness Care Evalua-
tion (ICICE)Heart Failure Symptom Scale
(HFSS)
Quotes: ”HFQOL improved from 58.5 to
64.6 for the TTG (intervention) group but
did not change for the BEI (control) group
(64.7 to 63.9; P < .001 for the difference
in change scores).“ ”The change was -0.6
versus 6.7, respectively, for the BEI and the
TTG groups (P < 0.001 for comparison of
the change between the 2 groups“
QoL
P = 0.001
Barth 2001 MLWHFQ pre and post-intervention for
experimental group.
Quote: ”Participants in the experimental
group showed significant improvement in
the physical dimension (t = 6.63, p ≤.
0005), the emotional dimension (t = 4.55,
p ≤ .0005), and the total LHFQ score (t =
7.80, p ≤.0005)“
QoL
P = 0.0005
Brandon 2009 MLWHFQ
Quote: ”Intervention group reported more
improvement in overall QoL, and the con-
trol group reported a decrease in overall
QoL
P = 0.026
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Table 2. Secondary Outcomes - Health-related quality of life (HRQoL) (Continued)
quality of life“
DeWalt 2006 Modified MLWHFQ
Quote: ”In unadjusted analysis, the control
group, on average, improved 5 points on
theMLHF and the intervention group im-
proved by 1 point. The difference was not
statistically significant (3.5 points, 95% CI
11, -4, p = 0.36). After adjusting for base-
line differences between the groups, the dif-
ference was 2 points (95% CI 9, -5, p =
0.59) suggesting no effect on heart failure-
related quality of life“
NS
P = 0.36 (unadjusted)
P = 0.59 (adjusted)
Galbreath 2004
(reported in Smith 2005)
Quote: “Analysis of the SF-36health transi-
tion measure showed a positive effect of the
intervention on self-reported improvement
in health at 6 months and at 12 months
(P= 0.04 and P= 0.004, respectively).How-
ever, no effect of disease management was
observed across any of the SF-36 compo-
nents. Women and patients with diastolic
heart failure had poorer HRQL scores.”
QoL
P = 0.04 (6 months)
P = 0.004 (12 months)
GESICA 2005 (DIAL) Improved MLWHFQ
Mean total score, intervention vs control
30.6 vs 35.0 (mean difference = 4.4, 95%
CI 1.8 to 6.9)
QoL
P = 0.001
Ramachandran 2007 KCCQ
Quote: ”There was no significant change
in the mean HRQoL score of the control
group during the study period (62.2 [22.
6] to 63.4 [21.9]; p=0.69. However, there
was a significant change in the intervention
group (0.60 [23.6] to 76.3 [17.3]; p<0.05”
QoL
P < 0.05
Riegel 2006 MLWHFQ
EQ-5D
Quote: “No beneficial effect was seen in
the disease-specific or generic measures of
HRQL”
NS
Sisk 2006 MLWHFQ
SF-12
Physical component score (39.9 vs 36.3,
difference 3.6 (CI 1.2 to 6.1)
MLWHFQ (38.6 vs 47.3, difference -8.8
(95% CI -15.3 to -2.2)
Significant,(overtime for the intervention)
P value not reported
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Table 2. Secondary Outcomes - Health-related quality of life (HRQoL) (Continued)
Wakefield 2008 MLWHFQ
Quote: “For all groups, quality of life scores
significantly improved over time (F = 8.90,
p = 0.0002). The magnitude of change was
greatest in the telephone group, followed
by the videophone and control groups, al-
though there were no statistically signifi-
cant differences among the three groups at
baseline, 3, or 6 months. Post-hoc compar-
isons did not identify any significant differ-
ences among the groups in pairwise com-
parisons.”
QoL
P = 0.0002 (over time for all groups)
Telemonitoring
Antonicelli 2008 SF-36
Quote: “...patients randomized to home
telemonitoring were characterized at fol-
low-up by a significantly better reported
health perception (HP) score as compared
to baseline. This improvement was signifi-
cantly greater as compared to controls (P <
0.046).”
NS for component scores. P < 0.046 for
health perception overtime with telemoni-
toring
Balk 2008 SF-36
MLWHFQ
Quote: “No differences in quality of life
and self care behaviour were found between
the Control group and the Intervention
group either at the start or at the end of the
study”
NS
NS
Biannic 2012 (SEDIC) MLWHFQ
No difference between groups in quality of
life (-10 in control and -11.9 in interven-
tion)
NS
Blum 2014 (MCCD) Quote: “Scores for SF-36 and MLWHFQ
improved (P<0.001) overtime, but there
were no differences between groups”
SF-36 composite physical and mental
scores
MLWHFQ total, physical, and emotional
scores improved statistically over the year
with the 3 measurements
SF36Mental composite and Physical com-
posites improved
No difference between groups.
QoL
Overtime:
P < .001
Between groups: NS
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Table 2. Secondary Outcomes - Health-related quality of life (HRQoL) (Continued)
De Lusignan 2001 CHFSQ
GHQ
Quote: “There is only a marginal differ-
ence between the telemedicine and con-
trol groupsCHFquestionnaire results there
is no significant difference between the
groups”
NS
Goldberg 2003 (WHARF) MLWHFQ
SF-12
HDS
All scores were improved but were not sta-
tistically significant
Quote: “...patients in both groups experi-
enced improvement between baseline and
6 months in their Minnesota Living with
Heart Failure, SF-12 and Health Distress
scores. Although no difference was statis-
tically significant, the intervention group
trended towards improvement in all qual-
ity of life measures”
NS
Koehler 2011 (TIM-HF) Quote: “Patients randomly allocated to the
RTM (intervention) group compared with
the usual care group showed an improved
score for SF-36 physical functioning over
the entire study period (P<0.05).”
Mean HRQoL at 12 months Intervention
vs. Control: 54.3 ± 1.2 vs 49.9 ± 1.2
Mean HRQoL at 24 months Intervention
vs. Control: 53.8 ± 1.4 vs. 51.7 ± 1.4
QoL
P < 0.05
Lyngå 2012 (WISH) SF-12
Physical component score Intervention vs
Control: (31.3 + 9.0) vs (31.6 + 8.0) P = 0.
76
Mental component score Intervention vs
Control: (45.0 + 11.0) vs (44.1 +10.8) P =
0.46
NS
Seto 2012 MLHFQ
Quote: “The telemonitoring group had
better post-study quality of life (emotional
dimension)”
Quote: “Quality of life significantly im-
proved for only the telemonitoring group
(P=0.02) including physical and emotional
dimensions (P=0.03) compared to standard
care group (P=0.05)”
QoL
MLHFQ
Physical P=0.02; Emotional P=0.03
overtime for telemonitoring only.
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Table 2. Secondary Outcomes - Health-related quality of life (HRQoL) (Continued)
Soran 2008 SF-12
KCCQ
Quote: “Mean values for quality of life, as
measured by the KCCQ and the SF-12,
were also similar by treatment arm”
NS
Woodend 2008 MLWHFQ
Quote: “Patients randomized to receive
telehome care had significantly better func-
tional status on both the overall score (P .
003) and the physical subscale (P .001) of
the LiHFe at 3 months than patients re-
ceiving usual care. There was no significant
difference between randomized groups in
the emotional subscale at 3 months.”
SF-36 improved
Quote: “The only subscale on which tele-
home-monitored patients had significantly
better quality of life at all three points in
time was the vitality subscale,which reflects
the subject’s energy level and fatigue. Pa-
tients with HF in both randomized groups
demonstrated significant improvements in
quality of life over time in all of the SF-36
subscales”
QoL (MLWHFQ)
Overall score P = 0.003
Physical P = 0.001 overtime with telemon-
itoring only.
SF-36 (all participants, overtime, all SF-36
subscales: P < 0.05
CHFSQ: Chronic Heart Failure Symptomatology Questionnaire; GHQ: General Health Questionnaire; ICICE: Improving chronic
illness care evaluation; HDS: Health Distress Score; HRQoL: Health Related Quality of Life; HFSS: Heart Failure Symptom
Scale (HFSS); ; KCCQ: Kansas City Cardiomyopathy Questionnaire; LiHFe: Minnesota Living with Heart Failure Questionnaire;
MLWHFQ: Minnesota Living with Heart Failure Questionnaire; NS: not significant; SF-12: Short Form 12-Item; SF-36: Short
Form 36-Item
Table 3. Secondary Outcomes - Cost of the intervention and cost effectiveness
Study Cost Outcomes
Structured telephone support
Barth 2001 Quote: ”Data on unexpected office visits,
emergency room visits, and readmissions
due to
exacerbation of CHF plus costs were col-
lected. No significant differences were
found.“
Cost of the intervention: USD 23.60 per
participant.
NS
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Table 3. Secondary Outcomes - Cost of the intervention and cost effectiveness (Continued)
Galbreath 2004
(reported in Smith 2008)
Quote: ”Repeated-measures ANOVA for
cost by group showed no significant dif-
ferences, even in the higher NYHA class
groups.“
Quote: ”Analyses of direct medical and in-
tervention costs showed no cost savings as-
sociated with the intervention.“
Cost of the intervention: Quote: ”Based on
the total cost of labor, benefits, and office
and operating expenses, as well as the num-
ber of patient-months for which services
were provided, the mean cost of DM ser-
vices per patient per month was $246“
NS
Laramee 2003 Quote: ”Total inpatient andoutpatientme-
dian costs were slightly less for the interven-
tion group ($15979 vs $18662, P=0.14)“
Cost of the intervention: not reported.
NS
Ramachandran 2007 Cost of the intervention: INR 7680 per
participant annually
Riegel 2002 USD 443 per participant.
46% reduction in inpatient costs.
Cost of the intervention: Quote: ”The in-
tervention was calculated to cost $443 per
patient, if the cost of training is included“
Cost
P = 0.04
Riegel 2006 NSdifference inHF cost of care or all-cause
hospital costs
Cost of the intervention: not reported.
NS
Sisk 2006
(reported in Herbert 2008)
Quote” “Intervention cost $2177 per pa-
tient were more than offset by reduced hos-
pital costs ($2378 per patient) but higher
costs for outpatient procedures, medica-
tions, and home health care but higher
costs for outpatient procedures, medica-
tions, and home health care prevented the
intervention from being cost-saving over
the 12-month study.”
NS
Tsuyuki 2004 CAD 2531 per participant reduction with
the intervention. P value not reported
Cost of the intervention: not reported.
Cost
Wakefield 2008 Mean heart failure-related readmission
costs were 86% and 84% lower in the
Cost
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Table 3. Secondary Outcomes - Cost of the intervention and cost effectiveness (Continued)
videophone and telephone groups, respec-
tively, compared to usual care
Cost of the intervention: not reported.
Telemonitoring
Balk 2008 Increase in costs in the Intervention group.
Quote: “With no decrease in hospital days
or health care consumption and with the
extra costs of the MOTIVA system and the
Medical Service Centre, overall costs were
higher in the Intervention group than the
Control group.”
Cost of the intervention: not reported.
Cost
Blum 2014 (MCCD) Total mean Medicare payment per partic-
ipant (all-cause hospitalisation): Interven-
tion vs Control: USD 64,788 ± USD 100,
452 vs USD 40,480 ± USD 58,572 (P = 0.
99)
Total mean Medicare payment per partici-
pant (heart failure-related hospitalisations)
: Intervention vs Control: USD 33,944 ±
USD 29,804 vs USD 32,914 ± USD 30,
575 (P = 0.83)
Cost of the intervention: not reported.
NS
Dendale 2012 (TEMA-HF1) Total cost of hospitalisation: Intervention
vs Control: EUR 2557 (4094) vs EUR
2643 (4363); P = 0.90
Cost of the intervention: not reported.
NS
Giordano 2009 Mean cost for hospital readmission was sig-
nificantly lower in HBT group (EUR 843
± 1733) than in UC group (EUR 1298 ±
2322), (−35%, P < 001)
Cost of the intervention: daily cost per par-
ticipant of intervention was EUR 0.65 and
mean annual cost per participant was EUR
185
Cost
Soran 2008
(reported in Soran 2010)
Quote: “We found that both Medicare and
total costs were significantly higher for pa-
tients who were randomized to the HFMS
arm than they were for the patients ran-
domized to the SC arm. The 6-month
mean total costs were estimated to be $20,
190 and$15,966 for theHFMSand the SC
groups, respectively, whereas the 6-month
NS
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Table 3. Secondary Outcomes - Cost of the intervention and cost effectiveness (Continued)
mean Medicare costs were estimated to
be $17,837 and $13,886, respectively. In
fact, we found that costs were higher for
most types of costs -inpatient costs,physi-
cian costs, home health costs, and outpa-
tient cost-for patients who were random-
ized to the HFMS than they were for pa-
tients randomized to SC. The difference in
costs was much higher than the cost of the
intervention.”
Total cost to Medicare programme: Inter-
vention vsControl: USD17,838 (USD20,
559) vs USD 13, 886 (USD 17,556)
Total medical cost: Intervention vs. Con-
trol: USD 20,191 (USD 22,089) vs USD
15,967 (USD 18,878)
Villani 2014 (ICAROS) Intervention costs (Intervention vs Con-
trol): USD 235,635 vs USD 81,275
Total cost of management (Intervention vs.
Control): USD 354,424 vs USD 284,464
Cost
P < 0.05
NS: not significant
Table 4. Secondary Outcomes - Adherence to intervention
Study Adherence
Structured telephone support
Angermann 2012 (INH) Participant compliance with self monitoring and drug adherence was high both
at baseline and follow-up (85 ± 17% and 84 ± 19%)
Chaudhry 2010 (Tele-HF) Quote: “...85.6% of patients in the telemonitoring group made at least one call;
among these patients, adherence to the intervention was highest, 90.2%, during
the first week of the study period and decreased to 55.1% by week 26. A total of
29,163 variances were generated during the study period, with a median of 21
(interquartile range, 5 to 54) per patient.”
Krum 2013 (CHAT)
(reported in Clark 2007)
Adherence to intervention, 65.8% (P = 0.001).
Laramee 2003 Adherence to treatment plan (daily weighs) (P < 0.01).
Telemonitoring
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Table 4. Secondary Outcomes - Adherence to intervention (Continued)
Blum 2014 (MCCD) Adherence: mean of 6 days per week (95% CI 5.93 to 6.03) the 1st year to a low
of 5 days a week (95% CI 4.76 to 5.33) in the 4th year
Capomolla 2004 Compliance to telemonitoring was 82%.
De Lusignan 2001 The telemedicine group was sufficiently motivated to record their weight 75% of
the time
Blood pressure was measured 90% of the time.
Goldberg 2003 (WHARF) Compliance with the monitoring system was 98.5%.
Koehler 2011 (TIM-HF) Quote: “RTM patients: 81% were≥70% compliant with daily data transfers and
no break for >30 days (except during hospitalisations)”
Lyngå 2012 (WISH) Compliance with daily weighing: quote: “Mean compliance rate of 75%”
Scherr 2009 (MOBITEL) Adherence rate with the telemonitoring system: 95%.
Seto 2012 Quote: “...42, 33, and 16 out of the 50 telemonitoring group patients (84%,
66%, and 32%) completed at least 91 (50%), 146 (80%), and 173 (95%) of
possible daily readings over the six months”
Quote: “By the final week of our trial, 89% of our patients were taking their
measurements at least 3 times per week”
Soran 2008 Compliance with the monitoring intervention: 97%.
Vuorinen 2014 Quote: “Patients adherence to the weekly reporting plan was close to 90%”
Quote: “Adherence, calculated as a proportion of weekly submitted self-measure-
ment, was 86% in weight reporting and 89% in BP, HR and symptom reporting”
Structured telephone support and telemonitoring
Cleland 2005 (Struct Tele) (TENS-HMS) Home telemonitoring had 80% compliance with at least 1 daily measurement
(weight or blood pressure). 55% had 80% compliance with twice-daily measure-
ments
Mortara 2009 (Struct Tele) (HHH) Participants completed 81%of all practicable vital signs transmissions fromhome.
Overall, 92% of practicable recordings were carried out by the participants
Table 5. Secondary Outcomes - Acceptability (Satisfaction and Usability)
Study Acceptability of the intervention
Structured telephone support
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Table 5. Secondary Outcomes - Acceptability (Satisfaction and Usability) (Continued)
Krum 2013 (CHAT)
(reported in Clark 2007)
Participants assessed the CHAT project with a total acceptability rate of
76.45%
Laramee 2003 Satisfaction (P < 0.01).
Riegel 2002 Satisfaction was significantly higher among people assigned to the inter-
vention group than among those assigned to the usual-care group (P = 0.
01)
Wakefield 2008 Satisfaction between video and telephone (NS).
Telemonitoring
Balk 2008 The ease of use was rated very good or good by 80%.
70% of the users mentioned that their access to doctors and nurses was
better with remote patient management compared to the service they had
received before
De Lusignan 2001 Participants in the study didnot find the video link over standard telephone
lines to be useful
Koehler 2011 (TIM-HF)
(reported in Prescher 2013)
Usability of telemedical devices 224 (98.6%), robustness (88.8%), acces-
sibility of the 24/7 telemonitoring centre 193 (84.6%)
Vuorinen 2014 Quote: “The technology received excellent feedback from the patient and
professional side with a high adherence rate throughout the study”. “95%
of all patients found that making and reporting measurements with the
mobile phone app was ’very useful’ or ’quite useful”’
Woodend 2008 Overall participants found the equipment easy to use. 92 - 97% very
highly satisfied
Structured telephone support and telemonitoring
Cleland 2005 (Struct Tele) (TENS-HMS) 96% of participants were well satisfied with the system.
NS: not significant.
Table 6. Secondary Outcomes - Heart failure knowledge and self care as assessed by validated questionnaires
Study Heart Failure knowledge and Self-care P value
Structured telephone support
Baker 2011 Adapted version of the ICICE tele-
phone survey.
Quote: “The TTG (intervention)
Self care and knowledge
P < 0.001
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Table 6. Secondary Outcomes - Heart failure knowledge and self care as assessed by validated questionnaires (Continued)
had greater improvements in gen-
eral and salt knowledge (P<0.001)
and greater increases in self-care be-
haviours (from mean 4.8 to 7.6 for
TTG vs. 5.2 to 6.7 for BEI (con-
trol) P<0.001).” Adapted ICICE
telephone survey
Brandon 2009 Self-care behaviour scale.
Quote: “Improvement in the mean
SCB score for the intervention
group (from 95.9 to 128), whereas
the control group’s SCBmean score
did not change (m=94) (P=0.009)”
Self care
P = 0.009
DeWalt 2006 S-TOFHLA
Quote: “Heart failure
related knowledge improved more
in the intervention group than in
the control group. Mean difference
in score improvement was 12 per-
centage points (95% CI 6, 18; p <
0.001).”
Quote: “Heart failure self-efficacy
improved more in the intervention
group than in the control group.
Mean difference in score improve-
ment was 2 points (95% CI 0.7, 3.
1; p = 0.0026).”
Quote: “Significantlymore patients
in the intervention group than in
the control group reported daily
weight measurement at 12 months
(79% vs. 29%, p < 0.001).”
Heart failure knowledge improved
(P = 0.001)
Heart failure self efficacy improved
(P = 0.0026)
Heart failure self-care behaviour improved
(P < 0.001)
Domingues 2011 Heart failure and self-care informa-
tion questionnaire. Improvement
in heart failure awareness and
knowledge in both groups. Inter-
vention vs Control from baseline 4.
6 ± 1.9 to 3 months later 6.1 ± 2.
1 vs from baseline 4.5 ± 1.9 to 3
months later 5.8 ± 1.9 (P = 0.001)
There were no statistically signif-
icant differences between the two
groups (6.1 ± 2.1 versus 5.8 ± 1.9,
P = 0.41)
Heart failure knowledge improved over time for both groups (P = 0.001)
, no significant differences between groups (P = 0.41)
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Table 6. Secondary Outcomes - Heart failure knowledge and self care as assessed by validated questionnaires (Continued)
Wakefield 2008 Knowledge on medications im-
proved.
NS
Zamanzadeh 2013 SCHFI
Significant differences in self care
between the control and interven-
tion groups and significant differ-
ence in self-care behaviours over the
3 months, such that as time pro-
gressed self-care scores among par-
ticipants in the intervention group
continued to increase
Self-care behaviours (P = 0.003)
Telemonitoring
Balk 2008 Dutch Heart Failure Knowledge
Score.
Knowledge about heart failure in-
creased significantly more in the In-
tervention group
Heart failure knowledge improved
(P < 0.001)
Seto 2012 SCHFI
Quote: “A comparison of the post-
study data between groups found
only a statistically significant dif-
ference in SCHFI maintenance
scores, indicating the telemonitor-
ing group had greater self-care
maintenance (ie, a higher SCHFI
maintenance score) (P = .03).”
Self-care behaviours
(P = 0.03)
Vuorinen 2014 European Heart Failure Self-care
Behaviour Scale
Quote: “No statistically significant
differences in patients clinical status
or their self-care behaviour”
NS
ICICE: Improving chronic illness care evaluation; NS: not significant; S-TOFHLA: Short Test of Functional Health Literacy in Adults;
SCHFI: Self-Care Heart Failure Index
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A P P E N D I C E S
Appendix 1. Search strategies (2015 update)
CENTRAL
#1MeSH descriptor: [Heart Failure] explode all trees
#2(heart or cardiac or myocard*) near/2 (fail* or insufficien* or decomp*)
#3#1 or #2
#4MeSH descriptor: [Telemedicine] explode all trees
#5MeSH descriptor: [Telecommunications] explode all trees
#6MeSH descriptor: [Case Management] this term only
#7MeSH descriptor: [Comprehensive Health Care] explode all trees
#8MeSH descriptor: [Disease Management] this term only
#9MeSH descriptor: [Home Care Services] this term only
#10MeSH descriptor: [Home Care Services, Hospital-Based] this term only
#11MeSH descriptor: [Nurse Clinicians] this term only
#12MeSH descriptor: [Nurse Practitioners] this term only
#13MeSH descriptor: [Monitoring, Ambulatory] this term only
#14MeSH descriptor: [Clinical Protocols] this term only
#15MeSH descriptor: [Patient Care Planning] this term only
#16tele*
#17(remote near/3 consult*)
#18disease next management
#19nurse next led
#20phone*
#21(manage* near/3 program*)
#22(nurse* near/3 manage*)
#23case next management
#24(home near/3 service*)
#25nurse next practitioner*
#26nurse next clinician*
#27care next plan*
#28ehealth
#29mobile next health
#30(remote* or distan*) near/2 (care or caring or monitor* or program* or help or support*)
#31#4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or
#23 or #24 or #25 or #26 or #27 or #28 or #29 or #30
#32#3 and #31
MEDLINE OVID
1. exp Heart Failure/
2. ((heart or cardiac or myocard*) adj2 (fail* or insufficien* or decomp*)).tw.
3. 1 or 2
4. exp Telemedicine/
5. exp Telecommunications/
6. Case Management/
7. exp Comprehensive Health Care/
8. Disease Management/
9. tele med*.tw.
10. telecare*.tw.
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11. telecardiol*.tw.
12. telemonitor*.tw.
13. teleconsult*.tw.
14. teleconferenc*.tw.
15. telecommunicat*.tw.
16. telephon*.tw.
17. telehealth*.tw.
18. telemetry.tw.
19. (remote* adj3 consult*).tw.
20. tele-med*.tw.
21. tele-consult*.tw.
22. tele-conferenc*.tw.
23. tele-health*.tw.
24. Home Care Services/
25. Home Care Services, Hospital-Based/
26. disease management.tw.
27. Nurse Clinicians/
28. Nurse Practitioners/
29. nurse led.tw.
30. Monitoring, Ambulatory/
31. telehome.tw.
32. tele-home.tw.
33. phone*.tw.
34. Clinical Protocols/
35. Patient Care Planning/
36. telefon*.tw.
37. telemed*.tw.
38. ehealth.tw.
39. mobile health.tw.
40. ((remote* or distan*) adj2 (care or caring or monitor* or program* or help or support*)).tw.
41. or/4-40
42. 3 and 41
43. randomized controlled trial.pt.
44. controlled clinical trial.pt.
45. randomized.ab.
46. placebo.ab.
47. drug therapy.fs.
48. randomly.ab.
49. trial.ab.
50. groups.ab.
51. 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50
52. exp animals/ not humans.sh.
53. 51 not 52
54. 42 and 53
55. (200811* or 200812* or 2009* or 2010* or 2011* or 2012* or 2013* or 2014* or 2015*).ed.
56. 54 and 55
EMBASE OVID
1. exp heart failure/
2. ((heart or cardiac or myocard*) adj2 (fail* or insufficien* or decomp*)).tw.
3. 1 or 2
4. exp telemedicine/
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5. exp telecommunication/
6. case management/
7. disease management/
8. telemed*.tw.
9. telecare*.tw.
10. telecardiol*.tw.
11. telemonitor*.tw.
12. teleconsult*.tw.
13. teleconferenc*.tw.
14. telecommunicat*.tw.
15. telephon*.tw.
16. telehealth*.tw.
17. telemetry.tw.
18. (remote* adj3 consult*).tw.
19. tele-med*.tw.
20. tele-consult*.tw.
21. tele-conferenc*.tw.
22. tele-health*.tw.
23. home care/
24. home monitoring/
25. disease management.tw.
26. nurse practitioner/
27. nurse led.tw.
28. ambulatory monitoring/
29. telehome.tw.
30. tele-home.tw.
31. phone*.tw.
32. patient care planning/
33. telefon*.tw.
34. ehealth.tw.
35. mobile health.tw.
36. or/4-35
37. 3 and 36
38. random$.tw.
39. factorial$.tw.
40. crossover$.tw.
41. cross over$.tw.
42. cross-over$.tw.
43. placebo$.tw.
44. (doubl$ adj blind$).tw.
45. (singl$ adj blind$).tw.
46. assign$.tw.
47. allocat$.tw.
48. volunteer$.tw.
49. crossover procedure/
50. double blind procedure/
51. randomized controlled trial/
52. single blind procedure/
53. 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52
54. (animal/ or nonhuman/) not human/
55. 53 not 54
56. 37 and 55
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57. (“200845” or “200846” or “200847” or “200848” or “200849” or “200850” or “200851” or “200852” or 2009* or 2010* or
2011* or 2012* or 2013* or 2014* or 2015*).em.
58. (2008112* or 2008113* or 200812* or 2009* or 2010* or 2011* or 2012* or 2013* or 2014* or 2015*).dd.
59. 57 or 58
60. 56 and 59
Web of Science
#12 #11 (Timespan=2008-2015)
#11 #10 AND #9
#10 TS=(random* or blind* or allocat* or assign* or trial* or placebo* or crossover* or cross-over*)
#9 #8 AND #1
#8 #7 OR #6 OR #5 OR #4 OR #3 OR #2
#7 TS=(“case management”)
#6 TS=(“home care”)
#5 TS=(“disease management”)
#4 TS=((nurse same led) or (nurse same practitioner*) or (nurse same clinician*))
#3 TS=(remote* same consult*)
#2 TS=(tele* or phone*)
#1 TS=((heart or cardiac or myocard*) near/2 (fail* or insufficien* or decomp*))
CINAHL
S36 S34 AND S35
S35 EM 20081110-20150112
S34 S27 AND S33
S33 S28 OR S29 OR S30 OR S31 OR S32
S32 electronic* N6 communicat*
S31 remote N6 consult*
S30 (tele) N6 (communicat* or med* or car* or monitor* or consult* or conferenc* or health or metr* or nurs*)
S29 telecommunicat* or telemed* or telecar* or telemonitor* or teleconsult* or teleconferenc* or telehealth* or telephon* or telemetr*
or phon*
S28 (MH “Telecommunications”) OR (MH “Interactive Voice Response Systems”) OR (MH “Telecommuting”) OR (MH “Telecon-
ferencing”) OR (MH “Telefacsimile”) OR (MH “Telehealth+”) OR (MH “Telephone”) OR (MH “Wireless Communications”)
S27 S3 AND S26
S26 S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19
OR S20 OR S21 OR S22 OR S23 OR S24 OR S25
S25 (MH “Patient Discharge+”)
S24 discharge N6 plan*
S23 multidisciplin*
S22 (MH “Nurses”) OR (MH “Advanced Practice Nurses+”) OR (MH “Case Managers”)
S21 nurs*
S20 (MH “Community Health Nursing”) OR (MH “Home Nursing, Professional”) OR (MH “Rehabilitation Nursing”) OR (MH
“Rural Health Nursing”)
S19 (MH “Rehabilitation”) OR (MH “Rehabilitation, Cardiac+”) OR (MH “Rehabilitation, Community-Based”)
S18 homecare or rehabilitat*
S17 disease N6 management
S16 secondary N6 prevent*
S15 home N6 intervention*
S14 (MH “Self Care”) OR (MH “Self Administration”) OR (MH “Self Medication”)
S13 (MH “After Care”) OR (MH “Cardiovascular Care”) OR (MH “Home Nursing”) OR (MH “Nursing Care”)
S12 (MH “Patient Care”)
S11 (MH “Home Health Care+”)
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S10 (MH “Medical Practice”) OR (MH “Nursing Practice+”) OR (MH “Occupational Therapy Practice”) OR (MH “Prescribing
Patterns”) OR (MH “Prescriptive Authority”) OR (MH “Professional Practice, Theory-Based+”)
S9 (MH “Health Maintenance Organizations”)
S8 (MH “Managed Care Programs+”)
S7 manag* N6 care
S6 (MH “Patient Care+”)
S5 patient* N6 care
S4 home N6 care
S3 S1 OR S2
S2 (heart or cardiac or myocard*) N2 (fail* or insufficien* or decomp*)
S1 (MH “Heart Failure+”)
AMED
1 exp Heart Failure Congestive/
2 heart failure.tw.
3 cardiac failure.tw.
4 or/1-3
5 exp Telecommunications/
6 exp Comprehensive Health Care/
7 disease management/
8 telemed$.tw.
9 telecare$.tw.
10 telecardiol$.tw.
11 telemonitor$.tw.
12 teleconsult$.tw.
13 teleconferenc$.tw.
14 telecommunicat$.tw.
15 telephon$.tw.
16 telehealth$.tw.
17 telemetry.tw.
18 (remote$ adj3 consult$).tw.
19 tele-med$.tw.
20 tele-consult$.tw.
21 tele-conferenc$.tw.
22 tele-health$.tw.
23 Home Care Services/
24 disease management.tw.
25 nurse led.tw.
26 telehome.tw.
27 tele-home.tw.
28 phone$.tw.
29 Clinical Protocols/
30 exp patient care management/
31 nurses/
32 Rural health services/
33 community health nursing/
34 or/5-33
35 4 and 34
36 (2008$ or 2009$ or 2010$ or 2011$ or 2012$ or 2013$ or 2014$).up.
37 35 and 36
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Appendix 2. Search strategies (2010 review)
Cochrane Central Register of Controlled Trials (CENTRAL), Database of Abstracts of Reviews of Effects
(DARE) and Health Technology Assessment Database (HTA) on The Cochrane Library
#1 MeSH descriptor Heart Failure explode all trees
#2 heart next failure in All Text
#3 cardiac next failure in All Text
#4 (#1 or #2 or #3)
#5 MeSH descriptor telemedicine explode all trees
#6 MeSH descriptor telecommunications explode all trees
#7 MeSH descriptor case management this term only
#8 MeSH descriptor comprehensive health care explode all trees
#9 MeSH descriptor disease management this term only
#10 MeSH descriptor home care services this term only
#11 MeSH descriptor Home Care Services, Hospital-Based this term only
#12 MeSH descriptor Nurse Clinicians this term only
#13 MeSH descriptor nurse practitioners this term only
#14 MeSH descriptor monitoring, ambulatory this term only
#15 MeSH descriptor clinical protocols this term only
#16 MeSH descriptor patient care planning this term only
#17 tele* in All Text
#18 (remote in All Text near/3 consult* in All Text)
#19 disease next management in All Text
#20 nurse next led in All Text
#21 phone* in All Text
#22 (manage* in All Text near/3 program* in All Text)
#23 (nurse* in All Text near/3 manage* in All Text)
#24 case next management in All Text
#25 (home in All Text near/3 service* in All Text) 7
#26 nurse next practitioner* in All Text
#27 nurse next clinician* in All Text
#28 care next plan* in All Text
#29 (#5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13)
#30 (#14 or #15 or #16 or #17 or #18 or #19 or #20 or #21)
#31 (#22 or #23 or #24 or #25 or #26 or #27 or #28)
#32 (#29 or #30 or #31)
#33 (#4 and #32)
Medline and Medline In Process on Ovid
1 exp Heart Failure/
2 heart failure.tw.
3 cardiac failure.tw.
4 or/1-3
5 exp Telemedicine/
6 exp Telecommunications/
7 Case Management/
8 exp Comprehensive Health Care/
9 disease management/
10 tele med$.tw.
11 telecare$.tw.
12 telecardiol$.tw.
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13 telemonitor$.tw.
14 teleconsult$.tw.
15 teleconferenc$.tw.
16 telecommunicat$.tw.
17 telephon$.tw.
18 telehealth$.tw.
19 telemetry.tw.
20 (remote$ adj3 consult$).tw.
21 tele-med$.tw.
22 tele-consult$.tw.
23 tele-conferenc$.tw.
24 tele-health$.tw.
25 Home Care Services/
26 Home Care Services, Hospital-Based/
27 disease management.tw.
28 Nurse Clinicians/
29 Nurse Practitioners/
30 nurse led.tw.
31 Monitoring, Ambulatory/
32 telehome.tw.
33 tele-home.tw.
34 phone$.tw.
35 Clinical Protocols/
36 Patient Care Planning/
37 or/5-36
38 37 and 4
39 randomized controlled trial.pt.
40 controlled clinical trial.pt.
41 Randomized controlled trials/
42 random allocation/
43 double blind method/
44 single-blind method/
45 or/39-44
46 exp animal/ not humans/
47 45 not 46
48 clinical trial.pt.
49 exp Clinical Trials as Topic/
50 (clin$ adj25 trial$).ti,ab.
51 ((singl$ or doubl$ or trebl$ or tripl$) adj (blind$ or mask$)).ti,ab.
52 placebos/
53 placebo$.ti,ab.
54 random$.ti,ab.
55 research design/
56 or/48-55
57 56 not 46
58 57 or 47
59 38 and 58
60 (2006$ or 2007$ or 2008$).ed.
61 59 and 60
EMBASE (Ovid)
1 exp Heart Failure/
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2 heart failure.tw.
3 cardiac failure.tw.
4 or/1-3
5 exp Telemedicine/
6 exp Telecommunications/
7 Case Management/
8 disease management/
9 telemed$.tw.
10 telecare$.tw.
11 telecardiol$.tw.
12 telemonitor$.tw.
13 teleconsult$.tw.
14 teleconferenc$.tw.
15 telecommunicat$.tw.
16 telephon$.tw.
17 telehealth$.tw.
18 telemetry.tw.
19 (remote$ adj3 consult$).tw.
20 tele-med$.tw.
21 tele-consult$.tw.
22 tele-conferenc$.tw.
23 tele-health$.tw.
24 Home Care/
25 Home Monitoring/
26 disease management.tw.
27 Nurse Practitioners/
28 nurse led.tw.
29 Ambulatory Monitoring/
30 telehome.tw.
31 tele-home.tw.
32 phone$.tw.
33 Patient Care Planning/
34 or/5-33
35 4 and 34
36 controlled clinical trial/
37 random$.tw.
38 randomized controlled trial/
39 follow-up.tw.
40 double blind procedure/
41 placebo$.tw.
42 placebo/
43 factorial$.ti,ab.
44 (crossover$ or cross-over$).ti,ab.
45 (double$ adj blind$).ti,ab.
46 (singl$ adj blind$).ti,ab.
47 assign$.ti,ab.
48 allocat$.ti,ab.
49 volunteer$.ti,ab.
50 Crossover Procedure/
51 Single Blind Procedure/
52 or/36-51
53 52 and 35
54 (2006$ or 2007$ or 2008$).em.
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55 53 and 54
CINHAL (Ovid)
1 cardiac output, decreased/ or heart failure, congestive/ or dyspnea, paroxysmal/ or ventricular dysfunction/ or ventricular dysfunction,
left/ or ventricular dysfunction, right/
2 (heart adj failure).tw.
3 (cardiac adj failure).tw.
4 1 or 3 or 2
5 (home adj care).tw.
6 (patient adj care).tw.
7 patient care/ or case management/ or “continuity of patient care”/ or discharge planning/ or disease management/ or multidisciplinary
care team/ or nursing care/ or nursing care delivery systems/ or differentiated nursing practice/ or functional nursing/ or modular
nursing/ or primary nursing/ or progressive patient care/ or team nursing/ or total patient care nursing/ or nursing care studies/ or
nursing intensity/ or nursing process/ or nursing assessment/ or nursing care plans/ or nursing diagnosis/ or nursing interventions/ or
nursing outcomes/ or nursing protocols/ or nursing care plans, computerized/ or nursing skills/ or patient care conferences/ or clinical
conferences/ or patient-family conferences/ or primary health care/ or “quality of health care”/ or accountability/ or guideline adherence/
or “outcomes (health care)”/ or medical futility/ or outcome assessment/ or “outcomes of prematurity”/ or treatment outcomes/ or fatal
outcome/ or treatment failure/ or practice guidelines/
8 (manag* adj care).tw.
9 managed care programs/ or health maintenance organizations/ or independent practice associations/ or preferred provider organiza-
tions/ or provider-sponsored organizations/
10 health maintenance organizations/ or medical practice/ or nursing practice/ or advanced nursing practice/ or nursing practice,
evidence-based/ or nursing practice, research-based/ or nursing practice, theory-based/ or “scope of nursing practice”/ or occupational
therapy practice/ or prescribing patterns/ or prescriptive authority/ or professional practice, evidence-based/ or medical practice,
evidence-based/ or exp nursing practice, evidence-based/ or occupational therapy practice, evidence-based/ or physical therapy practice,
evidence-based/ or exp professional practice, research-based/ or exp professional practice, theory-based/
11 (home adj care).tw.
12 home health care/ or home apnea monitoring/ or home intravenous therapy/ or home nursing, professional/
13 home care.mp. [mp=title, subject heading word, abstract, instrumentation]
14 patient care/ or after care/ or cardiovascular care/ or home nursing/ or nursing care/ or self care/ or self administration/ or self
medication/
15 (home adj intervention*).tw.
16 (secondary adj prevent*).tw.
17 (disease adj management).tw.
18 homecare.tw.
19 rehabilitat*.tw.
20 rehabilitation/ or rehabilitation, cardiac/ or conditioning, cardiopulmonary/ or rehabilitation, community-based/
21 community health nursing/ or home nursing, professional/ or rehabilitation nursing/ or rural health nursing/
22 nurs*.tw.
23 nurses/ or advanced practice nurses/ or clinical nurse specialists/ or nurse practitioners/ or case managers/
24 multidisciplin*.tw.
25 (discharge adj plan*).tw.
26 patient discharge/ or discharge planning/ or early patient discharge/ or patient discharge education/ or transfer, discharge/
27 or/5-26
28 27 and 4
29 telecommunications/ or interactive voice response systems/ or telecommuting/ or teleconferencing/ or telefacsimile/ or telehealth/
or telemedicine/ or remote consultation/ or telepathology/ or teleradiology/ or telenursing/ or telepsychiatry/ or telephone/ or wireless
communications/
30 telecommunicat*.tw.
31 (tele adj communicat*).tw.
32 telemed*.tw.
33 (tele adj med*).tw.
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34 telecar*.tw.
35 (tele adj car*).tw.
36 telemonitor*.tw.
37 (tele adj monitor*).tw.
38 teleconsult*.tw.
39 (tele adj consult*).tw.
40 teleconferenc*.tw.
41 (tele adj conferenc*).tw.
42 telehealth*.tw.
43 (tele adj health*).tw.
44 telephon*.tw.
45 telemetr*.tw.
46 (tele adj metr*).tw.
47 (remote adj consult*).tw.
48 phon*.tw.
49 (electronic* adj communicat*).tw.
50 (tele adj nurs*).tw.
51 telehealth/ or telemedicine/ or remote consultation/ or telenursing/
52 or/29-51
53 52 and 28
54 Experimental Studies/
55 exp Clinical trials/
56 ((control* or clinic* or prospectiv*) adj5 (trial* or study or studies)).tw.
57 ((allocat* or assign* or divid*) adj5 (condition* or experiment* or treatment* or control* or group*)).tw.
58 ((singl* or doubl*) adj (blind* or mask*)).tw.
59 cross?over*.tw.
60 placebo*.tw.
61 exp Clinical research/
62 Comparative studies/
63 exp Evaluation research/
64 exp “control (research)”/
65 Random assignment/
66 exp Prospective studies/
67 exp Evaluation research/
68 random*.tw.
69 RCT.tw.
70 (compar* adj5 (trial* or study* or studies)).tw.
71 or/54-70
72 53 and 71
77 limit 72 to yr=“2006 - 2008”
AMED (Allied and Complementary Medicine)
1 exp Heart Failure Congestive/
2 heart failure.tw.
3 cardiac failure.tw.
4 or/1-3
5 exp Telecommunications/
6 exp Comprehensive Health Care/
7 disease management/
8 telemed$.tw.
9 telecare$.tw.
10 telecardiol$.tw.
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11 telemonitor$.tw.
12 teleconsult$.tw.
13 teleconferenc$.tw.
14 telecommunicat$.tw.
15 telephon$.tw.
16 telehealth$.tw.
17 telemetry.tw.
18 (remote$ adj3 consult$).tw.
19 tele-med$.tw.
20 tele-consult$.tw.
21 tele-conferenc$.tw.
22 tele-health$.tw.
23 Home Care Services/
24 disease management.tw.
25 nurse led.tw.
26 telehome.tw.
27 tele-home.tw.
28 phone$.tw.
29 Clinical Protocols/
30 exp patient care management/
31 nurses/
32 “Rural health services”/
33 community health nursing/
34 or/5-33
35 4 and 34
36 (2006$ or 2007$ or 2008$).up.
37 35 and 36
Science Citations Index and Conference Citations Index on ISI Web of Knowledge
# 11 #9 and #10
Databases=SCI-EXPANDED, CPCI-S Timespan=2006-2008
# 10 ts=(random* or (clinical same trial) or rct or groups or (clinical same study)) and ts=(“heart failure” or “cardiac failure”)
# 9 #1 and #8
# 8 #2 or #3 or #4 or #5 or #6 or #7
# 7 ts=(“case management”)
# 6 ts=(“home care”)
# 5 ts=(“disease management”)
# 4 ts=((nurse same led) or (nurse same practitioner*) or (nurse same clinician*))
# 3 ts=(remote* same consult*)
# 2 ts=(tele* or phone* )
# 1 ts=(“heart failure” or “cardiac failure”)
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WH A T ’ S N E W
Last assessed as up-to-date: 12 January 2015.
Date Event Description
20 July 2015 New citation required and conclusions have changed We added 17 new studies of non-invasive telemonitoring or
structured telephone support in this updated review
6 July 2015 New search has been performed We have not included studies only available as conference ab-
stracts or theses and not a full-text peer-reviewed publication
in the review
We excluded studies if there was any documented previous
exposure to telemonitoring or structured telephone support
for the usual care or intervention arms prior to the start of
the study
We focused our searches on key databases and search engines.
We have added several new subgroup analyses, as well as a
meta-regression examining subgroups
We exclude Kielblock 2007 (included in 2010) from this
version of the review
Mortarra 2009 structured telephone support study arm re-
vised to Strategy 2 (was Strategy 1 in 2010 review). Telemon-
itoring arm revised to Strategy 3 (was Strategy 2 and 3 in
2010 review)
We reclassified Capomolla 2004 as structured telephone sup-
port in this update
H I S T O R Y
Protocol first published: Issue 3, 2008
Review first published: Issue 8, 2010
Date Event Description
6 May 2011 Amended Minor additions and corrections toQuality of life, Cost, Adherence, adaptation, satisfaction and other
outcomes section, including Table 1. Additional references for included studies added to ’References
to studies’ and study flowchart updated. Relabelled ’Parati 2007’ as ’Villani 2007’
17 January 2011 Amended As per correspondence with the author: The sensitivity anaylsis 1.3 has been corrected as the results
for intervention and usual care were interchanged. Text has been updated and Analysis 1.3 renamed
as correction
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Changes from protocol to the 2010 version of review:
Since our protocol was published we decided to limit the studies included to randomised controlled trials only. We also decided to
limit the inclusion of data in our meta-analysis to studies for which a full-text peer-reviewed publication was available. We also decided
that the planned sensitivity analysis was no longer appropriate due to considerable advances in diagnosis and knowledge of chronic
heart failure, and we performed sensitivity analyses examining the type of publication and length of intervention. We also included
all-cause hospitalisation and heart failure-related hospitalisations as primary outcomes, as it became evident that hospitalisations were
an important measure of the effectiveness of these interventions, especially as over time survival from heart failure improves, but
hospitalisations become frequent and costly. We also added adherence as a secondary outcome, as this was frequently reported in the
individual studies and we realised it was important to consider whether or not participants were adhering to the intervention.
Changes from protocol and 2010 version of review to current version of review:
We have not included studies only available as conference abstracts or theses and not as a full-text peer-reviewed publication. This
decision was based on research indicating inconsistency between trial findings presented as conference abstracts to those reported in a
full, peer-reviewed publication (Toma 2006). Another factor which was important in the decision to exclude studies only available as
a conference abstract was the lack of detail provided regarding the intervention and usual care, thereby not providing confidence as to
the classification of the study in terms of inclusion/exclusion in the review. Authors of studies available only as a conference abstract
or study protocol were contacted in order to identify a full peer-reviewed publication for the study. A response was not received from
several studies which are classified as ongoing or awaiting classification despite multiple attempts to contact authors.
We excluded studies if there was any documented previous exposure to telemonitoring or structured telephone support for the usual
care or intervention arms prior to the start of the study.
Searches have focused on key databases and search engines, in particular, we excluded searching of trial registries as we were interested
in studies published as full peer-reviewed publication only. We also excluded searching search engines such as Google Scholar as we
found the enormous volume of hits which these types of search engines identify was unhelpful.
We have added several new subgroup analyses, as well as a meta-regression examining subgroups.
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We have excluded Kielblock 2007 (included in 2010) from this version of the review.
Mortara 2009 (Struct Tele) (HHH) study arm revised to Strategy 2 (was Strategy 1 in 2010 review). Mortara 2009 (Telemon) (HHH)
arm revised to Strategy 3 (was Strategy 2 and 3 in 2010 review).
We reclassified Capomolla 2004 as structured telephone support.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Telephone; ChronicDisease;Heart Failure [mortality; ∗therapy];Hospitalization [statistics&numerical data]; Length of Stay [statistics
& numerical data]; Quality of Life; Randomized Controlled Trials as Topic; Telemetry [∗methods]
MeSH check words
Aged; Humans
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